Abstract
Phthalides are a relatively small group of natural compounds confined to several plant families and some genera of fungi and liverworts. They are divided into two structural groups, the monomeric and dimeric phthalides, and known mainly as bioactive constituents of different plant species used traditionally for medicinal purposes in Asia, Europe, and North America.
The first reports on the chemistry of phthalides appeared at the end of the nineteenth century, in which they were identified as the odor constituents of the essential oil of celery (Apium graveolens) by Ciamician and Silber (1897). In the first half of the last century, phthalides were isolated from Cnidium officinale and Ligusticum acutilobum, species widely used in Asian traditional medicine, and from Levisticum officinale, a species used as food and condiment. Throughout the second part of the twentieth century, phthalides have been characterized from several plant families, namely Asteraceae, Leguminosae, Orchidaceae and Rutaceae, among others, but mainly from the Umbelliferae (syn Apiaceae) family, and the major contributors have been the following species used in traditional medicine: Ligusticum chuanxiong (Chinese name: Chuanxiong), Angelica sinensis (Chinese name: Danggui), Cnidium officinale (Japanese name: Senkyu), Angelica acutiloba (Japanese name: Toki), and Ligusticum porteri (Hispanic name: Oshá). Phthalides are also constituents of several genera of fungi, such as Penicillium, Alternaria and Pestalotiopsis, and some liverworts.
Different chromatographic, spectrometric, and two-dimensional nuclear magnetic resonance (NMR) techniques have been used for the isolation and structural characterization of phthalides in extracts, and for assessing the quality of plant material containing this type of compound. Isotopic labeling has established the biosynthesis of phthalides via linkage of acetate units forming polyketide intermediates.
Chemical transformations of monomeric phthalides have included oxidation, reduction, addition, elimination, and cycloaddition reactions, and treatments with Lewis acids of (Z)-ligustilide have afforded linear dimers. Some intramolecular condensations and differentiated cyclizations of the dimeric phthalides have been carried out, providing evidences for the particular chemical reactivity of these compounds.
Several structural modifications of phthalides have been carried out subjecting them to microbial transformations by different species of bacteria, fungi and algae, and these included resolutions of racemic mixtures and oxidations, among others.
The [π4s + π2s] and [π2s + π2s] cycloadditions of (Z)-ligustilide for the synthesis of dimeric phthalides have been reported, and different approaches involving cyclizations, Alder–Rickert reactions, Sharpless asymmetric hydroxylations, or Grignard additions have been used for the synthesis of monomeric phthalides. The use of phthalides as building blocks for divergent oriented synthesis has been proven.
Many of the naturally occurring phthalides display different biological activities including antibacterial, antifungal, insecticidal, cytotoxic, and anti-inflammatory effects, among many others, with a considerable recent research on the topic. In the case of compounds isolated from the Apiaceae, the bioactivities correlate with the traditional medicinal uses of the natural sources. Some monomeric phthalides have shown their ability to attenuate certain neurological diseases, including stroke, Alzheimer’s and Parkinson’s diseases.
The present contribution covers the distribution of phthalides in nature and the findings in the structural diversity, chemical reactivity, biotransformations, syntheses, and bioactivity of natural and semisynthetic phthalides.
Access provided by CONRICYT-eBooks. Download chapter PDF
Similar content being viewed by others
Keywords
1 Introduction
Phthalides are a relatively small group of natural compounds found in several higher and lower plant and fungal genera. Classifiable by structure, the monomeric and dimeric phthalides are known principally as the bioactive constituents in several plants used in traditional medicine in Asia, Europe, and North America. Phthalides are also isolated from several species of fungi.
Although the ancient historical record is fragmentary, there is evidence of the exchange of medicinal herbs between Asia and Europe along the Silk Road trading routes established by Alexander the Great (356–326 bc), and several old Chinese texts mention medicinal plants that contain phthalides that were included in these routes. In northern Mexico and the southern United States, the medicinal use of the phthalide-containing rootstock of Ligusticum porteri has been recorded since the eighteenth century. Relatively few reviews have addressed the phthalides [1–3]. This contribution aims to provide a broad treatment of the topic, with an overview of phthalide chemical structures, natural sources, research methodologies, selected chemical syntheses and reactions, and the main reported bioactivities of phthalides.
1.1 Traditional Uses of Plants that Contain Phthalides
Compiled in ca. 200 ad from ancient oral traditions (ca. 2800 bc), the “Shen Nong Bencaojing” is one of the oldest Chinese texts on agriculture and plants used traditionally to include a description of the use of “Danggui” (Angelica sinensis (Oliv.) Diels roots, family Umbelliferae, a plant that contains phthalides) “for enriching the blood” [4]. This plant is included in the Pharmacopoeia of the People’s Republic of China, together with other two phthalide-containing plants, Ligusticum sinense Oliv. (“Rhizoma Ligustici”, “Chinese Lovage”, “Gaoben”, used to relieve pain) and Ligusticum chuanxiong S.H. Qiu, Y.Q. Zeng, K.Y. Pan, Y.C. Tang & J.M. Xu (“Rhizoma Chuanxiong” or “Szechwan Lovage Rhizome”, used to promote the flow of blood) [5]. The traditional uses, as well as the chemical constituents and bioactivities of the latter species have been reviewed [6, 7], including bioactivities with other plants [8].
A tea prepared with the rootstock of the North American phthalide-containing species, Ligusticum porteri J.M. Coult. & Rose, is commonly used to alleviate stomachache and colic [9], ulcers and diarrhea as well as to treat diabetes and circulatory problems [10, 11]. Infusions of this plant also play a role in the ritual-curing ceremonies in northern Mexico and the southern United States, for which this medicinal plant is highly regarded, mainly by the native Raramuri ethnic group [12]. Some illustrations of this plant material in different stages are shown in Fig. 1.
Not confined in the human sphere of activity, Kodiak bears have been reported to chew the roots of this plant, and to rub the root-saliva mixture into their fur [13].
1.2 Early Chemical Studies (1897–1977) of Phthalides in the Family Umbelliferae
Several of the first reports on the chemistry of phthalides appeared at the end of the nineteenth century, where they were identified as the odor constituents of celery (Apium graveolens L.) by the Italian researchers Ciamician and Silber in 1897. The provision of essential oil from celery seed (by the Schimmel Company, Leipzig, Germany) allowed Ciamician and Silber (working in Bologna, Italy) to isolate what they called sedanolide and sedanonic anhydride [14]; “sedane” is the Italian translation of celery. These substances could be structurally characterized as a result of their transformation to sedanonic acid [15], for which structure 1 was proposed and later, following the analyses of derivatives [16] and intermediates [16, 17], proven to be correct. The published account on these experiments [18] was, according to Barton, “one of the early classics of natural products chemistry” [19]. A decade later, in 1910, Swenholt obtained the volatile fraction from celery seeds provided by the John A. Salzer Seed Company (La Crosse, Wisconsin, USA). This fraction was saponified and from the organic residue sedanonic acid (1) was characterized [20]. Fourteen years later, Berlingozzi established that the odorant properties of celery correlated with the nature of the side chain of phthalides [21–25], a finding subsequently confirmed by other authors [26, 27].
In 1921, Murayama, when leading a chemical investigation of the highly regarded Japanese drug “Sen-Kyu”, isolated “cnidium lactone”, a compound that had been named previously by Sakai in 1916. This compound was also obtained from the roots of Cnidium officinale Makino, which has a long history in traditional Asian medicine, and is named “Hsiung-Ch’uang” in mainland China [28]. Following re-isolation from a second population of the same species [26], it was concluded that “cnidium lactone” was similar in structure to sedanolide, isolated by Ciamician and Silber. However, the instability and the practical difficulties of isolating phthalides hampered any further characterization or identification of these substances.
In 1934, Noguchi reisolated “cnidium lactone” and noting its close structural relationship with sedanolide, proposed that stereoisomeric characteristics may underlie any structural differences [27].
From the saponified extract of the fruits of another species in the Umbelliferae, Ligusticum acutilobum Siebold & Zucc., Kariyone and Kotani [29], isolated an acid, which could be transformed to a lactone; and these two compounds were later characterized as valerophenone o-benzoic acid (2) and (Z)-butylidenephthalide (3) [30, 31]. Although the structures of sedanolide and “cnidium lactone” remained unclear [32], a study of the essential oil of lovage by Naves [33], resulted in the characterization of (Z)-butylidenephthalide (3), butylphthalide (4) and what Ciamician and Silber had named sedanonic anhydride (sedanonic acid lactone), which was found to be (Z)-6,7-dihydro-ligustilide (5). Compound 2 was obtained as a saponification product of the essential oil of the crude drug named “Toki” (Angelica acutiloba (Siebold & Zucc.) Kitag.) [34].
Barton and de Vries [19] then determined the chemical formulas of sedanolide 6 (by NaBH4-mediated reduction of sedanonic acid (1)), and cnidium lactone (7, cnidilide), although without assigning the configurations of the chiral carbons.
(Z)-Ligustilide (8) was characterized from the roots of Ligusticum acutilobum (common name in Japanese: “Hokkai-Toki”) and from Cnidium officinale by Mitsuhashi and Nagai [35]. The 6,7-dihydro derivative 5 was found to generate sedanonic acid (1) following its saponification. The structures of neocnidilide (6) and cnidilide (7), determined following extraction from the roots of C. officinale, indicated that sedanolide (represented by formula 6, leaving aside the configurational assignments), actually comprised a mixture of neocnidilide (6) and butylphthalide (4) [36]. The configurations at C-3, C-3a, and C-7a for cnidilide (cnidium lactone) and at C-3 of isocnidilide (trans-sedanolide) were determined as shown in formulas 7 and 9, respectively, by using chiroptical methods [37, 38]. The synthesis of butyltetra- and hexahydrophthalides was used to establish the identity of neocnidilide and trans-sedanenolide with the configurational assignments showed in formula 6, and also confirmed structures 7 and 9 for cnidilide and isocnidilide, respectively [39].
At the same time, phthalides 3, 4, and 8 were characterized from Meum athamanticum Jacq. [40] and some experimental improvements for the separation and characterization of phthalides were reported [41].
Phthalides 10–13 were isolated from celery, indicating that they are responsible for its characteristic odor [42], since these substances were structurally similar to those reported by Berlingozzi and associates more than three decades earlier [21–25]. Butylphthalide (4), sedanolide (6), 3-n-butylhexahydrophthalide (14) [43], as well as senkyunolide A (formerly named sedanenolide) (15) were also isolated from celery [44].
3-Butylphthalide (4) and cnidilide (7) were characterized from the essential oil of the Chinese medicinal plant “Gaoben” (Ligusticum sinense) [45]. Reinvestigation of Cnidium officinale subsequently allowed the characterization of compounds 3–5, 8 and 15 (permitting the (3S)-configuration for 15 to be defined), and a mass spectrometric fragmentation pattern for these compounds was proposed [46].
A 1979 review of the phthalides in the family Umbelliferae included their chemotaxonomic aspects, biosynthesis, and stereochemical assignments [47]. It is interesting to note that, at that time, no dimeric phthalides had yet been isolated.
2 Distribution of Phthalides in Nature
2.1 Phthalides in the Umbelliferae (syn. Apiaceae)
A number of studies on phthalides from Umbelliferae family members have been conducted to verify the presence of phthalides, with investigations on the volatile odor constituents of celery (Apium graveolens). These studies permitted the characterization of compounds 3, 4, 8, and 10 [48], and 3, 6, 8, and 16 [49]. Additionally, the monomeric phthalides 3, 4, 6, 7, 8, and 15 were identified from Cnidium officinale [50].
The first dimeric phthalide reported in the literature was angeolide (17), which was isolated from Angelica glauca Edgew. (a species distributed in the Western Himalayas). The chemical structure of angeolide was confirmed to be a Diels–Alder adduct of (E)-ligustilide (18), which acts as diene and dienophile. Both (E)-17 and (Z)-ligustilide (8) were isolated and characterized from this plant species [51]. The direct nomenclature used to name the ligustilide dimers incorporates: (a) the numbers of the connected atoms (describing the adduct derived from the reaction diene + dienophile); (b) the stereochemical descriptors endo- and exo-, and (c) the name of the monomers. Therefore, angeolide (17) could be named as endo-[3.3′a,8.6′]-(E,E′)-diligustilide.
The monomeric phthalides 4, 6, 8, and 18 were identified from the roots of Cenolophium denudatum (Fisch. ex Hornem.) Tutin and Coriandrum sativum L. (coriander) [52]; compounds 3, 8, 15, 18, and 19–21 were found as constituents of the essential oil from the roots of Levisticum officinale W.D.J. Koch [53], and from the roots of Silaum silaus (L.) Schinz & Thell. and Anethum sowa Roxb. ex Fleming, 5, 6, 8, and 15 were characterized [54]. Neocnidilide (6), (Z)-ligustilide (8), and senkyunolide A (15) were present in Anethum graveolens L. (dill); phthalide 8 was characterized from Todaroa montana Webb ex Christ [55] and compounds 3, 4, 8, and 15 were identified from the roots of Opopanax chironium Koch.
From Ligusticum wallichii Franch. were isolated a trans-diol named (Z)-ligustidiol (22) [56] (later renamed as senkyunolide I, see below), and the Diels–Alder adduct of (Z)-ligustilide, termed (Z,Z′)-diligustilide (23) [57] (later renamed by Höfle as levistolide A, see below). This last compound could be named endo-[3a.7′,6.6′]-(Z,Z′)-diligustilide, following the nomenclature that indicates the connections between the monomers. The [π2s + π2s] dimer, [6.8′,7.3′]-(Z,Z′)-diligustilide 24, named riligustilide, was characterized from Ligusticum acutilobum [58].
Compounds 25 ((Z)-3-butylidene-7-hydroxy-phthalide, later renamed senkyunolide B), 26 (cis-6,7-dihydroxy-ligustilide, later renamed senkyunolide H), and 22 (senkyunolide I) were isolated from Ligusticum wallichii, together with a dimer named wallichilide 27 [59]. It is interesting to note that methyl ester 27 could be an artifact derived from the ring opening of diligustilide (levistolide A, 23) and esterification, given its isolation from a hot water extract, followed by HPLC purification using MeOH–H2O–HOAc.
A series of hydroxyphthalide derivatives were isolated from the rhizomes of Cnidium officinale by Mitsuhashi and associates; these were senkyunolides A (15), B (initially 25, but later corrected to 37, see below), C (28), D (29), E (30), F (31), G (32), H (26), I (22), and J (33). With the exception of senkyunolide J, all were optically inactive [60].
(Z)-Ligustilide (8) was found in the roots of Capnophyllum peregrinum Lange, while compounds 7, 8, and 15, were identified from the roots of Peucedanum ostruthium (L.) W.D.J. Koch [61]. (Z)-5-Hydroxy-butylidene-phthalide ((28) senkyunolide C) and the dihydroxyphthalide 34, were characterized from the rhizomes of Ligusticum wallichii [62].
(Z)- and (E)-Butylidenephthalides ((3) and (21)), butylphthalide (4), (Z)-ligustilide (8), senkyunolide A (15), angeolide (17), (Z,Z′)-diligustilide ((23), renamed by Höfle as levistolide A), and levistolide B (35), were all identified from the underground parts of Levisticum officinale (“Radix Levici”) [63]. This last compound could be also named endo-[3a.7′,6.6′]-(E,Z′)-diligustilide.
The [π2s + π2s]-cyclodimer derived from ligustilide, termed angelicolide (36), was found as an additional constituent from Angelica glauca, and its structure was confirmed by X-ray analysis as a derivative of (E)-ligustilide (18) [64].
Three phthalide derivatives, 15, 22, and 23, were isolated from the rhizomes of Meum athamanticum [65]. Additional compounds including senkyunolides I (22), H (26), C (28), E (30), and F (31) were also identified. The structure of senkyunolide B was corrected from 7-hydroxy- (25) to 4-hydroxy-butylidenephthalide (37) by comparison of spectroscopic properties, which was possible by their occurrence in this natural source [66].
From the roots of Apium graveolens were identified phthalides 4, 6, 7, 8, and 15, and from A. graveolens var. rapaceum (Mill.) DC., compounds 3, 4, 6, 8, 15, and 18 were characterized. Petroselinum crispum (Mill.) Fuss. var. tuberosum (Bernh. ex Richb.) Soó (parsley) was used to isolate 8 and 15, while from Bifora testiculata (L.) Roth, compounds 6, 8, and 15 were found [67]. A study of Angelicae Radix (“Chinese Tang-kuei”) allowed the characterization of (Z)-butylidenephthalide (3), butylphthalide (4), and (Z)-ligustilide (8) [68].
Diligustilide (levistolide A (23)), riligustilide (24), (Z)-6,7-epoxy-ligustilide (38), and an additional dimer, 3,8-dihydro-[6.6′,7.3a′]-(Z′)-diligustilide (39), were all identified from the rhizomes of Ligusticum wallichii [69]. The structure of this last dimer was corrected to structure 40 [70], which was then reisolated from Ligusticum chuanxiong and later renamed senkyunolide P [71].
The known senkyunolides I (22), H (26), E (30), F (31), as well as levistolide A (23), were found as constituents of Angelica acutiloba, along with 11-angeloyl-senkyunolide F (41), tokinolide A (42), and tokinolide B (43) [72]. A series of known monomeric phthalides, together with senkyunolides K (44), L (45), and M (46), was characterized from Ligusticum wallichii [73]. (Z)-Ligustilide (8), (Z,Z′)-diligustilide ((23) levistolide A) and riligustilide (24) were found as constituents of Ligusticum porteri [70], and senkyunolides O (47) and P (40) were identified from Ligusticum chuanxiong [71]. The 1H and 13C NMR spectroscopic data of some monomeric phthalides have been reported in the literature [74].
(Z)-Ligustilide (8) has been proposed as a benchmarking constituent for preparations of Ligusticum officinale [75], and its relative abundance in the essential oil of this species has been studied [76]. Both (Z)-butylidenephthalide (3), and (Z)-ligustilide (8) have been found in Pituranthos tortuosus (Desf.) Benth. & Hook. f. ex Asch. & Schweinf. [77], and these compounds together with (E)-ligustilide and monoterpenes were found as constituents of the rootstock of Ligusticum porteri [78].
The volatile aroma constituents of celery and related species have been the subject of several investigations [79, 80], and despite a wide variation in the chemical constituents reported [81, 82], these studies confirmed early observations that monomeric phthalides were responsible for the characteristic aroma of celery. Volatile components isolated from celery plants grown with different fertilizers have also been analyzed [83]. Compound NG-072 (48), purported as being useful for the treatment of Alzheimer’s disease, was characterized from celery, although without assigning the configuration of the chiral centers [84]. Phthalides 3, 4, 6, 9, 15, and 21, as well as the unstable compound 49, were characterized from parsley (Petroselinum crispum) [85]. The Diels–Alder adduct 50, derived from (Z)-ligustilide (8) (diene) and (E)-ligustilide (18) (dienophile), were isolated from Angelica sinensis and named E-232 [86]. An additional series of phthalides was isolated from Ligusticum chuanxiong, including (E)-senkyunolide E (51), senkyunolide N (52), and senkyunolide J (33) [44]. The absolute configurations of these last two compounds were established as depicted in their structural formulas [87]. From this source were isolated senkyunolide Q (53) and methyl 2-(1-oxo-pentyl)-benzoate (54) [88], which is the methyl ester of compound 2 characterized by Noguchi in earlier investigations of Ligusticum species [30, 31].
The preparation of derivatives of the monomeric and dimeric phthalides has been limited to structural studies. The reactivity of (Z)-ligustilide (8) acting as a biological electrophile, has been explored by Beck and Stermitz [89], and their interesting results obtained are described in Sect. 5.1.4.
(Z)-Ligustilide (8) was characterized from Ligusticum mutellina (L.) Crantz [90] and Angelica sinensis [91] and the monomeric phthalides 3, 8, 21, and 22 were found in Angelica glauca roots [92]. Both senkyunolide R (55) and senkyunolide S (56) were characterized as constituents of Ligusticum chuanxiong [93].
The separation of 3-butylphthalide enantiomers ((S)-enantiomer: structure 4) and their odor thresholds have now been established [94]. Enantioselective analyses of the flavor-imparting compounds (3-butylphthalide derivatives) in celery, celeriac, and fennel have also been investigated [95] with seasonal variations in the composition of volatile components (including phthalides) from different parts of the lovage plant reported [96]; compound 8 was found in the essential oils of Lomatium torreyi J.M. Coult. & Rose [97], Meum athamanticum [98] and Trachyspermum roxburghianum H. Wolff [99]. (Z)-Ligustilide (8) was also found as a constituent of non-polar extracts of the roots from Ligusticum porteri, L. filicinum, and L. tenuifolium [100].
From elicitor-treated parsley cell suspension cultures were isolated four phthalides, namely, 3-butylidene-7-hydroxy-phthalide (25), and 3-butylidene-5-hydroxy-phthalide (senkyunolide C (28)) and its 7-O-β-d-glucopyranoside (57) and 7-O-(6′-malonyl)-β-d-glucopyranoside (58) derivatives [101]. An analysis of the water-soluble fraction of the methanol extract of celery seed afforded three more phthalide glycosides, named celephthalide A (59), celephthalide B (60) (with an unresolved configuration at C-3), and celephthalide C (61) [102]. As noted in Beck and Chou’s review on phthalides [2], the structure of celephthalide C (61) was found to be similar to that of neocnidilide (6).
The accumulation of some secondary metabolites of Ligusticum chuanxiong (including phthalides) has been correlated with the developmental stages of the plant [103], with (Z)-butylidenephthalide (3) and (Z)-ligustilide (8) found as volatiles of Angelica tenuissima Nakai [104] and Meum athamanticum [105].
Several dimeric phthalides were isolated from Ligusticum chuanxiong, and characterized as levistolide A (23), riligustilide (24), tokinolide B (43), 4,5-dehydrotokinolide B (62), and 3,8-dihydrolevistolide A (63) [106]. This last compound had been previously prepared by catalytic reduction of [6.6′,7,3a′]-(Z,Z′)-diligustilide A (syn: levistolide A (23)) and its structure was firmly established [70]; therefore, the compound isolated from L. chuanxiong requires structural revision. A series of phthalides, including butylphthalide (4), cnidilide (7), (Z)-ligustilide (8), senkyunolide I (22), levistolide A (23), riligustilide (24), (Z)-7-hydroxy-butylidenephthalide (25), senkyunolide H (26), tokinolide B (43), the triol 64 [107], (S)-4-hydroxy-butylphthalide (65) [108] and the dimeric phthalides chuanxiognolides A (66) and B (67), were also reported as constituents of L. chuanxiong [103].
The dimeric phthalides riligustilide (24) and gelispirolide (68) were isolated from Angelica sinensis [109], with three new phthalides (69–71) purified from the same plant [110]. (Z)-Butylidenephthalide (3), (Z)-ligustilide (8), levistolide A (23), riligustilide (24), and compounds 72 and 73 were also isolated from a population of A. sinensis [111]. From an aqueous extract of Ligusticum chuanxiong was isolated a lactone derivative (74) considered as a phthalide analog [112].
Ligusticum chuanxiong is recognized widely as an effective medicinal plant. Of more than 200 compounds that have been isolated from this species, the phthalides are considered to be the characteristic metabolites. Recent reviews compiling the chemical profile of L. chuanxiong [113] and its pharmacological properties [114] have been published.
Four not previously reported phthalides (75–78), together with compounds 4, 7, 8, 22, 23, 27, and 43, have also been isolated from Ligusticum chuanxiong [115].
Sedanonic acid (1) and phthalides 6, 22, 26, 52, and 79–85, were isolated from Ligusticum sinense Oliv. cv. chaxiong, with some compounds displaying activity against neuronal injury [116]. From the roots of the same species were isolated (Z)-ligustilide (8), and the dimeric phthalides chaxiongnolide A (86) and chaxiongnolide B (87) [117]. This last-mentioned compound had been previously characterized as a semisynthetic substance that was obtained by the differentiated cyclization of the ketoacid derived from tokinolide B (43) [118]. 7-Acetyl-senkyunolide H (88) was isolated from the roots of Angelica sinensis [119], and (Z)-ligustilide (8) has been found in good yields in different plant parts of Kelussia odoratissima Mozaff [120].
2.2 Phthalides in Other Plant Families
This section refers to the presence of phthalides that have been found in several plant families, other than the Umbelliferae (Apiaceae).
2.2.1 Bignoniaceae
From a methanol extract of the wood of Catalpa ovata G. Don, used traditionally as a diuretic in Japan, was isolated catalpalactone (89) [121]. Inouye and co-workers confirmed its structure, by preparing several derivatives. Compound 89 was obtained from the same plant several years later [122, 123].
2.2.2 Cactaceae
Compounds from the leaves, flowers and fruits of Opuntia leindheimeiri var. linguiformis (Griffiths) L.D. Benson, the leaves and flowers of O. macrorhiza Engelm., and the leaves of O. microdasys (Lehm.) Pfeiff. were extracted by steam distillation, and (E)-butylidenephthalide (21) was identified by GC-MS [124].
2.2.3 Compositae (syn. Asteraceae)
Several species of the genus Helichrysum have yielded phthalides. 5,7-Dihydroxyphthalide (90) and 5-methoxy-7-hydroxy-phthalide (91) were isolated from H. italicum (Roth) G. Don [125, 126]. Both phthalides and arenophthalide A (92) were contained in the organic extracts of H. arenarium (L.) Moench [127, 128]. On the other hand, H. platypterum DC. yielded platyphterophthalide (93) [129]. Venditti and co-workers carried out a chemical analysis of a chromatographic fraction of H. microphyllum (Willd.) Benth. & Hook. f. ex Kirk of medium polarity, and characterized phthalides 94 and 95 [130].
Talapatra and co-workers [131] analyzed the petroleum ether, chloroform, and alcoholic extracts of Anaphalis contorta (D. Don) Hook. f., and from these were isolated 5,7-dihydroxyphthalide (90), 5-methoxy-7-hydroxyphthalide (91), and 5-hydroxy-7-O-(3′-methyl-but-2′-enyl)phthalide (anaphatol, 96). Phthalidochromene (97), araneophthalide (98) and aranochromanophthalide (99) were later obtained from the aerial parts of Anaphalis araneosa DC. [129].
A 3-substituted phthalide with thiophene, which was called chrycolide (100), was isolated from an extract of Chrysanthemum coronarium L. [132].
Stuppner’s research group analyzed Scorzonera tomentosa L., a plant that has been used traditionally for the treatment of infertility and as an analgesic, anthelmintic, and antirheumatic in Turkey. From the methanol extract were isolated three phthalides as racemic mixtures, namely, (±)-scorzophthalide (101), (±)-hydramacrophyllol A (102), and (±)-hydromacrophyllol B (103) [133].
From the aerial parts of Gnaphalium adnatum DC. (Wall.) ex Thwaites [134] were isolated compounds 90 and 104–108.
2.2.4 Fumaraceae
In a search for spirobenzyl-isoquinolines from Fumaria parviflora Lam., four phthalideisoquinolines were found, namely, (+)-adlumidine (109), (–)-corlumine (110), (+)-bicuculline (111), and (+)-α-hydrastine (112) [135].
2.2.5 Gentianaceae
From the leaves of Gentiana pedicellata (Wall. ex D. Don) Griseb., pedicelloside (113) [136] and pedirutinoside (114) were isolated by Chulia and co-workers [137]. Garcia and associates analyzed the aerial parts of Gentiana pyrenaica L. and obtained 3-(3-O-β-d-glucosylpropyl)phthalide, which was named pediglucoside (115), and 3-[3-(6-vanilloyloxy-O-β-d-glucosyl)propyl]phthalide, or 6′-vanilloylpediglucoside (116) [138].
2.2.6 Lamiaceae
Scutellaria baicalensis Georgi has been used in Chinese traditional medicine for the treatment of diarrhea and inflammatory diseases. Its phytochemical investigation has yielded butylidenephthalide (3), (S)-butylphthalide (4), neocnidilide (6), cnidilide (7), (Z)-ligustilide (8), and senkyunolide A (15) [139].
2.2.7 Leguminosae (syn. Fabaceae)
Malan and Roux performed the isolation of 5,6-dihydroxyphthalide (117), identified as meconine (118) after methylation with diazomethane, in the chemical analysis of Peltogyne pubescens Benth. and Peltogyne venosa (Vahl) Benth. [140]. 4,6-Dimethoxyphthalide (119) was isolated from a methanolic extract of Albizzia julibrissin Durazz. [141].
2.2.8 Loganiaceae
Preparations from the stem bark of Anthocleista djalonensis A. Chev. have been used traditionally for curing fever, as a purgative, and for stomachache, and from the organic extract of this species, 4-carbomethoxy-5,7-dimethoxy-6-methyl-phthalide (120) (djalonensin) was obtained [142].
2.2.9 Oleaceae
From the essential oil of the stem bark of Forsythia japonica Makino, Kameoka and co-workers isolated and characterized 3-ethyl-7-hydroxyphthalide (121) [143].
2.2.10 Onocleaceae
(±)-Matteucen C (122) and (±)-matteucen D (123) were isolated as racemic products, along with some isocoumarins, from the rhizomes of Matteuccia orientalis (Hook.) Trevis. [144].
2.2.11 Orchidaceae
Shihunine (124) is a secondary metabolite of Dendrobium lohohense Tang & F.T. Wang. It was found as a racemic mixture, as deduced by the lack of optical properties [145, 146]. Pierardine (126) was isolated from the methanol extract of Dendrobium pierardii Roxb. ex Hook. as an optically active compound [147]. Later, it was synthesized and its absolute configuration (S) was assigned by comparison of its physical characteristics with those previously reported for (3S)-butylphthalide (4) [148]. Shihunine (124) was also reported as a metabolite of D. pierardii, as well as betaine (125), which exists in polar solvents.
2.2.12 Papaveraceae
Setigerumine I (127) was isolated from Papaver setigerum DC., which also yielded the well known α-noscapine (128). The relative configuration of the new phthalide was determined through NMR spectroscopic experiments, and it was isolated as a racemic mixture [149].
2.2.13 Pittosporaceae
From the Chinese and Taiwanese Pittosporum illicioides Makino var. illicioides, were isolated six hitherto unknown phthalides, 129–134. According to the method described, enantiomers 129 and 132 eluted differentially by column chromatography over silica gel [150]; since this is not possible, a compound configurational error in this report seems probable [150]. The absolute configurations of the compounds were determined by comparison of their specific rotations with known 3-alkylphthalides [151].
2.2.14 Poaceae (syn. Gramineae)
4-Hydroxyphthalide (135) was isolated from an acetone extract of crushed oat grain (both Avena fatua L. and Avena sativa L.). Considering that 4-oxygen-substituted phthalides are seldom found in Nature, the author suggested that it cannot be ruled out that 4-oxy-phthalides have another biosynthetic origin than that through the more common 3-alkyl and 3,5- and/or 7-oxygen substituted phthalides [152].
2.2.15 Polygonaceae
From the methanol extract of the root tubers of Polygonum multiflorum Thunb., a medicinal plant used traditionally for the treatment of hyperlipidemia, were obtained trans- and cis-(E)-3-butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-3H-isobenzofuranone 136 and 137. The absolute configurations of these compounds were not determined [153].
2.2.16 Saxifragaceae
Thunberginol F (138) is a phthalide isolated from the methanol extract of “Hydrangeae Dulcis Folium”, i.e. the fermented and dried leaves of Hydrangea macrophylla (Thunb.) Ser. var. thunbergii Makino. The double bond configuration was established by NOE experiments of its trimethyl derivative [154, 155]. From the ethyl acetate-soluble part of the same extract, were found hydramacrophyllols A (102) and B (103), the former with low optical purity and the last as a racemic mixture, suggesting that 103 is an artifact. The absolute configuration of 102 was not determined [155–157].
2.2.17 Typhaceae
The phytochemical investigation of the rhizomes of Typha capensis (Rohrb.) N.E. Br. yielded typhaphthalide (139) and radulanolide (140) [158].
2.3 Phthalides in Fungi
In 1913, Alsberg and Black reported the isolation of an acid of molecular formula C17H20O6, which they called mycophenolic acid (MPA (141)), from Penicillium stonoliferum Thom [159]. Its structure was not correctly determined until the late 1940s and early 1950s as 141 [160–162]. This phthalide was also found in cultures of fifteen strains of Penicillium brevicompactum Dierckx and Penicillium biourgeianum K.M. Zalessky [163], as well as Penicillium brunneostoloniferum S. Abe [164], Penicillium echinulatum Raper & Thom ex Fassat. [165], Penicillium roqueforti Thom [166], Penicillum verrucosum Dierckx [167], and Phomopsis longicolla Hobbs [168]. San Martin and co-workers reported that P. brevicompactum produces not only mycophenolic acid, but also its methyl ester 142 [169]. From Penicillium crustosum Thom was also isolated 5-hydroxy-7-methoxy-4-methylphthalide (143) [170].
Structurally similar compounds to 141 have been isolated from different sources. Euparvic acid (144) and the phthalides 145–147 were isolated from Eupenicillium parvum Raper et Fennell [171], and compound 147 and penicacids A–C (148–150) were found to be metabolites from Penicillium sp. SOF07 [172]. Phthalides 151 [173], 152, and 153 [174] were obtained from Penicillium brevicompactum, but their configurations were not established. In all these cases, MPA (141) was isolated along with the aforementioned compounds.
Birkingshaw and co-workers [175] isolated cyclopaldic acid (154) from cultures of two strains of Penicillium cyclopium Westling. This compound has also been found to be a secondary metabolite of Aspergillus duricaulis Raper et Fennell [176], Seiridium cupressi (Guba) Boessew. [177], Penicillium commune Thom, and Penicillium mononematosum (Frisvad, Filt. & Wicklow) Frisvad [178]. Compound 154 was found in some Penicillium spp. along with the related metabolite deoxycyclopaldic acid (155) [179], which was also isolated from Microsphaeropsis arundinis PSU-G18 [180]. Aspergillus duricaulis also yielded chromanols 156–159 as additional terpenoidal phthalides [181].
Two sesquiterpene-cyclopaldic acid hybrid derivatives were found to be metabolites from Pestalotiopsis sp., an endophytic fungus isolated from the leaves of the mangrove Rhizophora mucronata Lam. These phthalides were named pestaliotiopens A (160) and B (161), and their configurations were determined through spectroscopic methods and theoretical calculations. The sesquiterpene moiety is derived from altiloxin B, which preserves its absolute configuration in the hybrid compounds. The authors suggested that the formation of each individual scaffold (mycophenolic acid and altiloxin B) occurs previously and then both moieties join to form these compounds [182].
McGowan and coworkers isolated gladiolic acid (162) from a culture of Penicillium gladioli L. McCullogh & Thom. This compound was found to display antibacterial and fungistatic activities [183]. Grove established its structure, suggesting that should there be a tautomeric equilibrium between the hydroxylactone 162 and the aldehydic acid 163, as occurs with mycophenolic acid (141) [184, 185].
Other studies have shown that gladiolic acid (162) and dihydrogladiolic acid (164) (which also exists in an equilibrium with aldehydic acid 165) are constituents of the culture of Penicillium gladioli [186–188]. A modification of the experimental procedure originally employed for the isolation, allowed the characterization of compound 166, which was considered an artifact [189]. From the endophytic fungal strain Phomopsis sp. A123 was isolated dihydrogladiolic acid (164) as an optically active compound, along with its 3-ethoxy derivative, 167, named phomotone [190].
Alternaria kikuchiana S. Tanaka is a well-known parasite, which causes black spot disease in Japanese pears. Chemical investigation of the culture filtrates of the broth yielded iso-ochracinic acid (168) [191], and this compound has also been characterized from a fungicolous hyphomycete resembling Cladosporium [192].
Herbaric acid (169), an analog of iso-ochracinic acid, is produced by Cladosporium herbarium (Pers.) Link, a fungus associated with the Indonesian sponge Callyspongia aerizusa. It is interesting to note that other strains of this fungus, isolated from Aplysina aerophoba, collected in the Mediterranean Sea, did not produce this phthalide [193]. A closely related phthalide to herbaric acid is acetophthalidin (170), which was isolated from the fungal strain BM923 [194].
Phthalide 171 and its β-d-glucopyranoside 172 were isolated from a mycophilic Hansfordia species, along with other natural products [195].
Several anti-Helicobacter pylori phthalides (173–179) were isolated from the basidiomycete Phanerochaete velutina CL6387, but these phthalides did not display antibacterial activities against other microorganisms against which they were evaluated. The stereochemical assignments of some of these compounds were not completed [196].
From the culture broth of Penicillium vulpinum (Cooke & Massee) Seifert & Samson were isolated several natural products including 3-butyl-7-hydroxy-phthalide (180), which did not display cytotoxic activity [197].
The phthalide 181, as well as its derivative 182, were isolated by Sobolevskaya and co-workers from the mycelial fungus Penicillium claviforme Bainter, as found on the surface of the seagrass, Zostera marina L. They determined the absolute configuration of 181 by comparison of its specific rotation with previously reported data [198]. The absolute configuration at the carbinolic carbon of 182 was determined through the modified Mosher method as (R) (the corrected drawing is depicted in the present contribution since in the original paper the (S)-enantiomer appeared).
Chemical analysis of the culture filtrate of Aspergillus silvaticus Fennell and Raper IFO8173 yielded silvaticol (183), O-methylsilvaticol (184), and nidulol (185) [199].
From Sporotrichum laxum CBS 578.63 were isolated two long-chain phthalides named spirolaxine (186) and sporotricale (187) [200].
The fungus Phomopsis convolvulus Ormeno-Nuñez, Reedeler, & A.K. Waston is a pathogen of the perennial plant Convolvulus arvensis L. (Convolvulaceae), and has been studied for the potential biological control of this plant. A chemical investigation of this fungus afforded the phthalides convolvulanic acid A (188), convolvulanic acid B (189), and convolvulol (190) [201].
Compounds 189–191 and xylariphthalide A (192) were also isolated from the fungus Everniastrum cirhatum (Fr.) Hale ex Sipman (Xylariaceae) [202]. The authors reported that compound 192 displayed a low specific rotation value, presumably due to tautomerism of the hemiacetal group.
Isopestacin (193) is a 3-phenylsubstituted phthalide found as a racemic mixture in a culture of Pestalotiopsis microspore (Speg.) But. & Peres, an endophyte from Terminalia morobensis Coode [203]. A similar phthalide is cryphonectric acid (194), an optically active abundant metabolite of Cryphonectria parasitica (Murrill) M.E. Barr [204].
An antioxidant phthalide, 4,5,6-trihydroxy-7-methylphthalide, named epicoccone (195), was isolated from the fungus Epicoccum sp. [205]. Phthalides 195 and 196 were purified and characterized from a culture of the fungus Cephalosporium sp. AL031 [206].
From the antibacterial active culture broth of Cytospora sp. and Diaporthe sp. collected in Costa Rica, several octaketides were obtained, including the bioactive phthalide cytosporone E (197) [207].
During a screening protocol to discover compounds that bind to the cancer target Akt1, it was found that the fungal culture of Oidiodendron sp. displayed activity. From this sample, a new phthalide was isolated and characterized as 3-methyl-4,5,6-trihydroxy-phthalide (198) [208].
The fungus Alternaria porri (Ellis) Cif. is a pathogen of onion, from a culture broth of which 5-(3′,3′-dimethylallyloxy)-7-methoxy-6-methylphthalide (199) was characterized [209], along with 200 [210]. Phthalide 199 was also isolated from a liquid culture of endophytic Pestalotiopsis photiniae (Thüm) Y.X. Chen, obtained from the plant Podocarpus macrophyllus D. Don [211, 212].
The O-prenylated phthalides 201 and 202 were isolated from an unidentified fungus named “Sterile Dark”. Both of these displayed modest antifungal activity against Cladosporium herbarium, but only phthalide 201 was active against Gaeumannomyces gramini var. tritici J. Walker, which causes the “take-all” disease in plants [213].
Silvaticol (185) and marilones A–C (203–205) were obtained from the culture medium of the fungus Stachylidium sp., which was isolated from the sponge Callispongia sp. Compound 203 displayed antiplasmodial activity, and 205 showed antagonistic activity towards the 5-HT2B serotonin receptor [214].
Compounds 199, 200, and 206–208 were characterized from Pestalotiopsis photiniae as antifungal constituents against Fusarium graminearum, Botrytis cinerea and Phytophtora nicotianae, which are considered plant pathogens [211]. Yoganathan and co-workers [215] isolated fuscinarin (209) from the soil fungus Oidiodendron griseum Robak.
Salfredin B11 (210) is a prenylated phthalide isolated from Crucibilum sp. (strain RF-3817), which displayed aldose reductase inhibitory activity [216].
From a marine fungus of the order Pleosporales were isolated (3S,3′R)-3-(3′-hydroxybutyl)-7-methoxy-phthalide (211) and the deoxy derivative 212. This last compound displayed weak cytotoxic activity against selected cancer cell lines [217]. The absolute configuration of 211 was determined through the Mosher ester method, and the absolute configuration of 212 was determined by comparison of the specific rotations of both these compounds.
The organic extract of the fermentation culture of the endophytic fungus Pestalotiopsis foedan exhibited activity against Candida albicans, Geotrichum candidum, and Aspergillus fumigatus. From this extract were isolated pestaphthalides A (213) and B (214), and compounds 215–217. Phthalides 213 and 214 exhibited modest activity toward the above-mentioned fungi [218].
From the edible and cultivable mushroom Sparassis crispa (Japanese common name: “Hanabiratake”), were purified the phthalides 218–223, in addition to other constituents [219]. Compounds 218–220 were named hanabiratakelides A–C, respectively [219]. Phthalides 221–223 were previously found from other sources [131, 220]. These compounds displayed discernible antioxidant, antiinflammatory, and cytotoxic activities.
The fungus Pestalotiopsis heterocornis (Guba) Y.X. Chen was isolated from the stems of Bruguiera gymnorhiza (L.) Lam. (Rhizophoraceae), and phthalides 171, 224, and 227 were isolated a fermentation broth [221].
Several radical scavenging and cytotoxic isocoumarins along with the antioxidant phthalide 226 were isolated from the endophytic fungus Colletotrichum sp. [222].
Microsphaeropsis arundinis PSU-G18 is a source of a wide range of phthalides. From its broth and mycelial ethyl acetate extract were characterized deoxycyclopaldic acid (155), microsphaerophthalides A–G (227–233), and another four highly substituted phthalides 234–237. Microsphaerophthalides C–G (229–233) belong to the less common 3-oxygenated phthalides. The absolute configurations of these compounds were determined by comparison of their specific rotations [180].
A crude extract obtained from the culture broth of the fungus Acremonium sp., an endophyte from the mangrove plant Rhizophora apiculata Blume (Rhizophoraceae), displayed antibiotic activity towards Candida albicans and Cryptococcus neoformans. Several isocoumarin derivatives and a phthalide named acremonide (238) were obtained from this endophytic fungus, and these compounds displayed activity toward both microorganisms [223].
The fungus Bipolaris sp. was isolated from the seagrass Halophila ovalis (R. Br.) Hook. f., and from this fungus were purified and characterized several chromanones, anthraquinones, and phenolic compounds, including the phthalide bipolaride (239) [224].
The absolute configuration of sporotricale (187) was determined using the Mosher ester method, and 6-hydroxysporotricale (240) was characterized from Sporotrichum laxum (syn: Phanerochaete pruinosum) CBS 578.63 [225]. This fungus was recently reinvestigated and the anti-Helicobacter pylori phthalides spirolaxine (186) and sporotricale (187) were reisolated [226].
Pseudaboydins A (241) and B (242) were obtained from the fungus Pseudallescheria boydii associated with the starfish Acanthaster planci. The configuration of both phthalides was established using their CD spectra, using previously developed empirical rules [227]. A Penicillium sp. (strain ZH58) was found to produce phthalide 243 [228]. Phthalide 244 was isolated from the fermentation broth of the fungus Pezicula sp., occurring in the twigs of Forsythia viridissima Lindl. (Oleaceae) [229].
Paecilocin A (245) was isolated from Paecilomyces variotii, a fungus obtained from the jellyfish Nepolinema nomurai. The absolute configuration of paecilocin A (245) was assigned by comparison of its specific rotation with that of (3S)-butylphthalide (4) [230]. 5,7-Dihydroxy-4-methylphthalide (148) was characterized from a culture filtrate of Aspergillus flavus [231]. Xylaral (246) was isolated from Xylaria polymorphus (Pers.) Grev., the well-known “dead man’s fingers” fungus [232].
7-Hydroxy-4,6-dimethylphthalide (247) was isolated from Penicillium megasporum NHL2977 [233]. It was also found in a culture of Diaporthe phaseolorum (Cooke & Ellis) Sacc. [234]. Compounds 248, 249, and 250 were characterized from Phomopsis sp. A123 [235]. Phthalide 250 has been previously isolated from the marine fungus Diaporthe sp. [236].
Excelsione, also named phomopsidone (251), was almost simultaneously isolated from an unidentified fungus growing in the inner stem of the tree Knightia excelsa R. Br. [237], and from Phomopsis strain E02091 [238]. Phomopsidone A (252), a phthalide that includes an oxetane ring in its structure, was found also in this last-named fungus [235].
As a result of an investigation of Penicillium vermiculatum Dang., a cytotoxic compound was isolated and named vermistatin [239–241]. Its structure was later elucidated as 253, and its absolute configuration was assigned by analysis of the CD spectrum [241]. Compound 253 has also been found in Penicillium verruculosum [242], and Talaromyces flavus FKI-0076 and IFM52668 [243, 244]. This compound was named fijiensin when it was isolated from Mycosphaerella fijiensis Morelet in 1990 [245].
From Mycosphaerella fijiensis, 253 was isolated with its dihydro- (254), acetoxydihydro- (255), and hydroxydihydro- (256) derivatives, as well as penisimplicissin (257). The absolute configurations of 254 and 255 were determined through the Mosher ester method [246]. Compounds 253 and 257 were also isolated from a culture of Talaromyces thailandiasis T. Douthop, L. Manoch, A. Kijjoa, M. Pinto, L. Gales, A. Damas, A.M.S. Silva, G. Eaton & W. Herz, together with 256 [247], and from Penicillium rubrum Stoll together with 254 [248].
The absolute configuration of 253 was confirmed through X-ray analysis, when it was isolated from the fungus Guignardia sp. no. 4382, along with two new derivatives, 258 and 259, for which the absolute configurations were in turn assigned by comparison of their CD spectra with that of 253. Compounds 253 and 258 were characterized from the fungus Eurotium rubrum [249].
The fungus Penicillium sp. HN29-2B1 was found to be a source of several derivatives. From its mycelium and culture medium were characterized 253, 258–259, 6-demethylvermistatin (260), 6-demethylpenicimplissinin (261), 5′-hydroxypenisimplicissin (262), and 2′′-epi-hydroxydihydrovermistatin (263). The absolute configurations of 260 and 261 were determined by analysis of their CD data, while that of 263 was assigned as (3R,2′′S) by means of single-crystal X-ray diffraction [250]. Phthalide 260 has been previously isolated from Guignardia sp. no. 4832 [251]. Compounds 257, 258, 260, and neosarphenol A (264) were isolated from an ethanol extract of the culture of Neosartorya glabra CGMCC32286 by Liu and co-workers [252].
Two anthraquinone phthalides, namely, rubellins C and D (265 and 266, respectively), were found in extracts from a strain of Mycosphaerella rubella (Niessl & J. Schröt.) Magnus [253]. Rubiginone H (267) was isolated from the methanol extract of the mycelium of Streptomyces sp. (strain Go N1/5) [254].
An extract from the culture broth of Penicillium rubrum Stoll yielded rubralides A–C (268–270) [255]. The absolute configurations of 268 and 270 were established by comparison of their CD spectra with that of vermistatin (253), while the absolute configuration of 269 was not determined. Compound 269 and talaromycolides A–C (271–273) were isolated from Talaromyces pinophilus AF-02 [256].
From a methanol extract of the culture of Penicillium sp. IFB-E022, an endophytic fungal strain residing in the stems of Quercus variabilis Blume (Fagaceae), were isolated penicidones A (274) and B (275) by Tan and co-workers [257]. The absolute configuration at C-8 for both compounds was established as (8R) by comparison of the specific rotation with those of vermistatin (253), dihydrovermistatin (254), and penisimplicissin (257).
Phthalides bearing two substituents at C-3 are not found frequently as natural products. One example is compound 276, which was isolated from an ethyl acetate extract of the culture broth of Halloroselinia oceanica BCC 5149 [258]. This phthalide was also found in broth cultures of Leptosphaeria sp. KTC 727 [259] and Paraphoma radicina (McAlpine) Morgan-Jones & J.F. White [260]. Hashimoto and coworkers characterized compounds 276 and 277 from Leptosphaeria sp. KTC 727 [259]. Another example of this class of phthalides is compound 278, isolated from an extract of the culture of Emericella unguis Malloch & Cain [261]. Corollosporine (279) is a compound from Corollospora maritima Werderm., which was characterized as a racemic mixture. It displayed antibacterial activity against S. aureus and other bacteria [262].
2.4 Phthalides in Lichens
Takenaka and co-workers isolated 3,5-dihydroxyphthalic acid and the phthalides 280–282 from the polyspore-derived mycobionts of Graphis proserpens Vain. [263].
2.5 Phthalides in Liverworts
Asakawa and co-workers reported that radulanolide (140) was isolated from an organic extract from Radula complanata (L.) Dumont, a liverwort which causes allergic contact dermatitis [264]. The methanol extract of Balantiopsis rosea Berggr. yielded balantiolide (283), for which the structure was established by analysis of its spectroscopic data and by the preparation of its acetyl derivative (284) [265].
Asakawa’s group [266] obtained 3-(4′-methoxy-benzyl)-5,6-dimethoxyphthalide (285) from the ether extract of the liverwort Frullania falciloba Taylor ex Lehm. This structure was similar to 3-substituted phthalides previously isolated from Radula complanata [264] and Balantiopsis rosea [265]. The same group reported the phthalide 286 [267]).
Kraut and co-workers [268] analyzed the constituents of the liverwort Frullania muscicola Steph., and from a crude extract was purified the previously isolated balantiolide (283) [265] as well as 3-(3′,4′-dimethoxybenzyl)-5,7-dimethoxyphthalide (287) and 3-(4′-hydroxy-3′-methoxybenzyl)-5,7-dimethoxyphthalide (288). From an organic extract of Plagiochila killarniensis Pears., Rycroft and co-workers characterized killarniesolide (289). Acetylation of compound 289 afforded 290, establishing the substitution of the benzylic ring [269].
Chemical investigation of Plagiochila buchtiniana Steph. provided 3-(4′-methoxybenzyl)-7-hydroxyphthalide (291), whereas work-up of P. diversifolia Lindenb. & Gottsche yielded 3-(4′-methoxybenzyl)-7-methoxyphthalide (292), 3-(3′,4′-dimethoxybenzyl)-7-methoxyphthalide (293), and 3-(3′,4′,5′-trimethoxybenzyl)-7-methoxyphthalide (294) [270].
Chemical analysis of the organic extracts of Frullania falciloba afforded 3-(4′-methoxybenzyl)-5,7-dimethoxyphthalide (295) [271], for which the structure was drawn in an erroneous manner in reference [266].
3 Analytical Aspects
This section summarizes some methods employed for the extraction, isolation, chemical characterization, dereplication, and to achieve quality control of phthalides.
3.1 Extraction, Isolation, and Chemical Characterization
Historically, the extraction techniques for obtaining phthalides have focused on the use of non-polar solvents such as petroleum ether [127, 140, 272], hexane [36, 78, 142], and pentane [50]. Steam distillation has been employed for the extraction of several phthalides, such as sedanenolide ((15) senkyunolide A), (Z)- (8) and (E)-lingustilide (18), (Z)- (3) and (E)-butylidenephthalide (21), and butylphthalide (4) [42, 44, 273–275]. For obtaining polar compounds such as the diols, senkyunolide I (22) and senkyunolide H (26), in older work the plant rhizomes were defatted with non-polar solvents and then extracted with more polar solvents such as chloroform [65], or with water, followed by partition with an organic solvent [59], or extracted with acetone and methanol [60, 101, 276]. Several conventional procedures such as decoction [277, 278], percolation [279], sonication [279, 280], and reflux [281] have been used. Other techniques employed include supercritical fluid extraction (SFE) [274, 282–284], solid-phase microextraction (SPME) [285], microwave-assisted extraction [113, 286], and the use of biomembranes [287]. Pressurized liquid extraction (PLE) is an option that allows the quantification of phthalides [288–290]. A recently developed high-pressure ultrasonic-assisted extracted technology method has been applied for the purification of this type of phytochemicals [291, 292].
Regarding phthalide isolation, in earlier work, crude organic extracts were subjected to basic aqueous partitioning to remove acid and phenolic compounds [42, 293]. The organic layer obtained was then subjected to distillation for obtaining several fractions, yielding phthalides [19, 293]. A frequently used method for the isolation of phthalides is column chromatography (CC) over adsorbents or solid supports such as silica gel [103, 116], alumina [51], polyamide (CC6) [69], Sephadex LH-20 [66], and reversed-phase (C18) silica gel [153]. Other reported methods are preparative thin-layer chromatography (PTLC) [294], vacuum-liquid chromatography (VLC) [294, 295], medium-pressure liquid chromatography (MPLC) [294], high-vacuum distillation [80, 106], centrifugal circular thin-layer chromatography (CCTLC) [69], high-speed countercurrent chromatography (HSCCC) [106, 296–298], and droplet-countercurrent chromatography (DCCC) [110]. Normal- [299], reversed-phase [110, 295], and high-performance liquid chromatography (HPLC) are common methods used for the isolation of phthalides.
The chemical characterization of phthalides has involved the determination of melting points [293], boiling points [36, 42], and chemical transformations such as saponification [293], hydrolysis [293], hydrogenation [35], ozonolysis [36], and oxidation [36], among others. Later on, these procedures were complemented with methods including infrared spectrometry [41, 44], ultraviolet spectroscopy [42, 44, 293], refractive indices [19, 293], optical rotations [293], gas chromatography (GC) [42], mass spectrometry (MS) [42], and NMR spectroscopy [36, 41]. Later, GC coupled to selective mass detectors and high resolution mass spectrometry (GC-MS) [44, 48] were included. The use of NMR spectroscopy [41, 51] and X-ray diffraction analysis has increased [51, 103], and a combination of both has been applied [93, 103, 300].
Figures 2, 3, and 4 show the 1H NMR spectra for compounds 8, 23, and 43, which are natural constituents of Ligusticum porteri [70].
3.2 Dereplication and Quality Control (HPLC, MS, NMR)
Dereplication is a process that facilitates the determination of the composition of a mixture of substances or of an extract [301]. It is focused on the rapid analysis of known components present in crude plant material or medicinal herbal products without the isolation of compounds, and is based on the use of TLC, HPLC, and HPLC-coupled spectroscopic techniques, for instance, LC-MS and LCMS/MS [302, 303], and GC-MS [304]. Access to 1D 1H NMR data at the initial steps of dereplication of crude extracts can accelerate substantially the whole process, e.g. the identification of the constituents in a crude acetone extract from rhizomes of Ligusticum porteri [300] (Fig. 5).
Quality control aims to ensure the consistency, efficacy, and safety of preparations from plants used in traditional medicine. A chemical fingerprint indicates the presence of multiple chemical markers within a sample. It has been used for determining the presence of phthalides in several Asian medicinal plants and herbal remedies [277, 305]. Among the phthalides present, (Z)-ligustilide (8) typically has been selected as a marker compound to perform the quality control of the roots of Angelica sinensis or Ligusticum chuanxiong, and HPLC and GC-MS are the main analytical methods for its quantification [281, 288, 305–308].
The identification and quantification of two major phthalides from Ligusticum porteri were established using a HPLC-diode array (DAD) method for quality control purposes [309]. The secondary metabolite profiles of plants may be affected by many factors, including seasonal changes, harvesting time, cultivation sites, post-harvesting processing, adulterants or substitutes of raw materials, and procedures of extraction and preparation [60, 310, 311]. A practical tool for determining the variation of the constituents of plants (in the form of crude fresh extracts) is NMR spectroscopy. A qualitative chemical analytical procedure of an acetone extract of the rhizomes of Ligusticum porteri using 1H NMR spectroscopy has been reported to establish the presence of the individual components (Fig. 5). This analysis verified that the dimeric phthalides diligustilide (23), riligustilide (24), and tokinolide B (43) occur as natural products in fresh L. porteri rhizomes. A protocol involving NMR spectroscopy has been developed for quantifying some of the constituents from this natural source [300].
Qin and co-workers reported the use of NMR spectroscopy to analyze Ligusticum chuanxiong rhizomes of several commercial types, collected from different regions in mainland China. The 1H NMR spectra and HPLC profiles allowed comparison of the characteristics of the major constituents [311].
3.3 DOSY Experiments of Extracts of Ligusticum porteri
NMR spectroscopy is a powerful analytical technique for the examination of mixtures of organic compounds, which includes a specific procedure called Pulsed Gradient Spin Echo (PGSE) NMR, or the so-called Diffusion Ordered SpectroscopY (DOSY). This experimental technique is a tool for analyzing complex mixtures based on different translation diffusion coefficients, D, which depend on the molecular weight, size and shape of each compound. DOSY spectra show the diffusion coefficients on the vertical axis and the 1H NMR chemical shifts on the horizontal axis [312, 313].
DOSY analysis [300] allowed the determination of the presence of (Z)-butylidenephthalide (3), (Z)-ligustilide (8), tokinolide B (43), diligustilide (23), ferulic acid (296), and coniferyl ferulate (297) in an acetone extract of the dried rhizomes of Ligusticum porteri. The NMR spectrum revealed four main diffusion rate levels: A, B, C, and D (Figs. 6 and 7). Looking at the δ 7.00–4.3 ppm region, the signals that appeared with a diffusion coefficient of 1.75 × 10−10 m2/s (highlighted as level A), corresponding to a mixture of ferulic acid (296) and coniferyl ferulate (297). At levels B and C (diffusion coefficient range 2.20–2.45 × 10−10 m2/s), the most representative signals were found for diligustilide (23) (H-7′ at δ 7.50, H-8 at δ 5.35 and H-8′ at δ 4.90 ppm) and tokinolide B (43) (H-7′ at δ 7.64 and H-8′ at δ 4.45 ppm). This analysis confirmed the occurrence of dimeric phthalides. The monomer (Z)-ligustilide (8) displayed a diffusion coefficient of 3.65 × 10−10 m2/s (level D). DOSY NMR is a useful tool for detection of adulterants in plant extracts, or for fast and complete analysis of the phytochemical content of extracts and herbal medicines.
4 Biosynthesis of Phthalides
The study of the biosynthesis of phthalides began with the structural determination of mycophenolic acid (141), which is constituted by a phthalide fragment (derived from the polyketide pathway) and a terpene fragment (derived from the isoprenoid pathway). Birch and co-workers reported labeling studies with [1-14C], identifying the polyketide and terpenoid pathways [314]. Afterwards, the presence of methoxy and methyl groups in the benzene ring of mycophenolic acid was demonstrated by the same group of investigators, using feeding experiments incorporating [14CH3]-methionine in cultures of Penicillium brevicompactum [315].
In 1966, the biosynthesis of phthalides was investigated also by Mitsuhashi and Nomura [272]. They studied the biogenetic origin of butylphthalides by conducting feeding experiments to explain the formation of ligustilide (8) in Levisticum officinale, and determined that the alkylphthalides have polyketide precursors.
In further work of this type, Canonica and co-workers [316] demonstrated by labeling experiments that the methyl group at C-4 in mycophenolic acid is incorporated at the tetraketide step, and that the formation of the benzene ring was carried out followed by subsequent transformations, yielding 5,7-dihydroxy-4-methylphthalide. Bedford et al. [317] studied the nature of the polyketide intermediates in the biosynthetic pathway from basic units, as acetate and mevalonate. Their study was performed with comparative incorporation experiments using [1′-14C]-orsellinic acid and [1′-14C]-4,6-dihydroxy-2,3-dimethylbenzoic acid, showing that the latter compound is a precursor of mycophenolic acid (141). A detailed review including the biosynthesis of mycophenolic acid (141) was published by Bentley [318].
The production of MPA (141) and analogs has been proposed using metabolic engineering as shown in Chart 1. Regueira et al. carried out experiments on the discovery of the involved enzymes (polyketide synthases, starter unit acyl carrier protein transacylase, β-ketoacylsynthase, acyltransferase, and methyltransferase, as well as the product template and acyl carrier protein responsible for the backbone synthesis of 141) by means of the production of mpaC (which assembled the phthalide fragment of 141) in a “gene cluster” in Penicillium brevicompactum [319].
Recently, Su and co-workers reported that phthalides could be biosynthesized through the acetate-malonate pathway. (Z)-Ligustilide (8), sedanolide (6), and some other derivatives are the result of reductions, oxidations, decarboxylation, cyclization, and dehydration [116].
5 Reactions of Phthalides
Phthalides have been studied widely by some investigators, in attempts to understand the reactivity of this class of natural products, as well as aiming to establish structure-activity relationships (SAR) of biologically active natural phthalides, or determining their structures.
5.1 Derivatives of Monomeric Phthalides
5.1.1 Diels–Alder Adducts from (Z)-Ligustilide
One remarkable feature of the apparently simple structure of (Z)-ligustilide (8) is the conjugated cyclohexadiene moiety, which makes it able to undergo Diels–Alder reactions, both as diene and dienophile. Several natural dimeric phthalides, such as diligustilide (23) and tokinolide B (43), are Diels–Alder adducts of (Z)-ligustilide (8), and have been partially synthesized from this compound [320, 321] (see Sect. 6.2.1).
Some semisynthetic derivatives have been prepared from (Z)-ligustilide (8) and several dienophiles through Diels–Alder reactions. Thus, in the early 1960s, Mitsuhashi and co-workers [35] carried out the reaction of this phthalide with maleic anhydride, obtaining both endo-298 and exo-298 isomers. A 3:1 ratio for the products was reported more recently (see Fig. 8) [322]. The reaction with ethyl acrylate afforded exo- and endo-299, with this last compound being the major product. Theoretical calculations agreed with the experimental results, since the transition state involved in the formation of the major isomer was lower in energy.
When (Z)-ligustilide (8) was reacted with allyl alcohol in the presence of p-TsOH, or with acrylic acid 301 and 302 were obtained. The regio- and stereoselectivity of both reactions is noteworthy, since only one product was observed in each case. In the same study, Alder–Rickert reactions of (Z)-ligustilide (8) with ethyl propiolate or dimethyl acetylenedicarboxylate (DMAD) were carried out, yielding butylidenephthalide-type derivatives 303–305 [322].
5.1.2 Preparation of Linear Dimers from (Z)-Ligustilide
In an attempt to explore the [π4s + π2s] cycloadditions of (Z)-ligustilide (8) catalyzed by Lewis acids, the formation of the linear dimers 306–309 was reported, rather than of Diels–Alder adducts [323].
The authors suggested that complexation of Lewis acids with carbonyl oxygen or olefinic carbons, promoted cationic mechanisms. Thus, as depicted in Chart 2, it was proposed that the formation of the major product proceeded by a nucleophilic attack from C-6–C-7 double bond electrons towards C-8, in a 1,6-addition, facilitated by the complexation of Lewis acid with oxygen. Subsequent isomerizations through proton transfer reactions led to a cyclohexadiene that was dehydrogenated to yield the observed product 306 [323] (Chart 2).
Similarly, the presence of Lewis acid promoted 1,2 addition of one olefin moiety of (Z)-ligustilide (8) to the C-6–C-7 double bond of another (Z)-ligustilide (8) molecule through other carbocations (Chart 3). It is interesting to note that the second major product corresponds to the formation of an allyl cation at C-7, which is more stable than that formed when the cation is formed at C-6 [323].
Then, nucleophilic attack of one molecule of 8 to one of the cationic intermediates produces the carbon–carbon bonds necessary to yield dimers 307–309, for which the formation takes place after acid–base equilibration steps, and dehydrogenation (in the case of 307) [323].
5.1.3 Instability of (Z)-Ligustilide
Pauli and co-workers evaluated the purity and relative stability of isolates of (Z)-ligustilide (8) through quantitative NMR spectroscopy and GC-MS, and found that this compound decomposed rapidly when stored in CDCl3 solution, or without solvent, even at −30°C. It was observed that the degradation process was slower when (Z)-ligustilide (8) was stored in hexane, methanol, DMSO, or in a mixture of hexane, ethyl acetate, methanol, and water (9:1:9:1). The degradation pathway was characterized by combining NMR and GC-MS techniques, leading to the determination of an epoxide, 4,5-dihydro-3-hydroxy-8-oxo-butylphthalide (310), butyraldehyde, and phthalic anhydride as degradation products [324].
Lin and co-workers detected that (Z)-ligustilide (8) spontaneously produced minor amounts of the dimeric phthalides diligustilide (levistolide A, 23), riligustilide (24), and a mixture of cis- and trans-ligustidiol (22 and 26), suggesting that these phthalides could be artifacts [310]. However, various attempts to transform (Z)-ligustilide (8) into its Diels–Alder adducts on a preparative scale, did not proceed in good yields [35, 320, 321]. In addition, dimeric phthalides have been found in freshly prepared extracts of L. porteri [300], confirming their existence as natural products.
Hu and co-workers established that decomposition of (Z)-ligustilide (8) is influenced by temperature, light, and oxygen, and that the addition of vitamin C delays its transformation [325].
Additional evidence of the facile transformation of (Z)-ligustilide (8) were provided by Lau and co-workers. They analyzed the chemical composition of crude extracts of Angelica sinensis roots and Ligusticum chuangxiong rhizomes by gas chromatography-triple quadrupole mass spectrometry, and comparison of the extracts of the same plants before and after treatment with wine. (S)-Butylphthalide (4), (Z)-butylidenephthalide (3), senkyunolide A (15), (Z)-ligustilide (8), and ferulic acid (296) were used as chemical markers. It was concluded that there were variations of the relative content of these compounds after wine treatment, indicating that the stability of phthalides depends on the presence of other compounds [326].
More recently, it was observed that (Z)-ligustilide (8), when exposed to sunlight at room temperature, was transformed into (Z)-6,7-epoxyligustilide (38), senkyunolide I (22), senkyunolide H (26), 311, and 312, as racemic mixtures, confirming the main degradation products of (Z)-ligustilide (8) [327].
5.1.4 Functional Group Transformations
Many reactions of phthalides have been carried out to determine the reactivity of this group of compounds, to establish structure–activity relationships, or as a tool for their structure elucidation.
Mitsuhashi and Kobayashi reported the epoxidation of (Z)-ligustilide (8) followed by hydrolysis, yielding senkyunolides H (26) and G (22), while senkyunolide A (15) gave senkyunolide J (33) [328]. When the hydrolysis of epoxyligustilide was conducted with hydrochloric acid, senkyunolide L (45), a chlorohydrin, was formed [73]. The same group also obtained reduced derivatives of ligustilide (8) [35], and, in an attempt to prepare the Diels–Alder adducts (tokinolide B (43) or diligustilide (23)), they subjected (Z)-ligustilide (8) to pyrolysis. The dimers were not observed, but instead small amounts of a dialdehyde, a product of oxidation of the C-6–C-7 double bond, was observed [72].
Beck and Stermitz submitted (Z)-ligustilide (8) to nitrogen and sulfur nucleophiles, obtaining a 1,2-addition product from the former nucleophile (313). It was found that the sulfur nucleophile gave a 1,6-addition to the α,β,γ,δ–unsaturated carbonyl fragment (314), and another addition–elimination product (315), and a disubstitution product (316). The results were in agreement with hard and soft acid and base theory [89].
Cyclopaldic acid (154) exhibited insect-biting deterrent and larvicidal activities. Thus, in order to establish a structure–activity relationship (SAR) profile, Cimmino and co-workers [329] synthesized isocyclopaldic acid (317) and prepared other cyclopaldic acid derivatives: this compound was mono- and tetraacetylated to afford 318 and 319. The aldehyde reacted with 2,4-dinitrophenylhydrazine to give the corresponding hydrazone (320). Treatment of cyclopaldic acid with dansyl hydrazine yielded products 321 and 322. The natural phthalide was also treated with 5-azidopentanoic acid and N,N′-dicyclohexylcarbodiimide, giving 323. Finally, when the natural phthalide was treated with NaBH4, the products 324 and 325 were obtained (see Chart 4) [329].
Wu and co-workers [330] prepared derivatives of mycophenolic acid (141). Its protected derivative was subjected to aminolysis, yielding the amidophenol 326. The phenolic group was then transformed to thioacetate 327, azide 328 and mesylate 329. Furthermore, the mesyl derivative was used for the preparation of three new heterocyclic compounds, the corresponding 2,3-dihydroisoindolone (330), 2,3-dihydro-N-methylisoindolone (331), and benzothiophenone (332).
5.2 Derivatives of Dimeric Phthalides
The natural dimeric phthalides are obtained basically as [π4s + π2s] and [π2s + π2s] cycloadducts from two units of monomeric phthalides such as (Z)-ligustilide (8) and from (Z)-butylidenephthalide (3). They display interesting reactivities due to their topological characteristics and the presence of several reactive sites.
One of the first reports concerning the reactivity of dimers led to the correction of a structure obtained from Ligusticum wallichii by means of the catalytic hydrogenation of diligustilide (23), which yielded a mixture of 3,8,7′,7a′-tetrahydrodiligustilide (333) and (Z′)-3,8-dihydro-[6.6′,7.3a′]-diligustilide (39). This last compound had been previously reported as a natural compound, but spectroscopic data analysis permitted a structural correction to 40 (Chart 5) [70].
5.2.1 Intramolecular Condensations of Dimeric Phthalides
Alkaline treatment of diligustilide (23) under different conditions yielded the intramolecular condensation products 339, 340 and 343. The mechanism was proposed as follows: the diketo diester 334 (obtained from the methanolysis of diligustilide (23)) underwent intramolecular reaction through deprotonation of the methylene at C-8′ (intermediate 335), and subsequent addition to the carbonyl group-generated intermediates 336 and 337. The carbanion of this last compound reacted intramolecularly to yield intermediate 338, which equilibrated yielding 339 and 340 (Chart 6). O-Alkylation of tautomers 341 and 342 afforded 343 [331].
Treatment of diligustilide (23) with Na2CO3 in Me2CO/MeOH/H2O afforded 340, 339, 343, 344 (demethylwallichilide), and 345 (Chart 7).
Attempts to find better conditions to obtain products 339 and 343 and the hydrolysis products 344 and 345 from diligustilide (23) were made [332].
Treatment of tokinolide B (43) under basic conditions (NaOH in THF) yielded cyclotokinolide B (346) derived from an intramolecular condensation procedure. Its formation began with a chemoselective nucleophilic attack of the hydroxide ion to the carbonyl group at C-1, to produce an enolate (intermediate A), followed by Michael addition of the carbanion to the enone, by means of 5-exo-trigonal cyclization, yielding intermediate B, which produced cyclotokinolide B (346) (Chart 8). The results showed that intramolecular cyclizations are a general feature for these dimeric phthalides [333].
Treatment of tokinolide B (43) with base in acetone under reflux afforded ketoacid 347 by chemoselective lactone ring opening.
The reaction of ketoacid 347 with the chiral amines ((–)-(S)-α-methyl-benzylamine and (+)-(R)-α-methylbenzylamine) under pressure afforded product 87, tokinolide B (43), and the starting material (Chart 9).
The ketoacid of tokinolide B (347) displayed chemoselectivity under basic conditions. Strong alkaline conditions afforded 346 via C-alkylation, while mild alkaline conditions produced compound 87 (via O-alkylation) [118] (Chart 10). This last compound was later characterized as a natural product from Ligusticum sinense cv. chaxiong and named chaxiongnolide B (87) [117] (see Chart 10).
Comparison of calculated energies for compounds 87, 346, and 347 indicated that 87 had a lower energy, followed by 346, and this outcome may be correlated with the number of rings and conformational constraints of the structures (Fig. 9) [118].
The results on derivatives of intramolecular condensation provided evidence of the particular chemical reactivity of the natural dimeric phthalides.
5.2.2 Synthesis and Stereochemical Assignments of Enantiopure Derivatives
Taking in consideration that natural dimeric phthalides are found as racemic mixtures [70], enantiomeric derivatives of tokinolide B (43) and diligustilide (23) were prepared and evaluated as cytotoxic agents. Treatment of 43 with (+)-(R)-α-methylbenzylamine ((R)-MBA) and (–)-(S)-α-methylbenzylamine ((S)-MBA) afforded pairs of diastereomeric products, namely, (−)-348 + (+)-349 and (+)-348 + (−)-349 (Chart 11) [334].
The absolute configurations of (−)-348, (+)-349, (+)-348, and (−)-349 were determined by analyzing their ECD curves, using the exciton chirality method and defining the direction of the transition dipole moments of the chromophores.
In a complementary manner, the enantiopure derivatives (−)-350 + (+)-351, and (+)-350 + (−)-351, were obtained, in turn, by treatment of diligustilide (23) with (R)- and (S)-α-MBA (Chart 12) [335].
The absolute configurations of the amides were determined by the interpretation of the electronic circular dichroism curves (ECD), as previously described for the derivatives of tokinolide B (43) [334, 335].
5.3 Biotransformations
Mycophenolic acid (141) and 143 were isolated from a culture of Penicillium crustosum, when mixtures of either ferulic (296) and quinic acids (352) or 3-methoxy-4-hydroxycinnamic acid (353) and 3,4-methylenedioxycinnamic (354) acids were added to the medium [170].
(S)-Butylidenephthalide (3) was prepared in 99% enantiomeric excess through microbial reduction of methyl 2-butyrylbenzoate (355) or microbial oxidation of methyl 2-pentylbenzoate (356) [336] (Chart 13).
Other derivatizations have been carried out for the resolution of racemic mixtures of phthalides. For example, the enzymatic resolution of racemic 3-butylidenephthalide (3) was achieved with Novozyme 435, which catalyzed the reaction between (S)-butylidenephthalide (3) and acetic anhydride to afford 2-((1S)-acetoxypentyl)-benzoic acid (357) in 98% ee, with up to 50.9% of unreacted 3-butylidenephthalide (3) remaining in 95.7% ee of the (R)-enantiomer [337–340] (Chart 14).
Several derivatives (358–365) of mycophenolic acid (141) were obtained by treatment with Streptomyces sp. [341, 342].
Other modifications of 141 have been carried out by subjecting this phthalide to microbial transformation by 21 different species of bacteria, fungi and algae, furnishing phthalides 360 and 366–382. The most common and abundant transformation products were the hydroxylactone 367, resulting from oxidation at C-3, and 360, by benzylic oxidation of the methyl group. Compound 372 was also obtained in relatively good yield. It is noteworthy that several Penicillium spp. were able transform mycophenolic acid (141) [343].
When Polyporus brumalis (Pers.) Fr. was supplemented with the phthalideisoquinoline derivative, (–)-β-hydrastine (383), this compound was hydroxylated with retention of configuration, yielding 384, probably due to the action of a cytochrome-P450-dependent monooxygenase [344] (Chart 15).
Spirolaxine (186) has been biotransformed by several microorganisms. Bacillus megaterium yielded phthalides 385–387 and Cunninghamella echinulata yielded 388 [345]. Trametes hirsuta transformed 186 into 389, while Absidia cuneospora produced 390 [346] (Chart 16).
6 Synthesis of Phthalides
In view of the relevant biological properties of phthalides and, in particular, their chemical reactivity, many investigations have been devoted to the synthesis of these compounds. Research on this topic has resulted in a number of specific and interesting methodological procedures. In this section, selected approaches concerned with this topic are described. As a prior consideration, it is important to mention that Mal and co-workers [3] recently published a review covering part of this topic; nonetheless, in the present chapter the specific syntheses of naturally occurring phthalides are featured.
6.1 Synthesis of Monomeric Phthalides
The most direct approach for the synthesis of natural phthalides is to start from other natural phthalides. For example, Cimmino and co-workers prepared isocyclopaldic acid through a Canizzaro reaction, by treatment of cyclopaldic acid with base, reducing C-3 and oxidizing the formaldehyde at C-5 [329]. Other examples of this approach are the semisynthesis of senkyunolides H-J (26, 22, and 33) and L (45) [73, 328] (see above).
Salfredin B11 (210) was synthesized by Babu and Mali [347] from 90 and 3-chloro-3-methylbutyne, and subsequent thermal cyclization with dimethylphenylamine (Chart 17).
The terpenoid phthalide 151 was proved to be involved in the biosynthesis of mycophenolic acid (141), and was prepared by semi- and total synthesis [173] (Chart 18). Mycophenolic acid (141) was reduced to the corresponding aldehyde and coupled with propenyl lithium. The resulting compound yielded the natural product 151 after a Claisen-type rearrangement and hydrolysis. On the other hand, the total synthesis consisted basically of transforming (E,E)-farnesol into 10-bromo-4,8-dimethyl-deca-4,8-dienoic acid, and conducting the alkylation of 5,7-dihydroxy-3-methylphthalide with the former compound, in the presence of Ag2O.
A number of more complex total syntheses of natural phthalides have been developed and some selected examples are described below.
6.1.1 Formation of the Cyclohexane Ring: The Alder–Rickert Reaction
The Diels–Alder reaction between cyclohexadienes and acetylenes, followed by retrocycloaddition, yields substituted benzenes and ethylene. This transformation is called the Alder–Rickert reaction and has been employed widely for the synthesis of phthalides substituted at C-4, C-5, C-6, and/or C-7 [348].
One of the first reports using the Alder–Rickert reaction was Birch and Wright’s total synthesis of mycophenolic acid (141) [315], devoted to the formation of the benzene ring needed for the phthalide moiety, as depicted in Chart 19. The synthesis started from resorcinyl dimethyl ether, which was subjected twice to sequential Vilsmeier–Haack formylation/Wolff–Kishner reduction steps, followed by Birch’s reduction and isomerization of the product. The resulting cyclohexadiene was subjected to an Alder–Rickert reaction with dimethyl acetylene dicarboxylate (DMAD), yielding a substituted dimethyl phthalic ester. It was then demethylated and converted into the corresponding phthalic anhydride, which was in turn selectively reduced with Zn/HCl. Alkylation of the hydroxy group followed by Claisen rearrangement furnished 391. This last compound was subjected to ozonolysis, then to a Wittig reaction, and next to the Horner–Wadsworth–Emmons reaction, yielding the ethyl ester of dehydromycophenolic acid 392. Finally, this compound was hydrolyzed and reduced with diimide to yield MPA (141) (see Chart 19).
Patterson also reported a synthesis of 141 involving the Alder–Rickert reaction between trimethylsilyloxy enol 393 and DMAD, as shown in Chart 20 [349]. The product was then isomerized through a Claisen rearrangement. The resulting dimethyl o-dicarboxylbenzoate 394 was reduced with Zn to yield phthalide 395, which was subjected to ozonolysis. This aldehyde was reacted with 2-propenyl magnesium bromide, and the thermolysis of the resulting alcohol with triethyl orthoacetate in the presence of propionic acid yielded MPA (141). More recently, Barrett and co-workers [350] reported an additional total synthesis of MPA (141) in 12 steps, which included a biomimetic cyclization–aromatization step starting from a polyketide-like compound.
The fungal phthalides 5-(3′,3′-dimethylallyloxy)-7-methoxy-6-methylphthalide (199), 6-(3′,3′-dimethylallyloxy)-4-methoxy-5-methylphthalide (207), and silvaticol (183) were prepared by Hariprakasha and co-workers [351] using the Alder–Rickert reaction between diene 396 and DMAD to furnish a polysubstituted benzene ring that was then O-prenylated and hydrolyzed to furnish 397 (see Chart 21).
Acid-catalyzed dehydration of diacid 397 yielded the corresponding phthalic anhydride, which was reduced with NaBH4 and hydrolyzed with K2CO3, yielding silvaticol (183) (Chart 22).
A mixture of prenylated phthalides 199 and 207 was obtained, accomplishing the cyclization of phthalic acid 397 with DCC, and then reducing with NaBH4. An alternative approach to these phthalides is to reduce the dimethyl phthalic ester 398 with DIBAL, followed by oxidative cyclization of the diol with PCC. It is interesting to note that the use of each procedure produces a switch in regioselectivity. Thus, the former methodology forms phthalides 199 and 207 in a 1:4 ratio; on the other hand, the ratio using the second methodology was 3:1 (see Chart 23) [351].
Kuwahara and co-workers [352] prepared both enantiomers of the fungal phthalide 202 starting from the protected dienol 399, which underwent an Alder–Rickert reaction and then deprotection to yield 4-hydroxy-6-methoxy-3,5-dimethyl-1,2-benzene-dicarboxylate (400). Alkaline hydrolysis and reduction with Zn in aqueous HCl furnished phthalide 401. After O-alkylation with the appropriate bromoester, deprotection, and oxidation, both enantiomers of 202 were obtained. The preparation of both enantiomers allowed identification of (S)-202 as the natural product (see Chart 24).
6.1.2 Preformed Cyclohexane Ring and Formation of the Lactone Ring
The syntheses of less substituted phthalides, and mainly 3-substituted phthalides, have been investigated widely. In these cases, the use of accessible preformed benzene rings is a common feature, and there are several procedures for obtaining the lactone ring. A procedure for the preparation of 3-(2,6-dihydroxyphenyl)phthalides was developed by Mal and co-workers. It is based on the reaction of phthalaldehydic acids with enamines of 1,3-cyclohexanediones and subsequent aromatization, and it was used for the preparation of isopestacin (193) and cryphonectric acid (194). This latter compound was esterified and hydrolyzed for its characterization. Attempts to prepare these natural products in an enantioselective manner were futile (see Charts 25 and 26) [353].
Ohzeki and Mori carried out four approaches to obtain corollosporine (279), which are shown in Chart 27. The first of these consisted of a one-step reaction of 3-hydroxyphthalic anhydride (402) with hexylmagnesium bromide, which was the most direct route (36% yield), although it lacked effectiveness because of difficulties in purification. The second method involved the preparation of N,N-diethylacetamide of o-methoxybenzoic acid, followed by the ortho-metalation of Snieckus conducted with sec-butyllithium in the presence of tetramethylethylenediamine (TMEDA), and then N,N-dimethylformamide (DMF), furnishing 403. This product was first converted into a secondary alcohol through a Grignard reaction with hexylmagnesium bromide, then oxidized to the ketone, and finally hydrolyzed and demethylated with hydrobromic acid to yield 279. Another synthetic route avoided the Grignard reaction of 403 by treatment of an ortho-metallated anion with heptanal and following the above-described steps (oxidation, hydrolysis, and demethylation), afforded the desired compound. The last strategy consisted of a reaction of N,N-diethylacetamide 404 with the appropriate Weinreb amide and hydrolysis and demethylation of the furnished ketone 405 to yield 279 [354].
In the procedure described by Ranade and co-workers, ethyl 3,5-dimethoxybenzoate (406) was reduced, acetylated, and formylated (by means of the Vilsmeier–Haack reaction) to produce 407. An oxidative cyclization of this last compound led to naturally occurring 5,7-dimethoxyphthalide (221), which was mono- or bidemethylated with AlCl3 to yield the corresponding natural phthalides 90 and 91 (see Chart 28) [355].
Similarly, Talapatra and Talapatra synthesized these three natural phthalides starting from methyl 2-formyl-3,5-hydroxybenzoate, with protection and selective reduction with LAH, yielding one of the natural phthalides (221). Compounds 90 and 91 were obtained through partial or total demethylation, almost in the same conditions reported previously (see Chart 29) [356].
The synthesis of 3-substituted phthalides, among them senkyunolides B (37) and C (28), was achieved starting from appropriate 3-hydroxybenzoates (408 or 409) that were converted into nonaflates, to effect cross coupling of the resulting products with alkynes through a palladium-catalyzed Negishi type reaction. Hydrolysis of the resulting 2-alkynylbenzoates (410 or 411) and selective 5-exo-dig cyclization catalyzed by silver powder gave these phthalides in good yield. It is worth mentioning that when AgNO3 was used as the catalyst instead of Ag powder, the resulting products were the analogous isocoumarins. In addition, senkyunolide E (30) was synthesized by saponification of methyl 2-(3-hydroxypentynyl)benzoate [357]. This procedure is shown in Chart 30.
In a similar manner, Kanazawa and Terada synthesized (Z)-butylidenephthalide (3) from o-pentynylbenzoic acid by means of a nucleophilic intramolecular addition, catalyzed by DBU (see Chart 31) [358].
Kuethe and Maloney employed a method essentially based on halogen–metal exchange of methyl o-iodoesters via a Barbier-type reaction with i-PrMgCl-LiCl, followed by quenching with carbonyl compounds, yielding racemic mixtures of the natural phthalides 3-butylidenephthalide (rac-3) and chrycolide (100) [359] (Chart 32).
Mondal and Argade reported regioselective procedures starting from 5,7-dihydroxyphthalide (90) and an α,β-unsaturated aldehyde, through which it proved possible to obtain selectively two kinds of skeletons, representing an adequate synthetic procedure for salfredin B11 (210) and phthalidochromene (97). When the starting phthalide was treated with DBU or other diaza-bases, a dianion was formed, and the more reactive C-6 anion underwent a nucleophilic attack (1,2-addition) at the carbonyl carbon from 3-methyl-3-butenal. The subsequent attack from oxygen at the remaining vinylic system, followed by dehydration, furnished the linear structure of salfredin B11-like products. However, if 5,7-dihydroxyphthalide (90) was refluxed in methanol, with subsequent additions of the aldehyde, the “angular” tricycle was obtained exclusively, after methylation in the presence of Ag2O, leading to the natural product 97 (see Chart 33) [360].
Wakamatsu and co-workers developed a synthetic pathway consisting of the lithiation of 2-methoxy-N-phenylbenzamide 412 (prepared from the corresponding carboxylic acid) with butyllithium in the presence of TMEDA, followed by nucleophilic attack on (trans)-2-pentenal, hydrolysis, and thermal cyclization, affording phthalide 414, which was further isomerized and demethylated to yield the natural compound (Z)-3-butylidene-7-hydroxyphthalide (25). Similarly, (Z)-3-butylidene-5-hydroxyphthalide (28) was obtained starting from benzamide 413 and phthalide 415 as the intermediate (see Chart 34) [361].
Li’s group synthesized (Z)-ligustilide (8) starting from o-formylbenzoic acid, which was converted into a 1:1 (E)/(Z) mixture of 2-butylidenebenzoic acid through a Wittig reaction, then oxidized with H2O2. The resulting threo/erythro mixture of 8-hydroxy-3-butylphthalide was reduced under Birch conditions, and the hydroxyphthalide obtained was dehydrated, affording 8 (see Chart 35) [362].
Beck and Stermitz reported an improved methodology for synthesizing phthalide 8 in three steps, starting from phthalide, which was treated with lithium diisopropyl amide (LDA) and then butyraldehyde, followed by Birch reduction and dehydration with MsCl (see Chart 36) [89].
Kobayashi and co-workers developed a procedure in which 5,7-dihydroxy-4-methylisobenzofuran-1-(3H)-one (146) was synthesized from benzocyclobutenone 416 (prepared from 2,4-dimethoxybenzaldehyde, which was brominated and then reduced through a Clemmensen reaction to afford 1-bromo-2,4-dimethoxy-5-methylbenzene, and then treated with 1,1-dimethoxyethylene under Birch conditions. This compound (416) was transformed into the natural phthalide through reduction (LiAlH4) and subsequent oxidation (with Pb(OAc)4) [363]. Phthalide 146 can be used for the synthesis of MPA (141), so it constitutes a formal synthesis of the last-mentioned compound (see Chart 37).
The synthesis of naturally occurring 7-hydroxy-4,6-dimethylphthalide (247) was achieved by Takei and co-workers by means of the silylation of butenolide 417 with trialkylsilyl chloride, furnishing a furan-type diene 418. The key step in this synthetic procedure was the Diels–Alder reaction between the former compound and maleic anhydride, for which the product, under hydrolysis, yielded the substituted phthalic anhydride 419. This product was selectively reduced with NaBH4 (as a result of chelation of sodium cation with the hydroxy and carbonyl groups; intermediate 420), yielding 247 (see Chart 38) [364].
Allison and Newbold accomplished the synthesis of naturally occurring 5,7-dihydroxyphthalide (90) and 7-hydroxy-5-methoxyphthalide (91) by benzylic bromination of ethyl dibromo orsellinate (421) or ethyl everninate (422) (producing 423 and 424, respectively), followed by treatment with aqueous dioxane, which furnished 91. To obtain 90, a further step of hydrogenolysis of 425 was necessary. An alternative method to obtain 91, also using the hydrolysis/cyclization process as an essential feature, took advantage of the by-product of the bromination reaction, i.e. the dibromo derivative of ethyl everninate, which, after hydrolysis, furnished phthalide 426. Through a hydrogenolysis of the resulting product, the bromine atom attached to C-4 was replaced by hydrogen, yielding 91 [365] (Chart 39).
Canonica and co-workers carried out the preparation of the phthalide framework necessary for the synthesis of MPA (141), via Michael addition of sodium diethylmalonate to 3-methyl-3-penten-2-one and subsequent Dieckmann condensation. The resulting product was aromatized and then methylated; the corresponding acid was obtained under hydrolysis, and its chloride was prepared and reacted with ammonia, producing an amide, which was N-chlorinated. The product was photolytically converted and demethylated to produce 146, which after alkylation and other functional group transformations, yielded 141 (see Chart 40) [366].
Mali and Patil reported a synthesis procedure in which a Wittig reaction between 427 and n-butylidenetriphenylphosphorane provided the corresponding vinyl benzoic acid, which was iodinated and cyclized with I2/KI aqueous solution. After treatment with NaOAc in EtOH, HI was eliminated. Finally, the oxygen at C-7 was demethylated with AlCl3 in CH2Cl2 to yield (Z)-3-butylidene-7-hydroxyphthalide (25), a natural compound isolated from Ligusticum wallichii (see Chart 41) [367].
Thibonnet’s group synthesized natural phthalides 432 and 433, using as a key step a Sonogashira coupling-oxacyclization, between o-iodobenzoic acid 428 and acetylenes 429 or 430. It is noteworthy that due to the presence of methoxy substituents on benzene, the only observed products are phthalides 431 and 432, from a 5-endo-dig oxacyclization, and not the coumarin, which would be formed through a 6-exo-dig attack (see Chart 42) [368].
Ohzeki and Mori used a simple two-step procedure consisting of ortho-lithiation of N,N-diethyl-o-methoxybenzamide (434) followed by nucleophilic attack on pentanal and lactonization to obtain a racemic mixture of 3-butyl-7-hydroxyphthalide (rac-212) (see Chart 43) [369].
6.1.3 Lactone Ring Formed Prior to Benzene Ring
Maldonado and co-workers reported an original synthesis of demethyl nidulol (435), a natural phthalide from Aspergillus nidulans (Eidam) G. Winter and A. duricaulis, where the formation of the lactone preceded the formation of the benzene ring. The procedure consisted of the preparation of compounds 436 and 437, which were able to undergo an intramolecular Michael addition from the anion of the diactivated methylene moiety to the α,β-unsaturated propargyl or iodovinyl carbonyl fragments to afford the lactone ring. A subsequent Dieckmann condensation led to 435 (see Chart 44) [370].
6.1.4 Stereoselective Syntheses of Phthalides
Butylphthalide (4), (+)-matteucen C ((+)-122), (−)-matteucen C ((−)-122), and demethyl pestaphthalide (216), were synthesized by Santhosh and co-workers, as shown in Chart 45, via oxidative cyclization of the corresponding o-cyanostyrenes (437, 438, and 439), achieved with chiral oxo osmium complexes AD-mix (α- or β-). The mechanism of cyclization was investigated through indirect experiments, and was suggested to consist of oxidation of the carbon–carbon double bond with two of the oxygen atoms bonded to osmium, followed by nucleophilic attacks of the benzylic oxygen to nitrile carbon and of nitrile nitrogen to osmium. Subsequent hydrolysis yielded the desired phthalide. It is worth mentioning that the synthesis of both (+)- and (−)-matteucen C (122) confirmed the syn relationship of the substituents at C-3 and C-8 (See Chart 45) [371].
Koert and co-workers prepared (+)-pestaphthalide A (213) and (−)-pestaphthalide B (214), as depicted in Chart 46, by a stereodivergent synthesis from 2,6-dimethoxytoluene, which was selectively meta borylated. The resulting arylboronate was submitted to Suzuki-Miyaura coupling with (Z)-1-bromopropene, delivering a (Z)-alkene, which was epoxidized asymmetrically under Katsuki–Jacobsen conditions, and subsequently hydrolyzed either with aqueous perchloric acid in the presence of manganese III catalyst, or with aqueous 10-camphorsulphonic acid, leading to 4:1 and 1:3 mixtures of cis/trans diols, respectively. The former was converted into cyclic carbonates with triphosgene. The convenient carbonate was subjected to bromination (with NBS), and then bromine–lithium exchange yielded an intermediate that rearranged to the corresponding phthalide, when heated to 20°C (see Chart 46) [372].
Watanabe and co-workers prepared a mixture of enantiomerically pure (−)-(S)-sedanenolide (senkyunolide A, 15) and (−)-(3S)-butylphthalide (4) and a mixture of their enantiomers. This was achieved by esterification of 2,4-pentadienoic acid with the appropriate enantiomer of 1-heptyn-3-ol. The resulting ester was cyclized through a Diels–Alder reaction to give the corresponding mixture of (–)-(S)-sedanenolide (15) and (−)-(3S)-butylphthalide (4) or their enantiomers (see Chart 47) [373].
In another approach, summarized in Chart 48, (R)-butylphthalide ((R)-4) and other phthalides were prepared enantioselectively via Grignard-type reactions with o-oxazynyl-substituted benzaldehydes as electrophiles, yielding the appropriate alcohol in a diastereoselective manner, according to the Felkin–Ahn model. Hydrolysis of the oxazine moiety led to the corresponding ethylacetal, which, after oxidation with MCPBA and BF3·OEt2, afforded phthalide (R)-4 [374].
A reverse Wacker oxidation, aided by the presence of lactone oxygen, was used by Brimble and co-workers to prepare (−)-herbaric acid ((−)-169), in the following manner. An enantiomerically pure benzylic alcohol (accessible by enzymatic resolution), was reacted with carbonyl diimidazole (CDI) and diethylamine, yielding a carbamate, which was lactonized by bromine–lithium exchange. The desired product ((−)-169) was obtained from the 5,7-dimethoxy-3-vinyl-phthalide, by reverse Wacker oxidation (PdCl2, CuCl, O2, DMF), oxidation of the resulting aldehyde (oxone, DMF), esterification, demethylation, and hydrolysis. This procedure is depicted in Chart 49 [375].
The syntheses of both enantiomers of acetophthalidin (S)-(170) and (R)-(170) were accomplished by Kitahara and co-workers, through stereoselective Sharpless dihydroxylation of 5-(1-propenyl)-bisbenzyl-resorcinol with either AD-mix-α or AD-mix-β, yielding (S,S)- and (R,R)- hydroxyphthalides, respectively. Oxidation of the alcohol to the ketone with Dess–Martin periodinane, followed by hydrogenolysis, yielded the enantioenriched (S)-(170) and (R)-(170) (see Chart 50) [376].
In order to confirm the configuration of (−)-3-butyl-4-hydroxyphthalide (65), Mitsuhashi’s research group developed an asymmetric synthesis for this compound, as shown in Chart 51. Thus, the chiral aminal of m-methoxybenzaldehyde (441) was ortho-alkylated stereoselectively with n-pentanal, and, after acidulation, a diastereomeric mixture of lactols was obtained. This mixture was oxidized to the corresponding lactone and the methyl ether was deprotected with BBr3, affording phthalide 65 [108].
Another approach for the syntheses of chiral 3-substituted alkylphthalides with high enantiomeric excesses, was the use of o-phthalaldehyde. This, after reaction with an appropriate enantiomerically pure N-alkylvalinol, yielded oxazolidinyl benzaldehyde 442, which was reacted with alkylmetallic reagents. The resulting product was further transformed to give enantioenriched 3-substituted natural phthalides (4, 443, 444). The stereoselective alkylation step was strongly influenced by the solvent, achieving enantiomeric excesses up to 90% of the (R)-enantiomer in a mixture of THF and dioxane, and 33% of the (S)-enantiomer in diethyl ether (see Chart 52) [151].
Both enantiomers of 3-butyl-7-hydroxyphthalide (212) were synthesized by Ohzeki and Mori, starting from methyl 2,6-dihydroxybenzoate, which was alkylated through a Suzuki–Miyaura coupling. The resulting olefin was dihydroxylated with either AD-mix-α or AD-mix-β to obtain enantiomerically pure diols. Further transformations gave both (R)- and (S)-enantiomers of the phthalide. The well-known stereochemistry of the Sharpless’ epoxidation was used to confirm the configuration of the natural product as (S) (see Chart 53) [369].
6.2 Synthesis of Dimeric Phthalides
The synthesis of dimeric phthalides has been studied, mainly using (Z)-ligustilide (8) as starting material. It is interesting to note that dimeric phthalides have been isolated as racemic mixtures from members of the Apiaceae (Umbelliferae) plant family, and have displayed several biological activities (see Sect. 7). Diligustilide (levistolide A, 23) and tokinolide B (43) have been derivatized to enantiomerically pure compounds, as described in Sect. 5.2.2.
6.2.1 [π4s + π2s] Cycloadditions
Wakamatsu and co-workers [320] described the preparation of diligustilide (levistolide A, 23) and tokinolide B (43) from (Z)-ligustilide (8), by a Diels–Alder process. It was observed that tokinolide B (43) was transformed partially to levistolide A (23) under the reaction conditions (Chart 54). Calculations of HOMO and LUMO of (Z)-ligustilide (8) were also carried out to explain the regioselectivity of the dimers formed. A similar thermal reaction in a sealed tube of (Z)-ligustilide (8) allowed its conversion to diligustilide (23), confirming the regio- and stereoselectivity of the reaction [321] (see Chart 54).
6.2.2 [π2s + π2s] Cycloadditions
Although the majority of natural dimeric phthalides are formed by [π4s + π2s] reactions, several dimeric phthalides such as riligustilide (24), tokinolide A (42), and endo-(Z,Z′)-[3.3′,8.8′]-diligustilide (445) are biosynthesized through [π2s + π2s] cycloadditions [72, 304, 377, 378].
The situ-, regio- and stereochemical possibilities of the three olefins of (Z)-ligustilide (8) have been considered in the formation of [π2s + π2s] photocyclodimers, but there are no direct guidelines available to predict the structure of the products. (Z)-Ligustilide (8) was exposed to photochemical conditions, affording the natural product riligustilide (24), endo-(Z,Z′)-[3.8′,8.3′]-diligustilide (446), endo-(Z,Z′)-[3a.7a′,7a.3a′]-diligustilide (447) and exo-(Z,Z′)-[3a.7a′,7a.3a′]-diligustilide (448) (Chart 55). It was found that in the triplet state the carbon atoms of the side chain of 8 were quasi-coplanar with the lactone ring, bringing down the steric hindrance for the transition states, and also that the regioselectivity was determined by orbital coefficients and energies. Frontier molecular orbitals and Mülliken charge calculations agreed with the experimental yields obtained for the reaction products [378].
7 Biological Activity
The evaluation of biological activity has been a prominent aspect of phthalide research. While a number of biological activities have been attributed to natural product extracts containing phthalides, these data have been complicated by the presence of more than one active constituent (i.e. the biologically active constituents are not exclusively phthalides). With this in mind, the present contribution reviews mainly the bioactivities of natural and semisynthetic phthalides as pure compounds.
Several reviews on related topics have been published [1, 114, 379–382], with some of them focusing exclusively on one compound, such as mycophenolic acid (141) [318] or noscapine (128) [383–386]. The current review is neither intended to be a comprehensive treatment of the biological activity of natural phthalides as whole, nor on the individual compounds mentioned. Instead, an integrated overview is presented of the most relevant biological activities of this type of compounds is presented here.
7.1 Antioxidant Effects
Several human diseases are associated with oxidative damage. The overproduction of reactive oxygen species (ROS) damages the cell [387], and eukaryotic cells have developed defensive enzymatic systems. (Z)-Butylidenephthalide (3), (Z)-ligustilide (8), senkyunolide I (22), sinaspirolide (70), and ansaspirolide (71), were screened for their antioxidant activity at 100 μM. All these compounds showed activity in scavenging 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals. Also, ansaspirolide (71) was the most active in inducing the activity of NAD(P)H-quinone oxidoreductase 1 (NQO1), but was also cytotoxic for the host hepatoma cells (Hepa1c1c7). (Z)-Butylidenephthalide (3) and (Z)-ligustilide (8) also successfully induced NQO1. The transcription of several antioxidant enzymes is regulated by antioxidant response elements (ARE) in promoter units. (Z)-Ligustilide (8) induced ARE reporter activity in a dose-dependent manner (5–20 μM) [388]. Senkyunolides I (22) and H (26) both induced heme oxygenase-1 (HO-1), with senkyunolide H showing the most potent effect, and the induction was related to the activation of Nrf2 (nuclear factor E2-related factor-2)/ARE pathway. Both compounds were inhibitors of ROS formation and lipid peroxidation in human liver hepatocellular carcinoma cells (HepG2) [389]. Colletotrialide (226) demonstrated a low antioxidant activity, scavenging DPPH with an IC50 value of >324 μM. It also inhibited weakly superoxide anion radical formation (by xanthine/xanthine oxidase) (IC50 > 648 μM); superoxide anion radical generation (in differentiated human promyelocytic leukemia cells (HL-60)) (IC50 > 130 μM); xanthine oxidase (IC50 > 648 μM), and aromatase (IC50 > 16.2 μM) [222].
The antioxidant properties of (Z)-ligustilide (8) and cis-(Z,Z′)-3a.7a′,7a.3a′-diligustilide (447) have been assessed using human umbilical vein endothelial cells (HUVECs), evaluating the oxidative damage caused by hydrogen peroxide (H2O2). Treatment with 447 protected HUVECs (IC50 = 15.14 μM), with (Z)-ligustilide (8) displaying an IC50 of 0.55 μM. Lactate dehydrogenase (LDH) leakage provoked by H2O2 was also reduced by 447 at concentrations of 25, 50, and 100 μM. The application of 447 also increased superoxide dismutase (SOD) activity and decreased malondialdehyde (MDA) levels, confirming its antioxidant properties [387].
Epicoccone (195) prevented lipid peroxidation (62%) when used at 37 μg/cm3 [205], while isopestacin (193) was found to scavenge hydroxyl radicals at a concentration of 0.22 mM and the superoxide radicals at 0.185 mM [203].
7.2 Analgesic Effects
(Z)-Ligustilide (8) has analgesic effects, since administration to mice at doses of 2.5, 5, and 10 mg/kg (p.o.), caused a dose-dependent reduction in the both the writhing response induced by acetic acid and formalin-induced licking time [390]. Compound 8 has also been evaluated at the higher dosages of 20, 60, and 100 mg/kg, with the same results: a delayed licking time and reduced writhing response both occurred [391]. In a similar study, (Z)-butylidenephthalide (3), (Z)-ligustilide (8), and diligustilide (23), suppressed the irritation induced by acetic acid, with diligustilide (23) showing the greatest effect. (Z)-Butylidenephthalide (3) and (Z)-ligustilide (8) also demonstrated an antinociceptive effect when using a hot-plate assay [392].
7.3 Antihyperglycemic Effects
Type 2 diabetes mellitus is a chronic condition associated with abnormal levels of blood glucose. Both (Z)-butylidenephthalide (3) and (Z)-ligustilide (8) decreased the postprandial blood glucose peak in mice treated with streptozotocin [393]. (Z)-Butylidenephthalide (3) also inhibited the activity of yeast α-glucosidase in vitro in a concentration-dependent manner (IC50 = 2.35 mM). Docking analysis (using the (E)-isomer (21)) showed that this compound binds close to the catalytic site [393].
In screens for competitive binding to PPAR-γ, paecilocin A (245) used at 100 μM demonstrated comparable activities to rosiglitazone, a PPAR-γ agonist used for the treatment of type 2 diabetes mellitus. Compounds 449 and 450 also showed comparable binding properties to rosiglitazone, whereas 451–454, which contain benzyl or methyl groups, were less effective. The introduction of additional substituents failed to enhance activity, as shown for compounds 452–454 and 457–460. Phthalides 455 and 456 showed no enhanced activity, with compound 455 slightly more active than 456 [394].
7.4 Antithrombotic and Antiplatelet Effects
Thrombosis is the main cause of the thromboembolic complications of ischemic disorders. One pharmacological strategy has been to re-establish the blood flow to the ischemic site by dissolving the clot. Another strategy is to prevent clot formation. To this end, the search for new antithrombotic agents has continued [395]. (Z)-Ligustilide (8), administered for three days at doses of 10 or 40 mg/kg (p.o.), demonstrated both antithrombotic and antiplatelet activities [395]. (Z)-Butylidenephthalide (3) showed antiplatelet activity, and inhibited the aggregation of washed rabbit-derived platelets, induced by collagen, arachidonic acid, platelet activating factor, and adenosine diphosphate (ADP). (Z)-Butylidenephthalide (3) also inhibited the release of adenosine triphosphate (ATP) from these platelets [396]. (R)-Butylphthalide (ent-4) and (S)-butylphthalide (4) inhibited also platelet aggregation [397], with blood viscosity reduced by rac-butylphthalide (rac-4), cnidilide (7), senkyunolide A (15), senkyunolide P (40), and tokinolide B (43) [398].
7.5 Neurological Effects
7.5.1 Stroke
Stroke is a leading cause of disability in adults and is the third most prevalent cause of mortality in the world [399, 400]. Treatment options are currently limited. Intraperitoneal administration of (Z)-ligustilide (8) to mice undergoing transient forebrain cerebral ischemia/reperfusion (I/R), at dosages of 5 and 20 mg/kg, reduced infarct volume in a dose-dependent manner. The administration of 8 also decreased MDA content, restored the activities of glutathione peroxidase (GSH-PX) and SOD in ischemic brain tissues, and regulated pro- and antiapoptotic effector proteins [401]. Oral administration of (Z)-ligustilide (8) at doses of 20 or 80 mg/kg to rats with middle cerebral artery occlusion (MCAO) also showed, after 24 h of obstruction, a marked reduction in infarct volume and brain edema. (Z)-Ligustilide also ameliorated neurobehavioral impairment and improved survival rate [400]. In terms of the immune response, microglia are activated during ischemia. Both (Z)-ligustilide (8) and senkyunolide A (15) inhibited neuroinflammation, blocked the production of TNF-α and nitrites in murine microglial cells (BV-2), and reduced TNF-α production from peripheral blood monocyte-derived macrophages (PBMac) [399].
Oral administration of (Z)-ligustilide (8) at doses of 20, 40 or 80 mg/kg, 3 and 0.5 h before the MCAO procedure, reduced the neurological deficit score, and the infarct volume in a dose-dependent manner. The expression of erythropoietin (EPO, an endogenous protective factor) was also enhanced and the level of the stress-induced protein RTP801 (an endogenous detrimental factor) was reduced. The cytoprotection conferred by EPO could be mediated by the phosphorylation of ERK promoted by 8. (Z)-Ligustilide (8) also increased cell viability and decreased the leakage of LDH, although concentrations above of 5 μM were cytotoxic to neurons maintained in cell culture. Transfection of human neuroblastoma cells (SH-SY5Y) with the pcDNA3.1-RTP801 plasmid DNA increased LDH leakage and RTP801 expression, both of which were inhibited by (Z)-ligustilide (8) [402]. Compound 8 protected PC12 cells from apoptosis induced by oxygen-glucose deprivation (OGD), induced tolerance to oxidative stress, induced HO-1 expression, and promoted translocation of Nrf2 [403] to the nucleus (an inducible transcription factor that regulates multiple cellular antioxidant systems during stroke) [404]. (Z)-Ligustilide (8) also regulated the homeostasis of glutathione (GSH) [403].
Zhu et al. evaluated the effect of (Z)-ligustilide (8) on the Nrf2/HO-1 pathway, and it was found that this compound provoked a significant decrease of infarct volume, improved neurological function, and attenuated neuronal loss (at 16 and 32 mg/kg, i.v.) in transient MCAO-induced damage [404]. The results concerning the Nrf2 and HO-1 proteins were similar to those obtained by Rong et al. [403]. (Z)-Ligustilide (8) activates the Nrf2 pathway, with its protective action possibly mediated by the Nrf2/HO-1 pathway [404]. Noscapine (128) improved clinical prognosis in ischemic stroke patients [405].
Subarachnoid hemorrhage (SAH) is a stroke subtype that can lead to cerebral vasospasm. The treatment of rats with (Z)-ligustilide (8) at a dose of 20 mg/kg improved neurobehavioral scores, reduced edema, improved the permeability of the blood brain barrier, and with vasospasms diminished. (Z)-Ligustilide (8) may ameliorate tissue damage caused by SAH by mechanisms that involve apoptosis [406].
Permanent bilateral ligation of the common carotid artery is an experimental model for cerebral hypoperfusion (used for the study of dementia), which impairs memory and learning. Administration of (Z)-ligustilide (8) prevented the structural and functional abnormalities in the brain of rats subjected to this procedure. (Z)-Ligustilide also protected the hippocampus from damage, ameliorated cognitive deficits, decreased MDA and acetylcholinesterase (AChE) levels, and increased the activity of the SOD and choline acetyltransferase (ChAT) [407].
7.5.2 Alzheimer’s Disease and Cognitive Impairment
Alzheimer’s disease is a progressive neurodegenerative disease characterized by damage to the regions of the brain that regulate cognitive function in the elderly [408]. The cytotoxicity induced by the amyloid β-peptide (Aβ) in Alzheimer’s disease, together the effects of (Z)-ligustilide (8) and 11-angeloylsenkyunolide F (41), have been evaluated. Cell viabilities following exposure to Aβ1–40 were 61.6 and 69.4%, respectively, at 10 and 50 μg/cm3 for (Z)-ligustilide (8). The same concentrations of 11-angeloylsenkyunolide F (41) produced viabilities of 59.5 and 67.1%. The toxicities of these compounds were also analyzed, with 50 μg/cm3 (Z)-ligustilide (8) shown to be toxic (53.0% of cell viability) [408].
A second group of investigators reported cytotoxicity data using Aβ25–35 and oral administration of 8 (40 mg/kg) for 15 days (from the 6th to 20th day). (Z)-Ligustilide (8) prevented cognitive dysfunction and attenuated the morphologic changes and neuronal loss induced by injection of Aβ25–35. The injection of Aβ25–35 increased the expression of Aβ, amyloid precursor protein, and Tau protein, with (Z)-ligustilide (8) preventing all of these effects [409].
Some studies have suggested that the widespread loss of ACh-containing neurons, and the reduction in activity of ChAT, are early biological signs of Alzheimer’s disease. (Z)-Ligustilide (8) (at 10 or 40 mg/kg daily for 26 days) was tested on an model of Alzheimer’s disease using scopolamine, which increases AChE activity and decreases ChAT activity. Phthalide 8 improved spatial long-term memory, prevented spatial short-term memory deficits, inhibited AChE activity (IC50 = 6.48 mg/kg), and increased ChAT activity (ED50 = 7.66 mg/kg) [410]. (Z)-Ligustilide (8) has also demonstrated a cytoprotective effect, and protected against the cognitive impairment and neurotoxicity induced by d-galactose (at a dose of 80 mg/kg/8 weeks) in aged mice brains, by improving spatial learning and memory. MDA levels and the expression of cleaved caspase-3 were both diminished on the administration of 8. The decline in activity of Na+–K+-ATPase provoked by d-galactose was also prevented by (Z)-ligustilide (8), with a diminution of astrocytic activation [411].
Phthalide NG-072 (48) has been reported to be effective in the potential treatment of Alzheimer’s disease, by enhancing axon growth [84].
7.5.3 Parkinson’s Disease
Parkinson’s disease is a neurodegenerative pathology characterized by a progressive loss of dopaminergic nigrostriatal neurons. Current therapies for Parkinson’s disease depend mainly on dopamine replacement using levodopa (l-dopa) and antioxidants; however, there is certain evidence of the toxicity of dopamine and its metabolites. Dopamine at concentrations ranging from 200 to 800 μM affected the viability of PC12 cells in a concentration-dependent manner. (Z)-Ligustilide (8) used at 50 μM decreased cell viability by 9.6%, but the combination of 8 (50 μM) and dopamine (500 μM) was even more cytotoxic to PC12 rat dopaminergic cells, reducing viability by almost 90%. The same treatment as for PC12 on the SH-SY5Y (human neuroblastoma), HepG2 (human hepatoma), MCF-7 (human breast adenocarcinoma), HeLa (human epithelial carcinoma), and PC3 (human prostate cancer) cell lines, revealed that only the dopaminergic cell lines were adversely affected. Cells treated with dopamine or (Z)-ligustilide (8) died via apoptosis and necrosis, with a mixture of these compounds increasing levels of cell death to 56.8%, and decreasing GSH levels to 28.8% [412].
7.5.4 GABAergic and Sedative Effects
The GABAA receptor is a target for drugs that modulate sedative, anxiolytic, anticonvulsant, muscle relaxant, and amnesic activities. Binding to the GABAA receptor using [3H] flunitrazepam and diazepam as positive controls, demonstrated that both gelispirolide (68) and riligustilide (24) inhibited [3H]diazepam binding to GABAA receptors (the IC50 values were 29 and 24 μM) [109].
(Z)-Ligustilide (8) at 5–20 mg/kg, and (Z)-butylidenephthalide (3) at 10–30 mg/kg (i.p.) reversed pentobarbital-induced sleep shortened by social isolation stress. Both phthalides (at 20 mg/kg) attenuated the effects of methoxamine and yohimbine, which decreased the time of the pentobarbital sleep period. (Z)-Ligustilide (8) potentiated the effects of diazepam in pentobarbital-induced sleep in mice, suggesting noradrenergic suppression. Both phthalides also attenuated the effect of a benzodiazepine receptor inverse agonist. Taken together, the GABAA receptor may be implicated in the activity of these compounds [413].
The hypnotic time induced by sodium pentobarbital in mice increased significantly by pretreatment with 50 mg/kg of (Z)-ligustilide (8), diligustilide (23), tokinolide B (43), senkyunolide F (31) and several semi-synthetic products, including the diketo diacid of diligustilide (345), demethylwallichilide (344), rel-(3′S)-3′,8′-dihydrodemethylwallichilide (461), and rel-(3′R)-3′,8′-dihydrotokinolide B (462). The increases in hypnosis, expressed as percentages, were 46.3, 24.6, 70.8, 34.6, 66.0, 52.3, 36.2, and 100%, respectively. Compounds 43 and 462 demonstrated the highest activities [276]. In the same model, compounds 15 and 4 displayed similar effects [414]. Phthalideisoquinolines, (+)-bicuculline (111) [415, 416], (+)-hydrastine (112), and corlumine (110) were found to be antagonists of the GABAA receptor, with the most potent antagonist proving to be 112, with 111 more potent than 110; all three phthalides are convulsive agents [417].
7.5.5 Anticonvulsive Effects
Epilepsy is a disorder characterized by abnormal neuronal electrical activity [418] with periodic and unpredictable seizures [419]. rac-Butylphthalide (rac-4) and senkyunolide A (15) were shown to be anticonvulsive agents against metrazole, electroshock-, and audio-induced seizures [420]. Yang et al. confirmed the anticonvulsive effects of both phthalides [421]. rac-Butylphthalide protected against chronic epilepsy induced by coriaria lactone [422], and at 700 mg/kg prevented abnormalities in the hippocampus [423]. Both enantiomers of butylphthalide (4) protected from the seizures induced by electro-shock [424].
7.6 Progestogenic Effects
The hormone progesterone is necessary for menstrual and reproductive health. During menopause, hormone replacement therapy is an effective treatment against hormonal disorders. Some phthalides have shown progesterone-like activity. For example, 3,8-dihydrodiligustilide (63) (EC50 = 91 nM) was shown to be a potent and specific activator of the progesterone receptor, with riligustilide (24) (EC50 = 81 μM) displaying weaker activity. Levistolide A ((23) (Z,Z′)-diligustilide) was inactive, which demonstrates the importance of minor structural variations in this type of molecule for biological activity [106].
7.7 Cytotoxic Effects
The current lack of specificity for multiple antitumor therapies has led to a search for novel, more targeted agents [219]. 3-Methyl-4,5,6-trihydroxyphthalide (198) is an agent that has been tested for activity against the serine/threonine-protein kinase Akt1, which regulates metabolism, proliferation, and cell survival, and showed an IC50 value of 19.7 μM. The IC50 for the functional inhibition of Bad phosphorylation by Akt1 was 30.4 μM [208]. Cytotoxicities for 198 against several cancer cell lines are listed in Table 1.
In the treatment of liver fibrosis, suppression of the growth of liver stellate cells (HSC) with the induction of apoptosis has been suggested to be a plausible therapeutic approach. (Z,Z′)-[6.8′,7.3′]-Diligustilide (24) and levistolide A (23) ((Z,Z′)-diligustilide) were found to reduce the cell proliferation stimulated by platelet-derived growth factor (PDGF-BB) in immortalized liver stellate cells (HSC-T6) and in immortalized human stellate cells (LI-90), with 23 showing a higher potency than 24. Both compounds induced apoptosis in HSC stimulated by PDGF-BB, without significant toxicity to primary hepatocytes, when used at 5–40 μM for 24, and 1–20 μM for 23 [425].
Noscapine (128) has been in Phase I/II clinical trials for non-Hodgkin’s lymphoma or chronic lymphocytic leukemia refractory to chemotherapy [426]. In addition, noscapine also displayed activity against HT-29, colon carcinoma (SW480), and the human colon adenocarcinoma (LoVo) cell lines, with selectivity against the latter cell line (IC50 = 75 μM) [427]. There have been several studies of the bioactivity of noscapine (128), which concluded that its mechanism of action is related to microtubule assembly [428–430].
Topoisomerases are enzymes that are involved in the progression of the cell cycle and their inhibition can be used as targets for cancer chemotherapy. Senkyunolides N (52) and J (33), and sedanolide (6) exhibited inhibitory effects against topoisomerases I and II, with 6 completely inhibiting both enzymes at 100 μg/cm3 [431]. The cytotoxic and antiproliferative effects of senkyunolide A (15), (Z)-ligustilide (8), and (Z)-butylidenephthalide (3) were evaluated using the human colon cancer cell line (HT-29) and the normal human colon fibroblast cell line (CCD-18Co). The phthalides decreased cell viability for tumor-derived cell lines (IC50 values ranging from 8.6 to 51.2 μM), without any significant effect on the viability of normal cells. Of these agents, senkyunolide A (15) was the most selective [432].
(Z)-Butylidenephthalide (3) prevented cell cycle entry in glioblastoma multiforme brain tumor cells, when used at 75 μg/cm3. This compound also induced apoptosis and prolonged the survival of mice after malignant brain tumor cell implantation [433].
(S)-3-Butyl-7-methoxyphthalide (212) is a natural product that has been previously synthesized; its IC50 values against several cell lines are shown in Table 2 [217].
Compound 199 displayed activity against HeLa and KB cells (IC50 36.0 and 14.0 μg/cm3) [210, 212]. Porriolide (200) also displayed activity against KB cells (IC50 = 59.0 μg/cm3) [209]. Phthalide 199 induced apoptosis, with the authors suggesting that proliferation was inhibited by a G1 phase arrest in HeLa cells [212].
Hanabiratakelides A ((218) HA), B ((219) HB), and C ((220) HC) were found to display cytotoxic activities against colon cancer cells (Caco-2 and colon-26 cells). The respective IC50 values for HA (218) and HC (220) were 342 and 535 μM in Caco-2 cells. In turn, the IC50 values for colon-26 cells were 96 μM for HA (218), 18 μM for HB (219), and 49 μM for HC (220). These compounds also showed superoxide dismutase (SOD)-like activity, with IC50 values of 15.7, 49.0, and 3.2 μM for HA (218), HB (219), and HC (220), respectively [219].
Marilones A (203), and C (205) also showed weak cytotoxic activities against three cell lines: NCI-H460 (lung), MCF7 (breast), and SF268 (central nervous system). Cytotoxicities were comparable for 203 (LC50 > 100 μM) and 205 (LC50 = 99.6 μM) against NCI-H460 and MCF7 [214].
Colletotrialide (226) has been tested against several cell lines with IC50 values of 162.1 μM for HuCCA-1, HepG2, and the A549 cell lines, and slightly less, at 147.8 μM, for the acute lymphoblastic leukemia line (MOLT-3) [222].
Several additional natural and semi-synthetic phthalides have been assayed for their bioactivities against three cancer cell lines. The enantiomers (–)-348, (+)-349, (+)-348, (–)-349, (–)-350, (+)-350, (+)-351, (–)-351, were more active (see Table 3), with helenalin used as a positive control [118, 334, 335].
5-(3′,3′-Dimethylallyloxy)-7-hydroxy-6-methylphthalide (463) exhibited moderate activity against the myeloid liver carcinoma (SMMC-7721) and MCF-7 cell lines, with IC50 values of 1.8 and 29.0 μM [434].
Multi-drug resistance (MDR) is an obstacle for many current cancer therapies. One of the mechanisms involved in MDR is the elimination of compounds by conjugating them by phase II enzymes, including glutathione S-transferase (GST). 11-Angeloylsenkyunolide F (41) and tokinolide B (43) inhibited GST enzyme (IC50 16.8 and 7.3 μM, respectively), in a reversible and noncompetitive process, docking analysis showed that both compounds interacted with the active site. Compounds 41 and 43 showed low cytotoxicity against the A549 and MDA-MB-231 cell lines, with both reversing MDR in these cell lines [435].
7.8 Inhibition of the Abnormal Proliferation of Vascular Smooth Muscle Cells
Another biological activity that has been investigated for natural occurring phthalide derivatives is the proliferation of vascular smooth muscle cells. Abnormal proliferation is seen in atherosclerosis and in atherosclerotic plaques [436, 437]. Some phthalides have been reported to inhibit this proliferation in a concentration-dependent manner. Senkyunolide H (26) was the most active (IC50 = 0.1 μg/cm3) of the following compounds: (Z)-butylidenephthalide (3) (IC50 = 3.25 μg/cm3), (Z)-ligustilide (8) (IC50 = 1.68 μg/cm3), senkyunolide A (15) (IC50 = 1.52 μg/cm3), and neocnidilide (6) (IC50 = 6.22 μg/cm3). 3-Butylphthalide (4), cnidilide (7), and senkyunolide I (22) also demonstrated weak effects [436].
Kobayashi et al. also investigated the effect of various phthalides on the competence and progression of the cell cycle proliferation. The most active phthalide was senkyunolide L (45), followed by senkyunolide H (26), senkyunolide J (33), senkyunolide I (22), (Z)-ligustilide (8), senkyunolide A (15), and (Z)-butylidenephthalide (3) [437].
The effect of phthalide 8 on the abnormal proliferation of vascular smooth muscle cells was related to its inhibition of ROS production [438]. (Z)-Butylidenephthalide (3) and (Z)-ligustilide (8) both inhibited the proliferation of vascular smooth muscle cells stimulated with basic fibroblast growth factor [439]. Compound 8 also displayed positive effects in a rat model of atherosclerosis [440].
7.9 Insecticidal Effects
The larvicidal activities of (Z)-butylidenephthalide (3) and (Z)-ligustilide (8) were evaluated against Drosophila melanogaster. Compound 3 was found to be more active than 8 (LC50 = 0.94 μmol/cm3 and LC50 = 2.54 μmol/cm3), although both were less effective than rotenone. Acute adulticidal activity, resulting in 100% mortality, was seen when compound 3 was used at a dose of 5.0 μg/adult (LD50 = 0.84 μg/adult), and was more potent than the value obtained for rotenone [441].
(Z)-Ligustilide (8) deterred the biting of both Aedes aegypti and Anopheles stephensi at 25 nmol/cm2 more effectively than N,N-diethyl-3-methylbenzamide, which is considered to be one of the most effective mosquito repellents [442]. Sedanolide (6) showed 100% of mortality at 50 μg/cm3 against A. aegypti [294].
Bemisia tabaci is one of the most important insect pests and participates in the transmission of numerous plant-pathogenic viruses. The most pathogenic biotypes of B. tabaci are the B- and Q-biotypes. The residual contact toxicities of (Z)-ligustilide (8) (LC50 = 268.4 ppm), and (Z)-butylidenephthalide (3) (LC50 = 254.2 ppm) were comparable to cypermethrin, but lower than other insecticides; 3 was more toxic than (S)-butylphthalide (4) (LC50 = 338.9 ppm) against the B-biotype females. The toxicity of these compounds against the Q-biotype females was also tested. (Z)-Ligustilide (8) and (Z)-butylidenephthalide (3) showed more pronounced toxicity against the B-biotype females than the Q-biotype. (Z)-Butylidenephthalide (3) also demonstrated acaricidal activity against two dust mite species, Dermatophagoides farina and D. pteronyssinus [443].
7.10 Bactericidal, Antifungal, Antiviral, Immunosuppressant, and Antiparasitic Effects
Mycophenolic acid (141) is an antibiotic agent with activity against a broad range of microorganisms including Cryptococcus neoformans, Candida albicans, C. stellatoidean, C. tropicalis, C. parakrusei, and Trichophyton species, and showed moderate inhibition of Staphylococcus aureus [444], which has developed some resistance to this antibiotic [445]. Mycophenolic acid (141; MPA) was effective in suppressing psoriasis [446], and its morpholine ester was useful in reducing episodes of allograft rejection [447]. The pharmacokinetics and pharmacodynamics of MPA analogs have been reviewed recently [448, 449].
The increasing prevalence of multidrug resistant organisms has led to the search for new, more effective, and nontoxic agents. (Z)-Ligustilide (8) showed a moderate potentiation of norfloxacin activity against a norfloxacin-resistant strain of S. aureus. It also reduced the minimum inhibitory concentration of norfloxacin (MICnorfloxacin = 16 μg/cm3) at 50 μg/cm3 [450].
Sedanolide (6) displayed 100% mortality against Panagrellus redivivus at 25 μg/cm3, and also against Caenorhabditis elegans at 50 μg/cm3. Senkyunolides N (52) and J (33) also showed nematicidal effects against P. redivivus at 100 μg/cm3 [294].
(Z)-Ligustilide (8) and the semi-synthetic product [7-(methyl thioglycolyl)-(6,7-dihydro)]-(Z)-ligustilide (315) showed weak activities against Bacillus subtilis, Staphylococcus aureus, Candida albicans, Sacharomyces cerevisiae, and Klebsiella pneumoniae. Phthalide 8 also displayed weak antiviral activity. (Z)-Ligustilide has a number of electrophilic sites and can accept nucleophiles, which might explain some of the mechanisms related to these bioactivities [89].
Cytosporone E (197) showed activity against Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, and Candida albicans [207], while corollosporine (279) was active against S. aureus [262]. The antibacterial activity of some synthetic analogs was determined. Data for MIC values and the minimum bactericidal concentrations (MBC) after 24 h against the Helicobacter pylori strain 11637 are listed in Table 4.
Epimers 173 and 178 containing a 5,5-spiroacetal functionality were found to be potent anti-Helicobacter pylori derivatives. The (2″R) diastereomer 464 showed less potent bioactivity than the (2″S) isomer 465 [451].
Spirolaxine (186) and sporotricale (187) showed specific activity against Helicobacter pylori. Awaad et al. also found that (–)-β-hydrastine (383), inhibited the growth of H. pylori (MIC 100 μg/cm3) [452]. Marilone A (203) exhibited antiplasmodial activity (against Plasmodium berghei) in a dose-dependent manner (IC50 = 12.1 μM) [214].
Microsphaerophthalide B (228) and microsphaerophthalide F (232) both displayed activity against Microsporum gypseum SH-MU-4 and Cryptococcus neoformans, respectively, both with a MIC value of 64 μg/cm3. Compound 232 showed weak activity against M. gypseum (MIC = 200 μg/cm3) [180].
(Z)-Butylidenephthalide (3), (S)-butylphthalide (4), (Z)-ligustilide (8), and (E)-butylidenephthalide (21), were evaluated against Mycobacterium tuberculosis H37Rv, and M. bovis BCG. All had comparable IC50 values, ranging from 200 to 250 mg/dm3 [453]. (±)-Concentricolide (466) inhibited the cytopathic effect (EC50 = 0.31 μg/cm3) induced by HIV-1 in C8166 cells [454].
7.11 Herbicidal and Antifungal Effects on Plant Pathogens
The search for agents with phytotoxic and antifungal activities is relevant to the control of weeds in agricultural crops. Convolvulanic acid B (189) was found to be a potent phytotoxic substance, inhibiting growth (100%) and chlorosis of Lemna paucicostata plants at concentrations of 5.9 × 10−4 and 3.5 × 10−4 M, respectively. Convolvulanic acid A (188) and convolvulol (190) also inhibited the growth of L. paucicostata, in turn, by 80% and 50% [201]. Phthalide 201 showed antifungal activity against Gaeumannomyces graminis var. tritici and Cladosporium herbarum. Compound 202 also displayed activity against Cladosporium herbarum [352].
Phthalides 199, 206, 208, and porriolide (200) were evaluated for their activity against Fusarium graminearum, Botrytis cinerea, and Phytophthora nicotianae (see Table 5). Porriolide (200) was found to be the most active phthalide, with MIC values comparable to ketoconazole, which was used as a reference compound [211].
Some phthalides alter the development of plants and fungi. Thus, rubralides A (268) and B (269) inhibited the root growth of Lactuca sativa at 100 mg/dm3 [255], cryphonectric acid (194) influenced the formation of tomato seedlings at 100 μM [204], basidifferquinones A (467), B (468), and C (469) induced fruiting-body formation of Favolus arcularius [455, 456], and isopestacin (193) had an inhibitory effect against Pythium ultimum, a plant pathogenic oomycete [203].
7.12 Bioavailability and Routes of Administration
The majority of previous studies have analyzed the effects of (Z)-butylidenephthalide (3) and (Z)-ligustilide (8), with reports of the low bioavailability of these compounds.
The absorption, distribution, metabolism and excretion of isotopically labeled (Z)-butylidenephthalide (3) after hot or cold dermal administration have been evaluated. Compound 3 was subsequently detected in the liver, bile, and kidney at 0 h, and in the intestinal contents at 4 h. Radioactivity was maximal at 0 h in the skin and plasma (and then decreased, t1/2 0.5–1 h), and was sustained in the liver, bile, and kidney until 1 h, and thereafter accumulated in the small and large intestines, cecum and its contents, reaching maximal values 1–2 h later. Altogether, 70% of the unaltered or metabolized (Z)-butylidenephthalide (3) was captured from the urine at 8 h, increasing to 80% within 24 h; only 5% was excreted into the feces within 24 h. The cysteine conjugate 470 was detected in both the urine and feces. It was demonstrated that (Z)-butylidenephthalide (3) immediately permeated through the skin into the circulatory system [457].
Multiple types of pharmacokinetic studies on (Z)-ligustilide (8) have been conducted. After intravenous (i.v.) administration, compound 8 (15.6 mg/kg) exhibited extensive distribution through the body (Vd 3.76 L/kg), with rapid elimination from the plasma (t1/2 0.31 h). When (Z)-ligustilide (8) was administered intraperitoneally (i.p.) at a low dose (26 mg/kg), it was rapidly absorbed (Tmax 0.05 h) and eliminated (t1/2 0.36 h), with i.p. bioavailability estimated to be 52%, which indicated an extensive hepatic first-pass metabolism. At a higher dose (52 mg/kg), the bioavailability was 98%, suggesting nonlinear and dose-dependent pharmacokinetics. In the case of oral administration, pharmacokinetic parameters could only be obtained at a concentration of 500 mg/kg. Compound 8 was found to be rapidly absorbed (Cmax 0.66 μg/cm3), with oral bioavailability established at 2.6%. Eight metabolites were identified, among them (Z)-butylidenephthalide (3), senkyunolides I (22) and H (26), and 3-hydroxybutylphthalide (471), as well as 11-hydroxyligustilide (472), 473, and 474. All metabolites were generated by NADPH-dependent monooxygenases [458]. Ding et al. also evaluated metabolite production after the oral administration of compound 8 (200 mg/kg), and obtained similar results to those obtained by Yan et al. [458], in addition to characterizing the metabolites 28, 475, and 476 [459].
Compound 8 has a neuroprotective effect (see above) with a rapid onset of action following direct transport from the nasal cavity to the central nervous system (CNS). Phthalide 8 was administered to each rat nostril at 45 mg/kg, and brain tissues were collected at sequential periods of time (5–240 min) after administration. HPLC analyses of the brain tissue homogenates, together with a pharmacokinetic study, showed that 8 could be detected 5 min after administration. It was concluded that intranasal administration of (Z)-ligustilide (8) could have a rapid effect and might be more effective in the treatment of acute CNS diseases [460].
The use of nano-emulsions as a strategy to increase bioavailability is under active consideration. For instance, the anti-inflammatory effects (endotoxin-induced uveitis in rats) of orally administered (Z)-ligustilide (8) versus a nano-emulsion of ligustilide (LIGNE) were evaluated. The emulsion improved absorption given that (Z)-ligustilide (8) (20 mg/kg) was not detectable in plasma, while LIGNE remained detectable for up to 1.5 h. The nano-emulsion also improved the anti-inflammatory effect of 8 [461].
A complex of (Z)-ligustilide (8) and hydroxypropyl-β-cyclodextrin (LIG/HP-β-CD) was also prepared and quantified in rat plasma; its absolute bioavailability was found to be higher than that for (Z)-ligustilide (8) alone [462].
The pharmacokinetics of noscapine (128) were evaluated in male and female mice following oral (75, 150, and 300 mg/kg) and i.v. (10 mg/kg) administration. Noscapine (128) was easily absorbed (Cmax 13.37, 24.48 and 49.47 μg/cm3 in male mice, and 12.18, 22.00, and 44.00 μg/cm3 in female mice). The AUClast at 75 and 150 mg/kg were similar, but at 300 mg/kg were threefold higher, which suggested a nonlinear or saturable behavior. The t1/2 values were similar at 75 and 300 mg/kg, but were lower at 150 mg/kg for both male and female mice. After i.v. administration, 128 was almost undetectable after 3–4 h of infusion; the t1/2 values were 0.39 and 1.05 for males and females, respectively. It was shown that noscapine (128) was absorbed rapidly, and widely distributed at all doses [426].
8 Concluding Remarks
Studies on the occurrence of phthalides in Nature suggest that they are mainly confined to several higher plant families, fungi, lichens, and liverworts, with some sections of the Apiaceae plant family providing the major natural sources of these compounds. Structural analogues of (Z)-ligustilide and their dimers, together with mycophenolic acid analogues, could be considered as chemical markers for plant and fungal phthalides, respectively.
Chemical derivatization studies on monomeric and dimeric phthalides have demonstrated that their distinct chemical reactivities could be explained in terms of specific stereoelectronic characteristics and relative instabilities.
In the future, new analytical techniques will accelerate the structural characterization of additional minor compounds from different natural sources, establishing their interactions with macromolecular receptors and their metabolism as xenobiotic agents.
Synthesis strategies for phthalides have evolved from linear preparations to convergent ones that include efficient enantiodifferentiated reactions using new catalysts. It is foreseeable that progress in the chemistry of phthalides will focus on the exploration of their chemical and biological spaces by means of greener methodologies, including more efficient syntheses and bioassays.
Phthalides have been extensively evaluated in terms of their bioactivity, with a considerable recent literature being available on this topic. For instance, mycophenolic acid analogues are commercially available immunosupressants prescribed for autoimmune diseases, with other applications under study. Many natural phthalides display a variety of biological activities, and, in the case of compounds from the Apiaceae, most agree with the traditional medicinal uses of their natural plant sources. It has been stated that “phthalides are responsible for numerous bioactivities; however their exact mode of action is not yet realized…” [2]. One would envisage that future efforts to investigate the biological activities of phthalides, particularly in terms of neurological diseases, might show considerable promise.
References
Lin G, Chan SS-K, Chung H-S, Li S-L (2005) Chemistry and biological activities of naturally occurring phthalides. Stud Nat Prod Chem 32:611
Beck JJ, Chou S-C (2007) The structural diversity of phthalides from the Apiaceae. J Nat Prod 70:891
Karmakar R, Pahari P, Mal D (2014) Phthalides and phthalans: synthetic methodologies and their applications in the total synthesis. Chem Rev 114:6213
Yang SZ (2007) The divine farmer’s Materia Medica. A translation of the Shen Nong Ben Cao Jing. Blue Poppy Press, Boulder, CO
Yao D, Zhang J, Chu L, Bao X, Shun Q, Qi P (1995) A colored atlas of the Chinese Materia Medica specified in pharmacopoeia of the People’s Republic of China. Guangdong Science and Technology Press, Guangzhou
Chan SS-K, Yan R, Lin G (2013) Chuanxiong (Ligusticum cuanxiong). In: Li SP, Wang YT (eds) Pharmacological activity-based quality control of Chinese herbs. Nova Science, New York, p 273
Li W, Tang Y, Chen Y, Duan J (2012) The advance in chemical isolation and analysis of Chuanxiong. Molecules 17:10614
Wang L, Zhang J, Hong Y, Feng Y, Chen M, Wang Y (2013) Phytochemical and pharmacological review of Da Chanxiong formula: a famous herb pair composed of Chuanxiong Rhizoma and Gastrodiae Rhizoma for headache. Evid Based Complement Altern Med Article ID 425369
Seiz de Lira BJ (1777) Descripción geográfica de Guazápares. Vol II. Relaciones topográficas de los pueblos de México. Biblioteca Nacional, Madrid, MS 2450
Appelt GD (1985) Pharmacological aspects of selected herbs employed in Hispanic folk medicine in the San Luis Valley of Colorado, USA: I. Ligusticum porteri (Osha) and Matricaria chamomilla (Manzanilla). J Ethnopharmacol 13:51
Bye RA, Linares E (1986) Ethnobotanical notes from the Valley of San Luis, Colorado (USA). J Ethnobiol 6:289
Linares E, Bye RA (1987) A study of four medicinal plant complexes of Mexico and adjacent United States. J Ethnopharmacol 19:153
Newton P (1992) Can animals teach us medicine? Over the counter and into the forest. Br Med J 305:1517
Ciamician G, Silber P (1897) Ueber die hochsiedenden Bestandtheile des Sellerieöls. Ber Dtsch Pharm 30:492
Cichy M, Höfle G (1897) Ueber die Spaltungs-producte der Sedanonsäure. Ber Dtsch Pharm 30:501
Ciamician G, Silber P (1897) Ueber die Sedanolsäure. Ber Dtsch Pharm 30:1424
Ciamician G, Silber P (1897) Ueber die Sedanolsäure und das Sedanolid. Ber Dtsch Pharm 30:1427
Ciamician G, Silber P (1898) Studi sui principii dell’essenza di sedano. Gazz Chim Ital 1:438
Barton DHR, DeVries JX (1963) The constitution of sedanolide. J Chem Soc C:1916
Swenholt J (1910) Oil of celery seed. Midl Drug Pharm Rev 44:220
Berlingozzi S, Mazza FP (1926) Sulle idroftalidi. I. Azione dei magnesio-iodo-alchili sull’anidride-d-tetraidroftalica. Gazz Chim Ital 56:88
Berlingozzi S, Cione L (1927) Sulle idroftalidi. II. Azione de l’amalgama di sodio sule monoalchiliden-ftalidi. Gazz Chim Ital 57:243
Berlingozzi S (1927) Sulle idroftalidi. III. Derivati della d-diidroftalidi. Gazz Chim Ital 57:248
Berlingozzi S, Lupo G (1927) Sulle idroftalidi. IV. Sul derivato n-butilico della tetraidroftalide. Gazz Chim Ital 57:255
Berlingozzi S (1927) Sulle idroftalidi. V. Contributo allo studio dei rapporti fra costituzione e odore. Gazz Chim Ital 57:264
Murayama Y, Itakagi T (1923) Chemical constituents of a Chinese drug “Hsiung- Ch’uang”. II. J Pharm Soc Jpn 43:143
Noguchi T (1934) Beitrage zur Kenntnis der chemischen Bestandteile von Sen-Kyu. J Pharm Soc Jpn 54:913
Murayama IY (1921) Chemical constituents of a Chinese drug “Hsiung-Ch’uang”. J Pharm Soc Jpn 41:951
Kariyone T, Kotani M (1937) Constituents of the fruits of Ligusticum acutilobum. III. J Pharm Soc Jpn 57:183
Noguchi T, Fujita S, Kawanami M (1937) Über die Bestandteile der Wurzel von Ligusticum actilobum. I. J Pharm Soc Jpn 57:769
Noguchi T, Kawanami M (1937) Über die Bestandteile der Wurzel von Ligusticum actilobum II, IV. Mitteil. Zur Kenntnis der chemischen Bestandteile der Umbelliferae. J Pharm Soc Jpn 57:783
Noguchi T, Kawanami M (1937) Über die Dehydrierungsprodukte des Sedanolid, Cnidiumlacton und Sedanonsäure. J Pharm Soc Jpn 57:778
Naves YR (1943) Études sur les matières vegetales volatiles XXIV. Composition de l’huile essentiele et du résinoïde de livéche (Levisticum officinale Koch). Helv Chim Acta 26:1281
Takahashi S, Hikino H, Sasaki Y (1958) Pharmacognostical components of Umbelliferous plants IX. Toki 9. Components of the roots of Angelica acutiloba and A. acutiloba var. sugiyamae. J Pharm Soc Jpn 79:1156
Mitsuhashi H, Nagai U (1963) Studies on the constituents of Umbelliferae. VII. Structure of ligustilide. Tetrahedron 19:1277
Mitsuhashi H, Muramatsu T (1964) Studies on the constituents of Umbelliferae plants. IX: Structure of cnidilide and neocnidilide. Tetrahedron 20:1971
Nagai U, Mitsuhashi H (1965) Constituents of Umbelliferae plants. X. Stereochemistry of 3-butylhydrophthalides. Tetrahedron 21:1433
Nagai U, Shishido T, Chiba R, Mitsuhashi H (1965) Constituents of Umbelliferae plants. XI. Stereochemistry of 3-butylhydrophthalides. Tetrahedron 21:1701
Cocker W, McMurry TBH, Sainsbury DM (1966) Synthesis of certain n-butyltetra- and hexa-hydrophthalides. J Chem Soc C:1152
Stahl E, Bohrmann H (1966) Phthalide als Hauptbestandteile des Ätherischen Öls der Früchte von Meum athamanticum. Naturwissenschaften 110:118
Bohrmann H, Stahl E, Mitsuhashi H (1967) Studies of the constituents of Umbelliferae plants. XIII. Chromatographic studies on the constituents of Cnidium officinale Makino. Chem Pharm Bull 15:1606
Gold J, Wilson CW (1963) Alkylidene phthalides and dihydrophthalides from celery. J Org Chem 28:985
Wilson CW (1970) Relative recovery and identification of carbonyl compounds from celery essential oil. J Food Sci 35:766
Bjeldanes LF, Kim IS (1977) Phthalide components of celery essential oil. J Org Chem 42:2333
Saiki Y, Okamoto (née Suzuki) M, Ueno A, Uchida M, Fukushima S (1970) Gas chromatographical studies on natural volatile oils. VIII. On the essential oils of Chinese Medicine “Gaoben.” J Pharm Soc Jpn 90:344
Yamagishi T, Kaneshima H (1977) Constituents of Cnidium officinale Makino. Structure of senkyunolide and gas chromatography-mass spectrometry of the related phthalides. J Pharm Soc Jpn 97:237
Gijbels MJM, Scheffer JJC, Baerheim Svendsen A (1979) Phthalides in Umbelliferae. Riv Ital EPPOS 61:335
Fehr D (1979) Study on the aroma substances of celery (Apium graveolens L.). Part I. Pharmazie 34:658
Fehr D (1981) Study on the aroma substances of celery (Apium graveolens L.). Part 2. Pharmazie 36:374
Gijbels MJM, Scheffer JJC, Baerheim Svendsen A (1981) Analysis of phthalides from Umbelliferae by combined liquid-solid and gas-liquid chromatography. Chromatographia 14:452
Banerjee SK, Gupta BD, Sheldrick WS, Höfle G (1982) Angeolide, a novel lactone from Angelica glauca. Liebigs Ann Chem:699
Gijbels MJM, Scheffer JJC, Svendsen Baerheim A (1982) Phthalides in roots of Cenolophium denudatum and in roots, herb and fruits of Coriandrum sativum. Fitoterapia 53:17
Gijbels MJM, Scheffer JJC, Baerheim Svendsen A (1982) Phthalides in the essential oil from roots of Levisticum officinale. Planta Med 44:207
Gijbels MJM, Scheffer JJC, Baerheim Svendsen A (1982) Phthalides in roots of Silaum silaus (L.) Schinz et Thell. Sci Pharm 50:158
Gijbels MJM, Fischer FC, Scheffer JJC, Baerheim Svendsen A (1983) Phthalides in roots of Anethum graveolens and Todaroa montana. Sci Pharm 51:414
Kaouadji M, Puech-Baronnat M, Mariot A-M (1983) (Z)-Ligustidiol, nouveau phthalide hydroxyle isole de Ligusticum wallichii Franch. Tetrahedron Lett 24:4675
Kaouadji M, Reutenauer H, Chulia AJ, Marsura A (1983) (Z,Z′)-Diligustilide, noveau phthalide dimere isole de Ligusticum wallichii Franch. Tetrahedron Lett 24:4677
Meng Y, Wang Q, Zhang H, Chen Y, Fab Y, Wang F (1984) Molecular structure of riligustilide. Lanzhou Daxue Xuebao, Ziram Kexueban 19:76 (Chem Abstr 100:135781j)
Wang P, Guo X, Wang Y, Fukuyama Y, Miura I, Sugawara M (1984) Phthalides from the rhizome of Ligusticum wallichii. Phytochemistry 23:2033
Kobayashi M, Fujita M, Mitsuhashi H (1984) Components of Cnidium officinale Makino: occurrence of pregnenolone, coniferyl ferulate, and hydroxyphthalides. Chem Pharm Bull 32:3770
Gijbels MJ, Fischer FC, Scheffer JJ, Baerheim Svendsen A (1984) Phthalides in roots of Capnophyllum peregrinum and Peucedanum ostruthium. Planta Med 50:110
Puech-Baronnat M, Kaouadji M, Mariotte AM (1984) (Z)-5-Hydroxy- and (Z)-4,5-dihydroxybutylidene-3-phthalides, new compounds isolated from Ligusticum wallichii. Planta Med 50:105
Cichy M, Wray V, Höfle G (1984) Neue Inhaltsstoffe von Levisticum officinale Koch Liebstöckel. Liebigs Ann Chem:397
Banerjee SK, Gupta BD, Sheldrick WS, Höfle G (1984) Lactonic constituents of Angelica glauca. Liebigs Ann Chem:888
Kaouadji M, Mariotte AM, Reutenauer H (1984) Phthalide derivatives from Meum athamanticum Jacq. Z Naturforsch C 39C:872
Kaouadji M, Pouget C, Kaouadji M (1986) Additional phthalide derivatives from Meum athamanticum. J Nat Prod 49:184
Gijbels MJM, Fischer FC, Scheffer JJC, Baerheim Svendsen A (1985) Phthalides in roots of Apium graveolens, A. graveolens var. rapaceum, Bifora testiculata and Petroselinum crispum var. tuberosum. Fitoterapia 56:17
Sheu SJ, Ho YS, Chen YP, Hsu HY (1987) Analysis and processing of Chinese herbal drugs: VI. The study of Angelicae Radix. Planta Med 53:377
Kaouadji M, De Pachtere F, Pouget C, Chulia A, Lavaitte S (1986) Three additional phthalide derivatives, an epoxymonomer and two dimers from Ligusticum wallichii rhizomes. J Nat Prod 49:872
Delgado G, Reza-Garduño RG, Toscano RA, Bye R, Linares E (1988) Secondary metabolites from the roots of Ligusticum porteri (Umbelliferae). X-ray structure of Z-6.6′,7,3′a-diligustilide. Heterocycles 27:1305
Naito T, Katsuhara T, Niitsu K, Ikeya Y, Okada M, Mitsuhashi H (1991) Phthalide dimers from Ligusticum chuangxiong Hort. Heterocycles 32:2433
Tsuchida T, Kobayashi M, Kaneko K, Mitsuhashi H (1987) Studies on the constituents of Umbelliferae plants. XVI. Isolation and structures of three new ligustilide derivatives from Angelica acutiloba. Chem Pharm Bull 35:4460
Kobayashi M, Mitsuhashi H (1987) Studies on the constituents of Umbelliferae plants XVII. Structures of three new ligustilide derivatives from Ligusticum wallichii. Chem Pharm Bull 35:4789
Fischer FC, Gijbels MJM (1987) cis- and trans-Neocnidilide; 1H- and 13C-NMR data of some phthalides. Planta Med 53:77
Segebrecht S, Schilcher H (1989) Ligustilide: guiding component for preparations of Levisticum officinale roots. Planta Med 55:572
Szebeni-Galambosi Z, Galambosi B, Holm Y (1992) Growth, yield and essential oil of lovage grown in Finland. J Essent Oil Res 4:375
Abdel-Mogib M, Ayyad SN, Metwally MA, Dawidar AM (1992) Lactones from Pituranthos tortusus (Apiaceae). Pak J Sci Ind Res 35:93
Delgado G, Reza-Garduño RG, Ríos MY, del Río F (1992) Phthalides and monoterpenes of the hexane of the roots of Ligusticum porteri. Planta Med 58:570
MacLeod AJ, Macleod G, Snyder CH (1988) Volatile aroma constituents of celery. Phytochemistry 27:373
MacLeod G, Ames JM (1989) Volatile components of celery and celeriac. Phytochemistry 28:1817
Van Wassenhove F, Dirinck P, Ghent B, Vulsteke G (1990) Aromatic volatile composition of celery and celeriac cultivars. HortScience 25:556
Tang J, Station AE, Brunswick N (1990) Free and glycosidically bound volatile compounds in fresh celery. J Agric Food Chem 38:1937
Van Wassenhove FA, Dirinck PJ, Schamp NM, Vulstekel GA (1990) Effect of nitrogen fertilizers on celery volatiles. J Agric Food Chem 38:220
Maruhashi M, Hanada K, Misogami K, Nagakura A (1992) Novel phthalide derivative as NGF enhancer from Apium graveolens. Jpn Kokai Tokkyo Koho JP 04334378 A 19921120 (Chem Abstr 118:240924)
Nitz S, Spraul MH, Drawert F (1992) 3-Butyl-5,6-dihydro-4H-isobenzofuranone, a sensorial active phthalide in parsley roots. J Agric Food Chem 40:1038
Hon P, Lee C, Choang F, Chui K, Wong HNC (1990) A ligustilide dimer from Angelica sinensis. Phytochemistry 29:1189
Naito T, Katsuhara T, Niitsu K, Ikeya Y, Okada M, Mitsuhashi H (1992) Two phthalides from Ligusticum chuanxiong. Phytochemistry 31:639
Naito T, Niitsu K, Ikeya Y, Okada M, Mitsuhashi H (1992) A phthalide and 2-farnesyl-6-methyl benzoquinone from Ligusticum chuanxiong. Phytochemistry 31:1787
Beck JJ, Stermitz FR (1995) Addition of methyl thioglycolate and benzylamine to (Z)-ligustilide, a bioactive unsaturated lactone constituent of several herbal medicines. An improved synthesis of (Z)-ligustilide. J Nat Prod 58:1047
Brandt JJ, Schultze W (1995) Composition of the essential oils of Ligusticum mutellina (L.) Crantz (Apiaceae). J Essent Oil Res 7:231
Dung NX, Cu LD, Moi LD, Leclerck PA (1996) Composition of the leaf and flower oils from Angelica sinensis (Oliv.) Diels cultivated in Vietnam. J Essent Oil Res 8:503
Kaul PN, Mallavarapu GR, Chamoli RP (1996) The essential oil composition of Angelica glauca roots. Planta Med 62:80
Naito T, Ikeya Y, Okada M, Mistuhashi H, Maruno M (1996) Two phthalides from Ligusticum chuangxiong. Phytochemistry 41:233
Bartschat D, Maas B, Smietana S, Mosandl A, Lebensmittelchemie I, Frankfurt JWG (1996) Stereoisomeric flavour compounds LXXIII: 3-butylphthalide: chirospecific analysis, structure and properties of the enantiomers. Phytochem Anal 7:131
Bartschat D, Beck T, Mosandl A (1997) Stereoisomeric flavor compounds. 79. Simultaneous enantioselective analysis of 3-butylphthalide and 3-butylhexahydrophthalide stereoisomers in celery, celeriac, and fennel. J Agric Food Chem 45:4554
Bylaité E, Venskutonis RP, Roozen JP (1998) Influence of harvesting time on the composition of volatile components in different anatomical parts of lovage (Levisticum officinale Koch.). J Agric Food Chem 46:3735
Bedrossian A, Beauchamp PE, Dev V, Kwan S, Munevar-Mendoza E, Okoreeh E (1998) Composition of the essential oil of Lomatium torreyi. J Essent Oil Res 10:473
Tirillini B, Pellegrino R, Menghini A, Tomaselli B (1999) Essential oil components in the epigeous and hypogeous parts of Meum athamanticum Jacq. J Essent Oil Res 11:251
Choudhury S, Rajkhowa A, Dutta S, Kanjilal PB, Sharma RK, Leclercq PA (2000) Volatile seed oils of Trachyspermum roxburghianum Benth. ex Kurz. from India. J Essent Oil Res 12:731
Gillespie SG, Duszynski J (1998) Phthalides and monoterpenes of the hexane extracts of the roots of Ligusticum porteri, L. filicinum and L. tenuifolium. Planta Med 64:1998
Hagemeier J, Batz O, Schmidt J, Wray V, Hahlbrock K, Strack D (1999) Accumulation of phthalides in elicitor-treated cell suspension cultures of Petroselinum crispum. Phytochemistry 51:629
Kitajima J, Ishikawa T, Satoh M (2003) Polar constituents of celery seed. Phytochemistry 64:1003
Li Y, Peng S, Zhou Y, Yu K-B, Ding L-S (2006) Two new phthalides from Ligusticum chuanxiong. Planta Med 72:652
Ka MH, Choi EH, Chun HS, Li KG (2005) Antioxidant activity of volatile extracts isolated from Angelica tenuissimae roots, peppermint leaves, pine needles, and sweet flag leaves. J Agric Food Chem 53:4124
Palá-Paúl J, Garc R (2004) Essential oil composition of the leaves and stems of Meum athamanticum Jacq., from Spain. J Chromatogr 1036:245
Lim LS, Shen P, Gong YH, Yong EL (2006) Dimeric progestins from rhizomes of Ligusticum chuanxiong. Phytochemistry 67:728
Wen Y, He S, Xue K, Cao F (1986) Chemical components of Ligusticum chuanxiong. Zhongcaoyao 17:122
Ogawa Y, Hosaka K, Chin M, Mitsuhashi H (1989) Synthesis of (-)-3-butyl-4-hydroxyphthalide. Heterocycles 29:865
Deng S, Chen SN, Lu J, Wang ZJ, Nikolic D, van Breemen RB, Santarsiero BD, Mesecar A, Fong HHS, Farnsworth NR, Pauli GF (2006) GABAergic phthalide dimers from Angelica sinensis (Oliv.) Diels. Phytochem Anal 17:398
Deng S, Chen SN, Yao P, Nikolic D, van Breemen RB, Bolton JL, Fong HHS, Farnsworth NR, Pauli GF (2006) Serotonergic activity-guided phytochemical investigation of the roots of Angelica sinensis. J Nat Prod 69:536
Lü J-L, Duan J-A, Tang Y-P, Yang N-Y, Zhang L-B (2009) Phthalide mono- and dimers from the radix of Angelica sinensis. Biochem Syst Ecol 37:405
Chang X-L, Jiang Z-Y, Ma Y-B, Zhang X-M, Tsim KWK, Chen J-J (2009) Two new compounds from the roots of Ligusticum chuanxiong. J Asian Nat Prod Res 11:805
Li W, Tang Y, Chen Y, Duan J-A (2012) Advances in the chemical analysis and biological activities of Chuanxiong. Molecules 17:10614
Ran X, Ma L, Peng C, Zhang H, Qin L-P (2011) Ligusticum chuanxiong Hort.: a review of chemistry and pharmacology. Pharm Biol 49:1180
Huang J, Lu XQ, Zhang C, Lu J, Li GY, Lin RC, Wang JH (2013) Anti-inflammatory ligustilides from Ligusticum chuanxiong Hort. Fitoterapia 91:21
Wei Q, Yang J, Ren J, Wang A, Ji T, Su Y (2014) Bioactive phthalides from Ligusticum sinense Oliv. cv. chaxiong. Fitoterapia 93:226
Yang J-B, Wang A-G, Wei Q, Ren J, Ma S-C, Su Y-L (2014) New dimeric phthalides from Ligusticum sinense Oliv. cv. chaxiong. J Asian Nat Prod Res 16:747
León A, Toscano RA, Cogordán JA, Delgado G (2010) Differentiated cyclization of the ketoacid derived from tokinolide B. Heterocycles 82:1567
Niu Y, Wang S (2014) A new phthalide from Angelica sinensis radix. China J Chin Mater Med 39:80
Raeisi S, Mirjalili MH, Nadjafi F, Hadian J (2015) Variability in the essential oil content and composition in different plant organs of Kelussia odoratissima Mozaff. (Apiaceae) growing wild in Iran. J Essent Oil Res 27:283
Inouye H, Okuda T, Hirata Y, Nagakura N, Yoshizaki M (1967) Structure of catalpalactone, a new phthalide from catalpa wood. Chem Pharm Bull 15:786
Inouye H, Okuda T, Hayashi T (1975) Quinones and related compounds in higher plants. II. On the naphthoquinones and related compounds from catalpa wood. Chem Pharm Bull 23:384
Fujiwara A, Mori T, Iida A, Ueda S, Hano Y, Nomura T, Tokuda H, Nishino H (1998) Antitumor-promoting naphthoquinones from Catalpa ovata. J Nat Prod 61:629
Bregaoui A, Boughallleb N, Ben Jannet H, Harzallah-Shiric F, El Mahjoub M, Mighri Z (2007) Chemical composition and antifungal activity of volatiles from three Opuntia species growing in Tunisia. Pak J Biol Sci 10:2485
Opitz L, Hansel R (1971) Phthalide aus Helichrysum italicum. Arch Pharm 304:228
Zapesochnaya GG, Dzyadevich TV, Karasartov BS (1990) Phenolic compounds of Helichrysum italicum. Chem Nat Compd 26:342
Vrkoč J, Ubik K, Sedmera P, Vrkoč J, Ubik K, Sedmera P (1973) Phenolic extractives from the achenes of Helichrysum arenarium. Phytochemistry 12:2062
Vrkoč J, Buděšínský M, Dolejš L, Vašíčková S (1975) Arenophthalide A: a new phthalide glycoside from Helichrysum arenarium roots. Phytochemistry 14:1845
Jakupovic J, Schuster A, Sun H, Bohlmann F, Bhakuni DS (1987) Prenylated phthalides from Anaphalis araneosa and Helichrysum platypterum. Phytochemistry 26:580
Venditti A, Lattanzi C, Ornano L, Maggi F, Sanna C, Ballero M, Alvino A, Serafini M, Bianco A (2016) A new glucosidic phthalide from Helichrysum microphyllum subsp. tyrrhenicum from La Maddalena Island (Sardinia, Italy). Nat Prod Res 30:789
Talapatra B, Roy MK, Talapatra SK (1980) Structures of two new phthalides from Anaphalis contorta Hook f. Indian J Chem B 19B:927
Tada M, Chiba K (1984) Novel plant growth inhibitors and an insect antifeedant from Chrysanthemum coronarium (Japanese name: Shungiku). Agric Biol Chem 48:1367
Sari A, Zidorn C, Ellmerer EP, Özgökçe F, Ongania KH, Stuppner H (2007) Phenolic compounds from Scorzonera tomentosa L. Helv Chim Acta 90:311
Zheng X-P, Cui Q-F, Zhao J-F, Yang L-J, Zhang H-B, Yang X-D, Li L (2014) Three new phthalides from Gnaphalium adnatum. Helv Chim Acta 97:1638
Blaskó G, Hussain SF, Shamma M (1981) (–)-Corlunmine, a new phthalideisoquinoline alkaloid from Fumaria parviflora. J Nat Prod 44:475
Chulia AJ, Kaouadji M, Mariotte A-M (1989) Pedicelloside, nouveau phtalide isole de Gentiana pedicellata Wall. Tetrahedron Lett 25:5039
Chulia AJ, Garcia J, Mariotte A-M (1986) New phthalide glycoside from Gentiana pedicellata. J Nat Prod 49:514
Garcia J, Mpondo Mpondo E, Chulia AJ, Kaouadji M, Cartier G (1989) Two phthalide glucosides from Gentiana pyrenaica. Phytochemistry 28:1759
Fukuhara K, Fujimori T, Shigematsu H, Ohnishi A (1987) Essential oil of Scutellaria baicalensis G. Agric Biol Chem 51:1449
Malan E, Roux DG (1974) (+)-2,3-trans-Pubeschin, the first catechin analogue of peltogynoids from Peltogyne pubescens and P. venosa. Phytochemistry 13:1575
Nakano Y, Takasima T (1975) Extractives of Albizzia julibrissin heartwood. Mokuzai Gakkaishi 21:577
Okorie DA (1976) A new phthalide and xanthones from Anthochleista djalonensis and Anthochleista vogelli. Phytochemistry 15:1799
Kameoka H, Miyazawwa M, Haze K (1975) 3-Ethyl-7-hydroxyphthalide from Forsythia japonica. Phytochemistry 14:1676
Shao P, Zhang X, Li B, Jiao W, Wu L, Yao X-S (2010) New isocoumarin and phthalide derivatives from the rhizomes of Matteuccia orientalis. Chem Pharm Bull 58:1650
Inubushi Y, Tsuda Y, Konita T, Matsumoto S (1964) Shihuhine: a new phthalide-pyrrolidine alkaloid. Chem Pharm Bull 12:749
Inubushi Y, Tsuda Y, Konita T, Matsumoto S (1968) The structure of shihunine, a new phthalide-pyrrolidine alkaloid. Chem Pharm Bull 16:1014
Elander M, Leander K, Lüning B (1969) Studies on Orchidaceae alkaloids XIV. A phthalide alkaloid from Dendrobium pierardii Roxb. Acta Chem Scand 23:2177
Elander M, Gawell L, Leander K (1971) Studies on Orchidaceae alkaloids XXII. Synthesis and absolute configuration of pierardine, lactone-betaine isomerization of shihunine. Acta Chem Scand 25:721
Lee C, Choe S, Lee JW, Jin Q, Lee MK, Hwang BY (2013) Alkaloids from Papaver setigerum. Bull Kor Chem Soc 34:1290
Chou TH, Chen IS, Hwang TL, Wang TC, Lee TH, Cheng LY, Chang YC, Cho JY, Chen JJ (2008) Phthalides from Pittosporum illicioides var. illicioides with inhibitory selectivity on superoxide generation and elastase release by neutrophils. J Nat Prod 71:1692
Takahashi H, Tsubuki T, Higashiyama K (1991) Highly diastereoselective reaction of chiral o-[2-(1,3-oxazolidinyl)]benzaldehydes with alkylmetallic reagents: synthesis of chiral 3-substituted phthalides. Chem Pharm Bull 39:3136
Knights BA (1966) Isolation of 4-hydroxyphthalide from oat grain. Nature 210:1261
Grech JN, Li Q, Roufogalis BD, Duke CC (1994) Novel Ca2+-ATPase inhibitors from the dried root tubers of Polygonum multiflorum. J Nat Prod 57:1682
Yoshikawa M, Uchida E, Chatani N, Murakami N, Yamahara J (1992) Thunberginols A, B, and F, new antiallergic and antimicrobial principles from Hydrangeae Dulcis Folium. Chem Pharm Bull 40:3121
Yoshikawa M, Shimada H, Yagi N, Murakami N, Shimoda H, Yamahara J, Matsuda H (1996) Development of bioactive functions in Hydrangeae Dulcis Folium. VI. Syntheses of thunberginols A and F and their 3′-deoxy-derivatives using regiospecific lactonization of stilbene carboxylic acid: structures and inhibitory activity on histamine release of hydramacraphyllols A and B. Chem Pharm Bull 44:1890
Yoshikawa M, Harada E, Naitoh Y, Inoue K, Matsuda H, Shimoda H, Yamahara J, Murakami N (1994) Development of bioactive functions in Hydrangeae Dulcis Folium. III. On the antiallergic and antimicrobial principles of Hydrangeae Dulcis Folium. (1). Thunberginols A, B, and F. Chem Pharm Bull 42:2225
Yoshikawa M, Harada E, Yagi N, Okuno Y, Muraoka O, Aoyama H, Murakami N (1994) Chemical transformation from dihydroisocoumarin into benzylidenephthalide by use of regiospecific oxidative lactonization mediated by copper chloride(II). Syntheses of thunberginol F and hydramacrophyllols A and B. Chem Pharm Bull 42:721
Shode FO, Mahomed AS, Rogers CB (2002) Typhaphthalide and typharin, two phenolic compounds from Typha capensis. Phytochemistry 61:955
Alsberg CL, Black OF (1913) Contributions to the study of maize deterioration. Biochemical and toxicological investigations of Penicillium puberulum and Penicillium stoloniferum. U S Dep Agric Bur Plant Ind 270:7
Clutterbuck PW, Raistrick H (1933) Studies in the biochemistry of micro-organisms. XXXI. The molecular constitution of the metabolic products of Penicillium brevi-compactum Dierckx and related species. II. Mycophenolic acid. Biochem J 27:654
Birkinshaw JH, Bracken A, Morgan EN, Raistrick H (1948) Studies in the biochemistry of micro-organisms. 78. The molecular constitution of mycophenolic acid, a metabolic product of Penicillium brevi-compactum Dierckx. Part 2. Possible structural formulae for mycophenolic acid. Biochem J 43:216
Birkinshaw JH, Raistrick H, Ross DJ (1952) Studies in the biochemistry of micro-organisms. 86. The molecular constitution of mycophenolic acid, a metabolic product of Penicillium brevi-compactum Dierckx. Part 3. Further observations on the structural formula for mycophenolic acid. Biochem J 50:630
Clutterbuck WP, Oxford AE, Raistrick H, Smith G (1932) Studies in the biochemistry of micro-organisms. XXIV: The metabolic products of Penicillium brevi-compactum series. Biochem J 26:1441
Nakajima S, Nozawa K (1979) Isolation in high yield of citrinin from Penicillium odoratum and of mycophenolic acid from Penicillium brunneo-stoloniferum. J Nat Prod 42:423
Anderson HA, Bracewell JM, Fraser AR, Jones D, Robertson GW, Russell JD (1988) 5-Hydroxymaltol and mycophenolic acid, secondary metabolites from Penicillium echinulatum. Trans Br Mycol Soc 91:649
Sumarah MW, Miller JD, Blackwell BA (2005) Isolation and metabolite production by Penicillium roqueforti, P. paneum and P. crustosum isolated in Canada. Mycopathologia 159:571
Torrenegra RD, Baquero JE, Calderón JS (2005) Actividad antimicrobiana y asignación completa de RMN 1H y 13C del ácido micofenólico aislado de Penicillium verrucosum. Rev Latinoam Quím 33:76
Erbert C, Lopes AA, Yokoya NS, Furtado NAJC, Conti R, Pupo MT, Lopes JLC, Debonsi HM (2012) Antibacterial compound from the endophytic fungus Phomopsis longicolla isolated from the tropical red seaweed Bostrychia radicans. Bot Mar 55:435
Rovirosa J, Diaz-Marrero A, Darias J, Painemal K, San Martin A (2006) Secondary metabolites from marine Penicillium brevicompactum. J Chil Chem Soc 51:775
Valente AMMP, Ferreira AG, Daolio C, Filho ER, Boffo EF, Souza AQL, Sebastianes FLS, Melo IS (2013) Production of 5-hydroxy-7-methoxy-4-methylphthalide in a culture of Penicillium crustosum. An Acad Bras Cienc 85:487
Habib E, León F, Bauer JD, Hill RA, Carvalho P, Cutler HG, Cutler SJ (2008) Mycophenolic derivatives from Eupenicillium parvum. J Nat Prod 71:1915
Chen Z, Zheng Z, Huang H, Song Y, Zhang X, Ma J, Wang B, Zhang C, Ju J (2012) Penicacids A-C, three new mycophenolic acid derivatives and immunosuppressive activities from the marine-derived fungus Penicillium sp. SOF07. Bioorg Med Chem Lett 22:3332
Colombo L, Gennari C, Potenza D, Scolastico C, Aragozzini F (1979) (E,E)-10-(1,3-Dihydro-4,6-dihydroxy-7-methyl-3-oxoisobenzofuran-5-yl)-4,8-dimethyldeca-4,8-dienoic acid: total synthesis and role in mycophenolic acid biosynthesis. J Chem Soc Chem Commun:1021
Lu X, Zheng Z, Zhang H, Huo C, Dong Y, Ma Y, Ren X, Ke A, He J, Gu Y, Shi Q (2009) Two new members of mycophenolic acid family from Penicillium brevicompactum Dierckx. J Antibiot 62:527
Birkinshaw JH, Raistrik H, Ross DJ, Stickings CE (1952) Studies in the biochemistry of micro-organisms. 85. Cyclopolic and cyclopaldic acids, metabolic products of Penicillium cyclopium Westling. Biochem J 50:610
Brillinger GU, Heberle W, Weber B, Achenbach H (1978) Metabolic products of microorganisms 167. Cyclopaldic acid from Aspergillus duricaulis. 1. Production, isolation and biological properties. Arch Microbiol 116:245
Evidente A, Motta A, Sparapano L (1993) Seiricardines B and C, phytotoxic sesquiterpenes from three species of Seiridium pathogenic for cypress. Phytochemistry 33:69
Frisvad JC, Filtenborg O (1989) Terverticillate penicillia: chemotaxonomy and mycotoxin production. Mycologia 81:837
Shimada A, Nakaya K, Takeuchi S, Kimura Y (2001) Deoxycyclopaldic acid and cyclopaldic acid, plant regulators, produced by Penicillium sp. Z Naturforsch B 449
Sommart U, Rukachaisirikul V, Tadpetch K, Sukpondma Y, Phongpaichit S, Hutadilok-Towatana N, Sakayaroj J (2012) Modiolin and phthalide derivatives from the endophytic fungus Microsphaeropsis arundinis PSU-G18. Tetrahedron 68:10005
Achenbach H, Mühlenfeld A, Weber B, Brillinger GU (1982) Highly substituted chromanols from cultures of Aspergillus duricaulis. Tetrahedron Lett 23:4659
Hemberger Y, Xu J, Wray V, Proksch P, Wu J, Bringmann G (2013) Pestalotiopens A and B: stereochemically challenging flexible sesquiterpene-cyclopaldic acid hybrids from Pestalotiopsis sp. Chem Eur J 19:15556
Brian PW, Curtis PJ, Grove JF, Hemming HG, McGowan JC (1946) Gladiolic acid: an antifungal and antibacterial metabolic product of Penicillium gladioli McCull. and Thom. Nature 157:697
Grove JF (1952) Gladiolic acid, a metabolic product of Penicillium gladioli. I. Structure. Biochem J 50:648
Grove JF (1953) Gladiolic acid, a metabolic product of Penicillium gladioli. 2. Structure and fungistatic activity. Biochem J 54:664
Raistrick H, Ross DJ (1952) Studies in the biochemistry of micro-organisms. 87. Dihydrogladiolic acid, a metabolic product of Penicillium gladioli Machacek. Biochem J 50:635
Duncanson LA, Grove JF, Zealley J (1953) Gladiolic acid. Part III. The structures of norisogladiolic acid, dihydrogladiolic acid, and cyclopolic acid. J Chem Soc:3637
Brown JJ, Newbold GT (1953) Phthalaldehydes and related compounds. Part III. Synthesis of deoxygladiolic acid and experiments relating to structure of dihydrogladiolic acid. J Chem Soc:3648
Starratt AN (1970) Structure of an artifact formed during isolation of Penicillium gladioli metabolites. Can J Chem 48:2940
Li Y-Y, Wang M-Z, Huang Y-J, Shen Y-M (2010) Secondary metabolites from Phomopsis sp. A123. Mycology 1:254
Kameda K, Namiki M (1974) A new phthalide from a fungus, Alternaria kikuchiana. Chem Lett 1491
Höller U, Gloer JB, Wicklow DT (2002) Biologically active polyketide metabolites from an undetermined fungicolous hyphomycete resembling Cladosporium. J Nat Prod 65:876
Jadulco R, Brauers G, Edrada RA, Ebel R, Wray V, Sudarsono, Proksch P (2002) New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum. J Nat Prod 65:730
Cui C-B, Ubukata M, Kakeya H, Onose R, Okada G, Takahashi I, Isono K, Osada H (1996) Acetophthalidin, a novel inhibitor of mammalian cell cycle, produced by a fungus isolated from a sea sediment. J Antibiot 49:216
Schneider G, Anke H, Sterner O (1997) New secondary metabolites from a mycophilic Hansfordia species. Nat Prod Lett 10:133
Dekker KA, Inagaki T, Gootz TD, Kaneda K, Nomura E, Sakakibara T, Sakemi S, Sugie Y, Yamauchi Y, Yoshikawa N, Kojima N (1997) CJ-12,954 and tts congeners, new anti-Helicobacter pylori compounds produced by Phanerochaete velutina: fermentation, isolation, structural elucidation and biological activities. J Antibiot 50:833
Makino M, Endoh T, Ogawa Y, Watanabe K, Fujimoto Y (1998) Studies on the metabolites of Penicillium vulpinum. Heterocycles 48:1931
Afiyatullov SS, Leshchenko EV, Sobolevskaya MP, Gerasimenko AV, Khudyakova YV, Kirichuk NN, Mikhailov VV (2015) New 3-[2′(R)-hydroxybutyl]-7-hydroxyphthalide from marine isolate of the fungus Penicillium claviforme. Chem Nat Compd 51:111
Fujita M, Yamada M, Nakajima S, Kawai K, Nagai M (1984) O-Methylation effect on the carbon-13 nuclear magnetic resonance signals of ortho-disubstituted phenols and its application to structure determination of new phthalides from Aspergillus silvaticus. Chem Pharm Bull 32:2622
Arnone A, Assante G, Nasini G, De Pava OV (1990) Spirolaxine and sporotricale: two long-chain phthalides produced by Sporotrichum laxum. Phytochemistry 29:613
Tsantrizos Y, Ogilvie K, Watson A (1992) Phytotoxic metabolites of Phomopsis convolvulus, a host-specific pathogen of field bindweed. Can J Chem 70:2276
Zou J, Li J, Wu Z-Y, Zhao Q, Wang G-Q, Zhao H, Chen G-D, Sun X, Guo L-D, Gao H (2015) New α-pyrone and phthalide from the Xylariaceae fungus. J Asian Nat Prod Res 17:705
Strobel G, Ford E, Worapong J, Harper JK, Arif AM, Grant DM, Fung PCW, Chau RMW (2002) Isopestacin, an isobenzofuranone from Pestalotiopsis microspora, possessing antifungal and antioxidant activities. Phytochemistry 60:179
Arnone A, Assante G, Nasini G, Strada S, Vercesi A (2002) Cryphonectric acid and other minor metabolites from a hypovirulent strain of Cryphonectria parasitica. J Nat Prod 65:48
Abdel-Lateff A, Fisch KM, Wright AD, König GM (2003) A new antioxidant isobenzofuranone derivative from the algicolous marine fungus Epicoccum sp. Planta Med 69:831
Huang XZ, Zhu Y, Guan XL, Tian K, Guo JM, Wang H Bin, Fu GM (2012) A novel antioxidant isobenzofuranone derivative from fungus Cephalosporium sp. AL031. Molecules 17:4219
Brady SF, Wagenaar MM, Singh MP, Janso JE, Clardy J (2000) The cytosporones, new octaketide antibiotics isolated from an endophytic fungus. Org Lett 2:4043
Mullady EL, Millett WP, Yoo HD, Weiskopf AS, Chen J, DiTullio D, Knight-Connoni V, Hughes DE, Pierceall WE (2004) A phthalide with in vitro growth inhibitory activity from an Oidiodendron strain. J Nat Prod 67:2086
Suemitsu R, Ohnishi K, Morikawa Y, Nagatomo S (1995) Zinnimidine and 5-(3′,3′-dimethylallyloxy)-7-methoxy-6-methylphthalide from Alternaria porri. Phytochemistry 38:495
Phuwapraisirisan P, Rangsan J, Siripong P, Tip-Pyang S (2009) New antitumour fungal metabolites from Alternaria porri. Nat Prod Res 23:1063
Yang X-L, Zhang S, Hu Q-B, Luo D-Q, Zhang Y (2011) Phthalide derivatives with antifungal activities against the plant pathogens isolated from the liquid culture of Pestalotiopsis photiniae. J Antibiot 64:723
Chen C, Yang RL (2013) A phthalide derivative isolated from endophytic fungi Pestalotiopsis photiniae induces G1 cell cycle arrest and apoptosis in human HeLa cells. Braz J Med Biol Res 46:643
Takahashi K, Koshino H, Narita Y, Yoshihara T (2005) Novel antifungal compounds produced by sterile dark, an unidentified wheat rhizosphere fungus. Biosci Biotechnol Biochem 69:1018
Almeida C, Kehraus S, Prudêncio M, König GM (2011) Marilones A-C, phthalides from the sponge-derived fungus Stachylidium sp. Beilstein J Org Chem 7:1636
Yoganathan K, Rossant C, Ng S, Huang Y, Butler MS, Buss AD (2003) 10-Methoxydihydrofuscin, fuscinarin, and fuscin, novel antagonists of the human CCR5 receptor from Oidiodendron griseum. J Nat Prod 66:1116
Matsumoto K, Nagashima K, Kamigauchi T, Kawamura Y, Yasuda Y, Ishii K, Uotani N, Sato T, Nakai H, Terui Y, Kikuchi J, Ikenisi Y, Yoshida T, Kato T, Itazaki H (1995) Salfredins, new aldose reductase inhibitors produced by Crucibulum sp. RF-3817 I. Fermentation, isolation and structures of salfredins. J Antibiot 48:439
Prachyawarakorn V, Mahidol C, Sureram S, Sangpetsiripan S, Wiyakrutta S, Ruchirawat S, Kittakoop P (2008) Diketopiperazines and phthalides from a marine derived fungus of the order Pleosporales. Planta Med 74:69
Ding G, Liu S, Guo L, Zhou Y, Che Y (2008) Antifungal metabolites from the plant endophytic fungus Pestalotiopsis foedan. J Nat Prod 71:615
Yoshikawa K, Kokudo N, Hashimoto T, Yamamoto K, Inose T, Kimura T (2010) Novel phthalide compounds from Sparassis crispa (Hanabiratake), Hanabiratakelide A-C, exhibiting anti-cancer related activity. Biol Pharm Bull 33:1355
Rana NM, Sargent MV, Elix JA (1975) Structure of the lichen depsidone variolaric acid. J Chem Soc Perkin Trans 1:1992
Xing J-G, Deng H-Y, Luo D-Q (2011) Two new compounds from an endophytic fungus Pestalotiopsis heterocornis. J Asian Nat Prod Res 13:1069
Tianpanich K, Prachya S, Wiyakrutta S, Mahidol C, Ruchirawat S, Kittakoop P (2011) Radical scavenging and antioxidant activities of isocoumarins and a phthalide from the endophytic fungus Colletotrichum sp. J Nat Prod 74:79
Rukachaisirikul V, Rodglin A, Sukpondma Y, Phongpaichit S, Buatong J, Sakayaroj J (2012) Phthalide and isocoumarin derivatives produced by an Acremonium sp. isolated from a mangrove Rhizophora apiculata. J Nat Prod 75:853
Arunpanichlert J, Rukachaisirikul V, Tadpetch K, Phongpaichit S, Hutadilok-Towatana N, Supaphon O, Sakayaroj J (2012) A dimeric chromanone and a phthalide: metabolites from the seagrass-derived fungus Bipolaris sp. PSU-ES64. Phytochem Lett 5:604
Bava A, Dallavalle S, Fronza G, Nasini G, Vajna de Pava O (2006) Absolute configuration of sporotricale and structure of 6-hydroxysporotricale. J Nat Prod 69:1793
Wang S, Zhang S, Zhou T, Zhan J (2013) Three new resorcylic acid derivatives from Sporotrichum laxum. Bioorg Med Chem Lett 23:5806
Lan W-J, Liu W, Liang W-L, Xu Z, Le X, Xu J, Lam C-K, Yang D-P, Li H-J, Wang L-Y (2014) Pseudaboydins A and B: novel isobenzofuranone derivatives from marine fungus Pseudallescheria boydii associated with starfish Acanthaster planci. Mar Drugs 12:4188
Yang J, Huang R, Qiu SX, She Z, Lin Y (2013) A new isobenzofuranone from the mangrove endophytic fungus Penicillium sp. (ZH58). Nat Prod Res 27:1902
Wang J, Wang G, Zhang Y, Zheng B, Zhang C, Wang L (2014) Isolation and identification of an endophytic fungus Pezicula sp. in Forsythia viridissima and its secondary metabolites. World J Microbiol Biotechnol 30:2639
Liu J, Li F, La Kim E, Li JL, Hong J, Bae KS, Chung HY, Kim HS, Jung JH (2011) Antibacterial polyketides from the jellyfish-derived fungus Paecilomyces variotii. J Nat Prod 74:1826
Grove JF (1972) New metabolic products of Aspergillus flavus. Part II. Asperflavin, anhydroasperflavin, and 5,7-dihydroxy-4-methylphthalide. J Chem Soc Perkin Trans 1:2406
Gunawan S, Steffan B, Steglich W (1990) Xylaral, ein Hydroxyphthalid-Derivat aus Fruchtkörpern von Xylaria polymorpha (Ascomycetes). Liebigs Ann Chem:825
Nozawa K, Udagawa S, Nakahima S, Kawai K (1989) A dioxopiperazine derivative from Penicillium megasporum. Phytochemistry 28:929
Wang R-Y, Fang M-J, Huang Y-J, Zheng Z-H, Shen Y-M (2006) 7-Hydroxy-4,6-dimethyl-3H-isobenzofuran-1-one. Acta Chrystallogr E E62:O4172
Zhang W, Xu L, Yang L, Huang Y, Li S, Shen Y (2014) Phomopsidone A, a novel depsidone metabolite from the mangrove endophytic fungus Phomopsis sp. A123. Fitoterapia 96:146
Lin X, Huang Y, Fang M, Wang J, Zheng Z, Su W (2005) Cytotoxic and antimicrobial metabolites from marine lignicolous fungi, Diaporthe sp. FEMS Microbiol Lett 251:53
Lang G, Cole ALJ, Blunt JW, Robinson WT, Munro MHG (2007) Excelsione, a depsidone from an endophytic fungus isolated from the New Zealand endemic tree Knightia excelsa. J Nat Prod 70:310
Meister J, Weber D, Martino V, Sterner O, Anke T (2007) Phomopsidone, a novel depsidone from an endophyte of the medicinal plant Eupatorium arnottianum. Z Naturforsch C 62:11
Fuska J, Fusková A, Nemec P (1979) Vermistatin, an antibiotic with cytotoxic effects, produced from Penicillium vermiculatum. Biologia 34:735
Proksa B, Liptaj T, Prónayová N, Fuska J (1994) (−)-Mitorubrinic acid, a new metabolite of Penicillium vermiculatum Dang. F-852. Chem Pap 48:429
Fuska J, Uhrin D, Proksa B, Voticky Z, Ruppeldt J (1986) The structure of vermistatin, a new metabolite from Penicillium vermiculatum. J Antibiot 39:1605
Murtaza N, Husain SA, Sarfaraz TB, Sultana N, Faizi S (1997) Isolation and identification of vermistatin, ergosterol, stearic acid and mannitol, metabolic products of Penicillium verruculosum. Planta Med 63:191
Arai M, Tomoda H, Okuda T, Wang H, Tabata N, Masuma R, Yamaguchi Y, Omura S (2002) Funicone-related compounds, potentiators of antifungal miconazole activity, produced by Talaromyces flavus FKI-0076. J Antibiot 55:172
Komai S, Hosoe T, Itabashi T, Nozawa K, Okada K, de Galba Maria CT, Chikamori M, Yaguchi T, Fukushima K, Miyaji M, Kawai K (2004) A new funicone derivative isolated from Talaromyces flavus IFM52668. Mycotoxins 54:15
Upadhyay RK, Strobel GA, Coval SJ, Clardy J (1990) Fijiensin, the first phytotoxin from Mycosphaerella fijiensis, the causative agent of black sigatoka disease. Experientia 46:982
Komai S, Hosoe T, Itabashi T, Nozawa K, Yaguchi T, Fukushima K, Kawai K (2005) New vermistatin derivatives isolated from Penicillium simplicissimum. Heterocycles 65:2771
Dethoup T, Manoch L, Kijjoa A, Pinto M, Gales L, Damas AM, Silva AMS, Eaton G, Herz W (2007) Merodrimanes and other constituents from Talaromyces thailandiasis. J Nat Prod 70:1200
Stierle AA, Stierle DB, Girtsman T (2012) Caspase-1 inhibitors from an extremophilic fungus that target specific leukemia cell lines. J Nat Prod 75:344
Xia XK, Huang HR, She ZG, Cai JW, Lan L, Zhang JY, Fu LW, Vrijmoed LLP, Lin YC (2007) Structural and biological properties of vermistatin and two new vermistatin derivatives isolated from the marine-mangrove endophytic fungus Guignardia sp. No. 4382. Helv Chim Acta 90:1925
Liu Y, Xia G, Ma L, Ding B, Lu Y, He L, Xia X, She Z (2014) Vermistatin derivatives with α-glucosidase inhibitory activity from the mangrove endophytic fungus Penicillium sp. HN29-3B1. Planta Med 80:912
Xia X-K, Liu F, She Z-G, Yang L-G, Li M-F, Vrijmoed LLP, Lin Y-C (2008) 1H and 13C NMR assignments for 6-demethylvermistatin and two penicillide derivatives from the mangrove fungus Guignardia sp. (no. 4382) from the South China Sea. Magn Reson Chem 46:693
Liu W, Zhao H, Li R, Zheng H, Yu Q (2015) Polyketides and meroterpenoids from Neosartorya glabra. Helv Chim Acta 98:515
Arnone A, Nasini G (1989) Secondary mould metabolites. XXV. The structures of rubellins C and D, two novel anthraquinone metabolites from Mycosphaerella rubella. Gazz Chim Ital 119:35
Puder C, Zeeck A (2000) New biologically active rubiginones from Streptomyces sp. J Antibiot 53:329
Imura YK, Oshinari TY, Oshino HK, Ujioka SF, Kada KO, Himada AS (2007) Rubralactone, rubralides A, B and C, and rubramin produced by Penicillium rubrum. Biosci Biotechnol Biochem 71:1896
Zhai M-M, Niu H-T, Li J, Xiao H, Shi Y-P, Di D-L, Crews P, Wu Q-X (2015) Talaromycolides A–C, novel phenyl-substituted phthalides isolated from the green Chinese onion-derived fungus Talaromyces pinophilus AF-02. J Agric Food Chem 63:9558
Ge HM, Shen Y, Zhu CH, Tan SH, Ding H, Song YC, Tan RX (2008) Penicidones A-C, three cytotoxic alkaloidal metabolites of an endophytic Penicillium sp. Phytochemistry 69:571
Chinworrungsee M, Kittakoop P, Isaka M, Chanphen R, Tanticharoen M, Thebtaranonth Y (2002) Halorosellins A and B, unique isocoumarin glucosides from the marine fungus Halorosellinia oceanica. J Chem Soc Perkin Trans 1:2473
Tayone WC, Honma M, Kanamaru S, Noguchi S, Tanaka K, Nehira T, Hashimoto M (2011) Stereochemical investigations of isochromenones and isobenzofuranones isolated from Leptosphaeria sp. KTC 727. J Nat Prod 74:425
El-Elimat T, Raja HA, Figueroa M, Falkinham III JO, Oberlies NH (2014) Isochromenones, isobenzofuranone, and tetrahydronaphthalenes produced by Paraphoma radicina, a fungus isolated from a freshwater habitat. Phytochemistry 104:114
Kawahara N, Nakajima S, Satoh Y, Yamakazi M, Kawai K-I (1988) Studies on fungal products XVIII. Isolation and structures of a new fungal depsidone related to nidulin and new phthalide from Emericella unguis. Chem Pharm Bull 36:1970
Liberra K, Jansen R, Lindequist U (1998) Corollosporine, a new phthalide derivative from the marine fungus Corollospora maritima Werderm. 1069. Pharmazie 53:578
Takenaka Y, Morimoto N, Hamada N, Tanahashi T (2011) Phenolic compounds from the cultured mycobionts of Graphis proserpens. Phytochemistry 72:1431
Asakawa Y, Takikawa K, Toyota M, Takemoto T (1982) Novel bibenzyl derivatives and ent-cuparene-type sesquiterpenoids from Radula species. Phytochemistry 21:2481
Asakawa Y, Takikawa K, Tori M, Campbell EO (1986) Isotachin C and balantiolide, two aromatic compounds from the New Zealand liverwort Ballantiopsis rosea. Phytochemistry 25:2543
Asakawa Y, Takikawa K, Tori M (1987) Bibenzyl derivatives from the Australian liverwort Frullania falciloba. Phytochemistry 26:1023
Asakawa Y, Ludwiczuk A, Nagashima F (2013) Chemical constituents of Bryophytes. Bio- and chemical diversity, biological activity, and chemosystematics. In: Kinghorn AD, Falk H, Kobayashi J (eds) Progress in the chemistry of organic natural products, vol 95. Springer, Vienna, 796 p
Kraut L, Mues R, Simsim M (1994) Sesquiterpene lactones and 3-benzylphthalides from Frullania muscicola. Phytochemistry 37:1337
Rycroft DS, Cole WJ, Aslam N, Lamont YM, Gabriel R (1999) Killarniensolide, methyl orsellinates and 9,10-dihydrophenanthrenes from the liverwort Plagiochila killarniensis from Scotland and the Azores. Phytochemistry 50:1167
Heinrichs J, Anton H, Gradstein SR, Mues R, Heirichs J, Anton H, Gradstein SR, Mues R (2000) Systematics of Plagiochila sect. Glaucescentes Carl (Hepaticae) from tropical America: a morphological and chemotaxonomical approach. Plant Syst Evol 220:115
Nagashima F, Toyota M, Asakawa Y (2006) Bazzanane sesquiterpenoids from the New Zealand liverwort Frullania falciloba. Chem Pharm Bull 54:1347
Mitsuhashi H, Nomura M (1966) Studies on the constituents of Umbelliferae plants. XII. Biogenesis of 3-butylphthalide. Chem Pharm Bull 14:777
Kim MR, El-Aty AMA, Kim IS, Shim JH (2006) Determination of volatile flavor components in Danggui cultivars by solvent free injection and hydrodistillation followed by gas chromatographic-mass spectrometric analysis. J Chromatogr A 1116:259
Kim MR, El-Aty AMA, Choi J-H, Lee KB, Shim JH (2006) Identification of volatile components in Angelica species using supercritical-CO2 fluid extraction and solid phase microextraction coupled to gas chromatography-mass spectroscopy. Biomed Chromatogr 20:1267
Dong L, Deng C, Wang B, Shen X (2007) Fast determination of Z-ligustilide in plasma by gas chromatography/mass spectrometry following headspace single-drop microextraction. J Sep Sci 30:1318
León A, Toscano RA, Tortoriello J, Delgado G (2011) Phthalides and other constituents from Ligusticum porteri: sedative and spasmolytic activities of some natural products and derivatives. Nat Prod Res 25:1234
Su S, Cui W, Zhou W, Duan J, Shang E, Tang Y (2013) Chemical fingerprinting and quantitative constituent analysis of siwu decoction categorized formulae by UPLC-QTOF/MS/MS and HPLC-DAD. Chin Med 8:1
Song ZH, Ji ZN, Lo CK, Dong TTX, Zhao KJ, Ll OTW, Haines CJ, Kung SD, Tsim KWK (2004) Chemical and biological assessment of a traditional Chinese herbal decoction prepared from Radix Astragali and Radix Angelica sinensis: orthogonal array design to optimize the extraction of chemical constituents. Planta Med 70:1222
Yang X, Wu X, Guo H (2012) Effect of different solvents on extraction of effective components from Ligusticum chuanxiong. China J Chin Mater Medica 37:1942
Yi T, Leung KS-Y, Lu G-H, Chan K, Zhang H (2006) Simultaneous qualitative and quantitative analyses of the major constituents in the rhizome of Ligusticum chuanxiong using HPLC-DAD-MS. Chem Pharm Bull 54:255
Tang Y, Zhu M, Yu S, Hua Y, Duan JA, Su S, Zhang X, Lu Y, Ding A (2010) Identification and comparative quantification of bio-active phthalides in essential oils from Si-Wu-Tang, Fo-Shou-San, Radix Angelica and Rhizoma Chuanxiong. Molecules 15:341
Dauksas E, Venskutonis PR, Sivik B (1999) Supercritical CO2 extraction of the main constituents of lovage (Levisticum officinale Koch.) essential oil in model systems and overground botanical parts of the plant. J Supercrit Fluids 15:51
Dauksas E, Venskutonis PR, Sivik B, Nillson T (2002) Effect of fast CO2 pressure changes on the yield of lovage (Levisticum officinale Koch.) and celery (Apium graveolens L.) extracts. J Supercrit Fluids 22:201
Teng J, Chen H, Li D, Luo A (2006) Identification and characterization of supercritical fluid extracts of Rhizoma Chuanxiong by high performance liquid chromatography ion trap mass spectrometry. Front Chem China 4:454
Zhang C, Qi M, Shao Q, Zhou S, Fu R (2007) Analysis of the volatile compounds in Ligusticum chuanxiong Hort. using HS-SPME-GC-MS. J Pharm Biomed Anal 44:464
Yansheng C, Zhida Z, Changping L, Qingshan L, Peifang Y, Welz-Biermann U (2011) Microwave-assisted extraction of lactones from Ligusticum chuanxiong Hort. using protic ionic liquids. Green Chem 13:666
Dong ZB, Li SP, Hong M, Zhu Q (2005) Hypothesis of potential active components in Angelica sinensis by using biomembrane extraction and high performance liquid chromatography. J Pharm Biomed Anal 38:664
Lao SC, Li SP, Kan KKW, Li P, Wan JB, Wang YT, Dong TTX, Tsim KWK (2004) Identification and quantification of 13 components in Angelica sinensis (Danggui) by gas chromatography-mass spectrometry coupled with pressurized liquid extraction. Anal Chim Acta 526:131
Li P, Li SP, Lao SC, Fu CM, Kan KKW, Wang YT (2006) Optimization of pressurized liquid extraction for Z-ligustilide, Z-butylidenephthalide and ferulic acid in Angelica sinensis. J Pharm Biomed Anal 40:1073
Xie J-J, Lu J, Qian Z-M, Yu Y, Duan J-A, Li S-P (2009) Optimization and comparison of five methods for extraction of coniferyl ferulate from Angelica sinensis. Molecules 14:555
Liu J-L, Zheng S-L, Fan Q-J, Yuan J-C, Yang S-M, Kong F-L (2014) Optimization of high-pressure ultrasonic-assisted simultaneous extraction of six major constituents from Ligusticum chuanxiong rhizome using response surface methodology. Molecules 19:1887
Zhang Y, Liu C, Qi Y, Li Y, Li S (2015) Development of circulating ultrasonic-assisted online extraction coupled to countercurrent chromatography and centrifugal partition chromatography for simultaneous extraction and isolation of phytochemicals: application to Ligusticum chuanxiong Hort. Ind Eng Chem Res 54:3009
Mitsuhashi H, Nagai U, Muramatsu T, Tashiro H (1960) Studies on the constituents of Umbelliferae plants. II. Isolation of the active principles of Ligusticum root. Chem Pharm Bull 8:243
Momin RA, Nair MG (2001) Mosquitocidal, nematicidal, and antifungal compounds from Apium graveolens L. seeds. J Agric Food Chem 49:142
Chou S-C, Everngam MC, Sturtz G, Beck JJ (2006) Antibacterial activity of components from Lomatium californicum. Phytother Res 20:153
Zhang DL, Teng HL, Li GS, Liu K, Su ZG (2006) Separation and purification of Z-ligustilide and senkyunolide A from Ligusticum chuanxiong Hort. with supercritical fluid extraction and high-speed counter-current chromatography. Sep Sci Technol 41:3397
Wang X, Shi X, Li F, Liu J, Cheng C (2008) Application of analytical and preparative high-speed counter-current chromatography for separation of Z-ligustilide from crude extract of Angelica sinensis. Phytochem Anal 19:193
Wei Y, Huang W, Gu Y (2013) Online isolation and purification of four phthalide compounds from Chuanxiong Rhizoma using high-speed counter-current chromatography coupled with semi-preparative liquid chromatography. J Chromatogr A 1284:53
Kwon JH, Ahn YJ (2002) Acaricidal activity of butylidenephthalide identified in Cnidium officinale rhizome against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae). J Agric Food Chem 50:4479
León A, Chávez MI, Delgado G (2011) 1H and DOSY NMR spectroscopy analysis of Ligusticum porteri rhizome extracts. Magn Reson Chem 49:469
Lang G, Mayhudin NA, Mitova MI, Sun L, Van Der Sar S, Blunt JW, Cole ALJ, Ellis G, Laatsch H, Munro MHG (2008) Evolving trends in the dereplication of natural product extracts: new methodology for rapid, small-scale investigation of natural product extracts. J Nat Prod 71:1595
Zschocke S, Liu JH (1998) Comparative study of roots of Angelica sinensis and related Umbelliferous drugs by thin layer chromatography, high‐performance liquid chromatography, and liquid chromatography-mass spectrometry. Phytochem Anal 9:283
Zschocke S, Klaiber I, Bauer R, Vogler B (2005) HPLC-coupled spectroscopic techniques (UV, MS, NMR) for the structure elucidation of phthalides in Ligusticum chuanxiong. Mol Divers 9:33
Beauchamp PS, Bottini AT, Dev V, Melkani AB, Timbrook J (1993) Analysis of the essential oil from Lomatium californicum (Nutt.) Math. and Const. Dev Food Sci 32:605
Lu G-H, Chan K, Liang Y-Z, Leung K, Chan C-L, Jiang Z-H, Zhao Z-Z (2005) Development of high-performance liquid chromatographic fingerprints for distinguishing Chinese Angelica from related Umbelliferae herbs. J Chromatogr A 1073:383
Lu GH, Chan K, Chan CL, Leung K, Jiang ZH, Zhao ZZ (2004) Quantification of ligustilides in the roots of Angelica sinensis and related umbelliferous medicinal plants by high-performance liquid chromatography and liquid chromatography-mass spectrometry. J Chromatogr A 1046:101
Yang B, Chen J, Lee FS-C, Wang X (2008) GC-MS fingerprints for discrimination of Ligusticum chuanxiong from Angelica. J Sep Sci 31:3231
Yi T, Leung KS-Y, Lu G-H, Zhang H, Chan K (2005) Identification and comparative determination of senkyunolide A in traditional Chinese medicinal plants Ligusticum chuanxiong and Angelica sinensis by HPLC coupled with DAD and ESI-MS. Chem Pharm Bull 53:1480
Rivero I, Juárez K, Zuluaga M (2012) Quantitative HPLC method for determining two of the major active phthalides from Ligusticum porteri roots. J AOAC Int 95:84
Li S-L, Yan R, Tam Y-K, Lin G (2007) Post-harvest alteration of the main chemical ingredients in Ligusticum chuanxiong Hort. (Rhizoma Chuanxiong). Chem. Pharm Bull 55:140
Qin HL, Deng AJ, Du GH, Wang P, Zhang JL, Li ZH (2009) Fingerprinting analysis of Rhizoma Chuanxiong of commercial types using H-1 nuclear magnetic resonance spectroscopy and high performance liquid chromatography method. J Integr Plant Biol 51:537
Morris KF, Johnson CS (1992) Diffusion-ordered two-dimensional nuclear magnetic resonance spectroscopy. J Am Chem Soc 114:3139
Morris KF, Johnson CS (1993) Resolution of discrete and continuous molecular size distributions by means of diffusion-ordered 2D NMR spectroscopy. J Am Chem Soc 115:4291
Birch AJ, English RJ, Massy-Westropp RA, Slaytor M, Smith H (1958) Studies in relation to biosynthesis. Part XIV. The origin of nuclear methyl groups in mycophenolic acid. J Chem Soc 365
Birch AJ, Wright JJ (1969) A total synthesis of mycophenolic acid. Aust J Chem 22:2635
Canonica L, Kroszczynski W, Ranzi BM, Rindone B, Santaniello E, Scolastico C (1972) Biosynthesis of mycophenolic acid. J Chem Soc Perkin Trans 1:2639
Bedford CT, Knitell P, Money T, Phillips GT, Salisbury P (1973) Biosynthesis of mycophenolic acid. Can J Chem 51:694
Bentley R (2000) Mycophenolic acid: a one hundred year odyssey from antibiotic to immunosuppressant. Chem Rev 100:3801
Regueira TB, Kildegaard KR, Hansen BG, Mortensen UH, Hertweck C, Nielsen J (2011) Molecular basis for mycophenolic acid biosynthesis in Penicillium brevicompactum. Appl Environ Microbiol 77:3035
Ogawa Y, Mori Y, Maruno M, Wakamatsu T (1997) Diels-Alder reaction of ligustilide giving levistolide A and tokinolide B. Heterocycles 45:1869
Rios MY, Delgado G, Toscano RA (1998) Chemical reactivity of phthalides. Relay synthesis of diligustilide, rel-(3′R)-3′,8′-dihydrodiligustilide and wallichilide. Tetrahedron 54:3355
Lager E, Sundin A, Toscano RA, Delgado G, Sterner O (2007) Diels-Alder adducts derived from the natural phthalide Z-ligustilide. Tetrahedron Lett 48:4215
Rios MY, Delgado G (1999) Lewis acid catalyzed transformations of Z-ligustilide. J Mex Chem Soc 43:127
Schinkovitz A, Pro SM, Main M, Chen SN, Jaki BU, Lankin DC, Pauli GF (2008) Dynamic nature of the ligustilide complex. J Nat Prod 71:1604
Cui F, Feng L, Hu J (2006) Factors affecting stability of Z-ligustilide in the volatile oil of Radix Angelica sinensis and Ligusticum chuanxiong and its stability prediction. Drug Dev Ind Pharm 32:747
Zhan JY-X, Zhang WL, Zheng KY-Z, Zhu KY, Chen J-P, Chan P-H, Dong TT-X, Choi RC-Y, Lam H, Tsim KW-K, Lau DT-W (2013) Chemical changes of Angelica sinensis Radix and Chuanxiong Rhizoma by wine treatment: chemical profiling and marker selection by gas chromatography coupled with triple quadrupole mass spectrometry. Chin Med 8:12
Zuo A-H, Cheng M-C, Zhuo R-J, Wang L, Xiao H-B (2013) Structure elucidation of degradation products of Z-ligustilide by UPLC-QTOF-MS and NMR spectroscopy. Acta Pharm Sin 48:911
Kobayashi M, Fujita M, Mitsuhashi H (1987) Studies on the constituents of Umbelliferae plants. XV. Constituents of Cnidium officinale: occurrence of pregnenolone, coniferyl ferulate and hydroxyphthalides. Chem Pharm Bull 35:1427
Cimmino A, Andolfi A, Avolio F, Ali A, Tabanca N, Khan IA, Evidente A (2013) Cyclopaldic acid, seiridin, and sphaeropsidin A as fungal phytotoxins, and larvicidal and biting deterrents against Aedes aegypti (Diptera: Culicidae): structure-activity relationships. Chem Biodivers 10:1239
Nelson PH, Carr SF, Devens BH, Eugui EM, Franco F, Gonzalez C, Hawley RC, Loughhead DG, Milan DJ, Papp E, Patterson JW, Rouhafza S, Sjogren EB, Smith DB, Stephenson RA, Talamas FX, Waltos AM, Weikert RJ, Wu JC (1996) Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase by nuclear variants of mycophenolic acid. J Med Chem 39:4181
Rios MY, Delgado G, Espinosa-Pérez G (1998) Base-catalyzed intramolecular condensations of diligustilide. Tetrahedron Lett 39:6605
Quiroz-García B, Hernández-Ortega S, Sterner O, Delgado G (2004) Transformations of the natural dimeric phthalide diligustilide. Tetrahedron 60:3681
Quiroz-García B, Hernández L, Toscano RA, Sterner O, Delgado G (2003) Base-catalyzed intramolecular condensation of tokinolide B. Tetrahedron Lett 44:2509
León A, Cogordán JA, Sterner O, Delgado G (2012) Enantiomeric derivatives of tokinolide B: absolute configuration and biological properties. J Nat Prod 75:859
León A, Delgado G (2012) Diligustilide: enantiomeric derivatives, absolute configuration and cytotoxic properties. J Mex Chem Soc 56:222
Kitayama T (1997) Microbial asymmetric syntheses of 3-alkylphthalide derivatives. Tetrahedron Asymmetry 8:3765
He L, Sun J, Xu Y, Sun Z, Zheng C (2008) Novozyme 435-catalyzed efficient acylation of 3-n-butylphthalide in organic medium. Prep Biochem Biotechnol 38:376
He L, Sun J, Xu Y, Sun ZH (2008) A novel method to resolve (R,S)-3-n-butylphthalide catalyzed by Novozyme 435 in microaqueous medium. Process Biochem 43:1215
He L, Li C, Gao B (2009) Novozyme 435-catalyzed asymmetric acylation of (R,S)-3-n-butylphthalide in hexane. Prep Biochem Biotechnol 39:266
Li C, He L, Qiu B, Gao B (2010) An efficient system for the asymmetric acylation of (R,S)-3-n-butylphthalide catalyzed by Novozyme 435. Prep Biochem Biotechnol 40:354
Jekkel A, Barta I, Kónya A, Süto J, Boros S, Horváth G, Ambrus G (2001) Microbiological transformation of mycophenolic acid. J Mol Catal B Enzym 11:423
Jekkel A, Barta I, Boros S, Suto J, Horváth G, Szabó Z, Ambrus G (2002) Microbial transformation of mycophenolic acid. Part II. J Mol Catal B Enzym 19–20:209
Jones DF, Moore RH, Crawley GC (1970) Microbial modification of mycophenolic acid. J Chem Soc C 1725
Herath WHMW, Ferreira D, Khan IA (2003) Microbial transformation of the phthalideisoquinoline alkaloid, beta-hydrastine. Nat Prod Res 17:269
Nasini G, Bava A, Fronza G, Giannini G (2007) Microbial transformation of spirolaxine, a bioactive undecaketide fungal metabolite from the Basidiomycete Sporotrichum laxum. Chem Biodivers 4:2772
Bava A, Nasini G, Fronza G (2012) Biotransformation of spirolaxine by Absidia cuneospora and Trametes hirsuta: formation of β-glycosyl and β-xylosyl derivatives. J Mol Catal B Enzym 82:59
Mali RS, Babu KN (1998) Naturally occurring prenylated phthalides: first total synthesis of salfredin B11. J Chem Res 292
Alder K, Rickert HF (1936) Zur Kenntnis der Dien-synthese. I. Über eine Methode der Direkten Unterscheidung Cyclischer Penta- und Hexa-diene. Justus Liebigs Ann Chem 524:180
Patterson JW (1993) The synthesis of mycophenolic acid. Tetrahedron 49:4789
Brookes PA, Cordes J, White AJP, Barrett AGM (2013) Total synthesis of mycophenolic acid by a palladium-catalyzed decarboxylative allylation and biomimetic aromatization sequence. Eur J Org Chem 32:7313–7319
Hariprakasha HK, Subba Rao GSR (1998) Synthesis based on cyclohexadienes. Part 26. Total synthesis of some naturally occurring phthalides from Alternaria species. Indian J Chem B 37:851
Katoh N, Nakahata T, Kuwahara S (2008) Synthesis of novel antifungal phthalides produced by a wheat rhizosphere fungus. Tetrahedron 64:9073
Mal D, Pahari P, De SR (2007) Regiospecific synthesis of 3-(2,6-dihydroxyphenyl) phthalides: application to the synthesis of isopestacin and cryphonectric acid. Tetrahedron 63:11781
Ohzeki T, Mori K (2001) Synthesis of corollosporine, an antibacterial metabolite of the marine fungus Corollospora maritima. Biosci Biotechnol Biochem 65:172
Paradkar MV, Kulkarni A, Joseph AR, Ranade AA (2000) An efficient synthesis of dimethoxyphthalides. J Chem Res:364
Talapatra B, Roy MK, Talapatra SK (1983) Syntheses of methyl ether of anaphatol and three other natural phthalides. J Indian Chem Soc 60:1169
Bellina F, Ciucci D, Vergamini P, Rossi R (2000) Regioselective synthesis of natural and unnatural (Z)-3-(1-alkylidene) phthalides and 3-substituted isocoumarins starting from methyl 2-hydroxybenzoates. Tetrahedron 56:2533
Kanazawa C, Terada M (2007) Organic-base-catalyzed synthesis of phthalides via highly regioselective intramolecular cyclization reaction. Tetrahedron Lett 48:933
Kuethe JT, Maloney KM (2013) A concise synthesis of 3,4-fused spiro[isobenzofuran-3-ones], spiro[furo[3,4-b]pyridin-5(7H)-ones], 3-aryl-, and alkylphthalides. Tetrahedron 69:5248
Mondal M, Argade NP (2004) DBU-induced phenol-keto resonance in 3,5-dihydroxyphthalide: regioselectivities in condensations with α, β-unsaturated aldehydes - facile synthesis of bioactive natural and unnatural benzopyrans. Synlett 7:1243
Ogawa Y, Maruno M, Wakamatsu T (1994) Efficient synthesis of hydroxyphthalides. Heterocycles 1:47
Li S, Wang Z, Fang X, Li Y (1993) Synthesis of (Z)-ligustilide. Synth Commun 23:2909
Kobayashi K, Shimizu H, Itoh M, Sugimone H (1990) An efficient synthesis of 5,7-dihydroxy-4-methylisobenzofuran-1(3H)-one, a metabolite of Aspergillus flavus and a key intermediate in the synthesis of mycophenolic acid. Bull Chem Soc Jpn 63:2435
Asaoka M, Miyake K, Takei H (1977) Synthesis of 7-hydroxyphthalides starting from unsaturated lactones via 2-trialkylsiloxyfurans. Chem Lett:167
Allison WR, Newbold GT (1959) Lactones. Part VI. The preparation of 5,7-dihydroxyphthalide, its methyl ether and related compounds. J Chem Soc:3335
Canonica L, Rindone B, Santaniello E, Scolastico C (1972) A total synthesis of mycophenolic acid, some analogues and some biogenetic intermediates. Tetrahedron 28:4395
Mali RS, Patil SR (1990) Synthesis of 3-butylidene-7-hydroxyphthalide. Synth Commun 20:167
Petrignet J, Inack Ngi S, Abarbri M, Thibonnet J (2014) Short and convenient synthesis of two natural phthalides by a copper(I) catalysed Sonogashira/oxacyclisation copper(I) process. Tetrahedron Lett 55:982
Ohzeki T, Mori K (2003) Synthesis and absolute configuration of (-)-3-butyl-7-hydroxyphthalide, a cytotoxic metabolite of Penicillium vulpinum. Biosci Biotechnol Biochem 67:2240
Jimenez R, Maldonado LA, Salgado-Zamora H (2010) Synthesis of demethylated nidulol via an intramolecular Michael reaction. Nat Prod Res 24:1274
Reddy RS, Kiran INC, Sudalai A (2012) CN-assisted oxidative cyclization of cyano cinnamates and styrene derivatives: a facile entry to 3-substituted chiral phthalides. Org Biomol Chem 10:3655
Schwaben J, Cordes J, Harms K, Koert U (2011) Total syntheses of (+)-pestaphthalide A and (-)-pestaphthalide B. Synthesis 18:2929
Oguro D, Watanabe H (2011) Asymmetric synthesis and sensory evaluation of sedanenolide. Biosci Biotechnol Biochem 75:1502
Pedrosa R, Sayalero S, Vicente M (2006) A direct efficient diastereoselective synthesis of enantiopure 3-substituted-isobenzofuranones. Tetrahedron 62:10400
Choi PJ, Sperry J, Brimble MA (2010) Heteroatom-directed reverse Wacker oxidations. Synthesis of the reported structure of (-)-herbaric acid. J Org Chem 75:7388
Kitahara T, Uchida K, Watanabe H, Usui T, Osada H (1998) Syntheses and bioactivities of acetophthalidin and its derivatives. Heterocycles 48:2649
Lin L, He X, Lian L, King W, Elliott J (1998) Liquid chromatographic-electrospray mass spectrometric study of the phthalides of Angelica sinensis and chemical changes of Z-ligustilide. J Chromatogr A 810:71
Quiroz-García B, Figueroa R, Cogordan JA, Delgado G (2005) Photocyclodimers from (Z)-ligustilide. Experimental results and FMO analysis. Tetrahedron Lett 46:3003
Fang L, Xiao X, Liu C, He X (2012) Recent advance in studies on Angelica sinensis. Chin Herb Med 4:12
Sowbhagya HB (2014) Chemistry, technology and nutraceutical function of celery (Apium graveolens L.): an overview. Crit Rev Food Sci Nutr 54:389
Chen XP, Li W, Xiao XF, Zhang LL, Liu CX (2013) Phytochemical and pharmacological studies on radix Angelica sinensis. Chin J Nat Med 11:577
Yang J, Chen H, Wu J, Gong S (2012) Advances in studies on pharmacological functions of ligustilide and their mechanisms. Chin Herb Med 4:26
Chen X, Dang TT, Facchini PJ (2015) Noscapine comes of age. Phytochemistry 111:7
Neerupma D, Ankur S, Archana S (2013) Noscapine: an anti-mitotic agent. World J Pharm Pharm Sci 3:324
DeBono A, Capuano B, Scammells PJ (2015) Progress toward the development of noscapine and derivatives as anticancer agents. J Med Chem 58:5699
Tripathi M, Reddy PL, Rawat DS (2014) Noscapine and its analogues as anti-cancer agents. Chem Biol Interface 4:1
Li W, Wu Y, Liu X, Yan C, Liu D, Pan Y, Yang G, Yin F, Weng Z, Zhao D, Chen Z, Cai B (2013) Antioxidant properties of cis-(Z,Z′)-3a.7a′,7a.3a′-dihydroxy-ligustilide on human umbilical vein endothelial cells in vitro. Molecules 18:520
Dietz BM, Liu D, Hagos GK, Yao P, Schinkovitz A, Pro SM, Deng S, Farnsworth NR, Pauli GF, van Breemen RB, Bolton JL (2008) Angelica sinensis and its alkylphthalides induce the detoxification enzyme NAD(P)H:quinone oxidoreductase 1 by alkylating Keap1. Chem Res Toxicol 21:1939
Qi H, Siu SO, Chen Y, Han Y, Chu IK, Tong Y, Lau ASY, Rong J (2010) Senkyunolides reduce hydrogen peroxide-induced oxidative damage in human liver HepG2 cells via induction of heme oxygenase-1. Chem Biol Interact 183:380
Du J, Yu Y, Ke Y, Wang C, Zhu L, Qian ZM (2007) Ligustilide attenuates pain behavior induced by acetic acid or formalin. J Ethnopharmacol 112:211
Lin Q, Zhao AG, Chen JN, Lai XP, Gui SH, Fang CP (2011) Anti-inflammatory and analgesic effects of ligustilide. Chin J Exp Med Formulae 17:165
Juárez-Reyes K, Ángeles-López GE, Rivero-Cruz I, Bye R, Mata R (2014) Antinociceptive activity of Ligusticum porteri preparations and compounds. Pharm Biol 52:14
Brindis F, Rodríguez R, Bye R, González-Andrade M, Mata R (2011) (Z)-3-Butylidenephthalide from Ligusticum porteri, an α-glucosidase inhibitor. J Nat Prod 74:314
Xiao B, Yin J, Park M, Liu J, Li JL, La Kim E, Hong J, Chung HY, Jung JH (2012) Design and synthesis of marine fungal phthalide derivatives as PPAR-gamma agonists. Bioorg Med Chem 20:4954
Zhang L, Du J-R, Wang J, Yu D-K, Chen Y-S, He Y, Wang C-Y (2009) Z-Ligustilide extracted from Radix Angelica sinensis decreased platelet aggregation induced by ADP ex vivo and arterio-venous shunt thrombosis in vivo in rats. Yakugaku Zasshi 129:855
Teng CM, Chen WY, Ko WC, Ouyang CH (1987) Antiplatelet effect of butylidenephthalide. Biochim Biophys Acta 924:375
Xu H, Feng Y (2001) Effects of 3-n-butylphthalide on thrombosis formation and platelet function in rats. Acta Pharm Sin 36:329
Naito T, Kubota K, Shimoda Y, Sato T, Ikeya Y, Okada M, Maruno M (1995) Effects of constituents of Chinese crude drug, Ligustici Chuanxiong Rhizoma, on vasoconstriction and blood viscosity. Nat Med 49:288
Or TCT, Yang CLH, Law AHY, Li JCB, Lau ASY (2011) Isolation and identification of anti-inflammatory constituents from Ligusticum chuanxiong and their underlying mechanisms of action on microglia. Neuropharmacology 60:823
Peng H-Y, Du J-R, Zhang G-Y, Kuang X, Liu Y-X, Qian Z-M, Wang C-Y (2007) Neuroprotective effect of (Z)-ligustilide against permanent focal ischemic damage in rats. Biol Pharm Bull 30:309
Kuang X, Yao Y, Du JR, Liu YX, Wang CY, Qian ZM (2006) Neuroprotective role of (Z)-ligustilide against forebrain ischemic injury in ICR mice. Brain Res 1102:145
Wu XM, Qian ZM, Zhu L, Du F, Yung WH, Gong Q, Ke Y (2011) Neuroprotective effect of ligustilide against ischaemia-reperfusion injury via up-regulation of erythropoietin and down-regulation of RTP801. Br J Pharmacol 164:332
Qi H, Han Y, Rong J (2012) Potential roles of PI3K/Akt and Nrf2-Keap1 pathways in regulating hormesis of (Z)-ligustilide in PC12 cells against oxygen and glucose deprivation. Neuropharmacology 62:1659
Peng B, Zhao P, Lu YP, Chen MM, Sun H, Wu XM, Zhu L (2013) Z-Ligustilide activates the Nrf2/HO-1 pathway and protects against cerebral ischemia-reperfusion injury in vivo and in vitro. Brain Res 1520:168
Mahmoudian M, Mehrpour M, Benaissa F, Siadatpour Z (2003) A preliminary report on the application of noscapine in the treatment of stroke. Eur J Clin Pharmacol 59:579
Chen D, Tang J, Khatibi NH, Zhu M, Li Y, Wang C, Jiang R, Tu L, Wang S (2011) Treatment with Z-ligustilide, a component of Angelica sinensis, reduces brain injury after a subarachnoid hemorrhage in rats. J Pharmacol Exp Ther 337:663
Kuang X, Du JR, Liu YX, Zhang GY, Peng HY (2008) Postischemic administration of (Z)-ligustilide ameliorates cognitive dysfunction and brain damage induced by permanent forebrain ischemia in rats. Pharmacol Biochem Behav 88:213
Ho CC, Kumaran A, Hwang LS (2009) Bio-assay guided isolation and identification of anti-Alzheimer active compounds from the root of Angelica sinensis. Food Chem 114:246
Kuang X, Du JR, Chen YS, Wang J, Wang YN (2009) Protective effect of (Z)-ligustilide against amyloid B-induced neurotoxicity is associated with decreased pro-inflammatory markers in rat brains. Pharmacol Biochem Behav 92:635
Cheng LL, Chen XN, Wang Y, Yu L, Kuang X, Wang LL, Yang W, Du JR (2011) Z-Ligustilide isolated from Radix Angelica sinensis ameliorates the memory impairment induced by scopolamine in mice. Fitoterapia 82:1128
Li J-J, Zhu Q, Lu Y-P, Zhao P, Feng Z-B, Qian Z-M, Zhu L (2015) Ligustilide prevents cognitive impairment and attenuates neurotoxicity in d-galactose induced aging mice brain. Brain Res 1595:19
Qi H, Zhao J, Han Y, Lau ASY, Rong J (2012) Z-Ligustilide potentiates the cytotoxicity of dopamine in rat dopaminergic PC12 cells. Neurotoxic Res 22:345
Matsumoto K, Kohno S, Ojima K, Tezuka Y, Kadota S, Watanabe H (1998) Effects of methylene chloride-soluble fraction of Japanese Angelica root extract, ligustilide and butylidenephthalide, on pentobarbital sleep in group-housed and socially isolated mice. Life Sci 62:2073
Bjeldanes LF, Kim I-S (1978) Sedative activity of celery oil constituents. J Food Sci 43:143
Straughan DW, Neal MJ, Simmonds MA, Collins GG, Hill RG (1971) Evaluation of bicuculline as a GABA antagonist. Nature 233:352
Curtis DR, Duggan AW, Felix D, Johnston GAR (1970) GABA-[aminobutyric acid], bicuculline, and central inhibition. Nature 226:1222
Huang JH, Johnston GA (1990) (+)-Hydrastine, a potent competitive antagonist at mammalian GABAA receptors. Br J Pharmacol 99:727
Branco C dos S, Scola G, Rodrigues AD, Cesio V, Laprovitera M, Heinzen H, Telles MDS, Fank B, de Freitas SCV, Coitinho AS, Salvador M (2013) Anticonvulsant, neuroprotective and behavioral effects of organic and conventional yerba mate (Ilex paraguariensis St. Hil.) on pentylenetetrazol-induced seizures in Wistar rats. Brain Res Bull 92:60
Sadek B, Kuder K, Subramanian D, Shafiullah M, Stark H, Lazewska D, Adem A, Kiec-Kononowicz K (2014) Anticonvulsive effect of nonimidazole histamine H3 receptor antagonists. Behav Pharmacol 25:245
Yu S, You S (1984) Anticonvulsant effect of 3-n-butylphthalide and 3-n-butyl-4,5-dihydrophthalide. Acta Pharm Sin 19:566
Yang J, Chen Y (1984) Isolation and identification of anticonvulsive constituents of Apium graveolens. Chin Pharm Bull 19:670
Yu SR, Gao NN, Li LL, Wang ZY, Chen Y, Wang WN (1988) The anticonvulsant effect of 3-butylphthalide in rats. Acta Pharm Sin 23:656
Yu S, Gao N, Li L, Wang Z, Chen Y, Wang W (1988) Facilitated performance of learning and memory in rats by 3-n-butylphthalide. Zhongguo Yaoli Xuebao 9:385
Dong G, Feng Y (1999) Anticonvulsant effects of 3-n-butylphthalide and its optical isomers. Chin Pharmacol Bull 15:88
Lee TF, Lin YL, Huang YT (2007) Studies on antiproliferative effects of phthalides from Ligusticum chuanxiong in hepatic stellate cells. Planta Med 73:527
Aneja R, Dhiman N, Idnani J, Awasthi A, Arora SK, Chandra R, Joshi HC (2007) Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent. Cancer Chemother Pharmacol 60:831
Yang Z-R, Liu M, Peng X-L, Lei X-F, Zhang J-X, Dong W-G (2012) Noscapine induces mitochondria-mediated apoptosis in human colon cancer cells in vivo and in vitro. Biochem Biophys Res Commun 421:627
Landen JW, Lang R, McMahon SJ, Rusan NM, Yvon A, Adams AW, Sorcinelli MD, Campbell R, Bonaccorsi P, Ansel JC, Archer DR, Wadsworth P, Armstrong CA, Joshi HC (2002) Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma. Cancer Res 62:4109
Zhou J, Panda D, Landen JW, Wilson L, Joshi HC (2002) Minor alteration of microtubule dynamics causes loss of tension across kinetochore pairs and activates the spindle checkpoint. J Biol Chem 277:17200
Ye K, Ke Y, Keshava N, Shanks J, Kapp JA, Tekmal RR, Petros J, Joshi HC (1998) Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells. Proc Natl Acad Sci USA 95:1601
Momin RA, Nair MG (2002) Antioxidant, cyclooxygenase and topoisomerase inhibitory compounds from Apium graveolens Linn. seeds. Phytomedicine 9:312
Kan WLT, Cho CH, Rudd JA, Lin G (2008) Study of the anti-proliferative effects and synergy of phthalides from Angelica sinensis on colon cancer cells. J Ethnopharmacol 120:36
Tsai NM, Chen YL, Lee CC, Lin PC, Cheng YL, Chang WL, Lin SZ, Harn HJ (2006) The natural compound n-butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo. J Neurochem 99:1251
Guo H, Li Z-H, Feng T, Liu J-K (2014) One new ergostane-type steroid and three new phthalide derivatives from cultures of the basidiomycete Albatrellus confluens. J Asian Nat Prod Res 17:107
Huang F, Li SJ, Lu XH, Liu AL, Du GH, Shi GG (2011) Two glutathione S-transferase inhibitors from Radix Angelica sinensis. Phytother Res 25:284
Kobayashi S, Mimura Y, Notoya K, Kimura I, Kimura M (1992) Antiproliferative effects of the traditional Chinese medicine Shimotsu-to, its component Cnidium Rhizome and derived compounds on primary cultures of mouse aorta smooth muscle cells. Jpn J Pharmacol 60:397
Kobayashi S, Mimura Y, Naitoh T, Kimura I, Kimura M (1993) Chemical structure-activity of Cnidium Rhizoma-derived phthalides for the competence inhibition of proliferation in primary cultures of mouse aorta smooth muscle cells. Jpn J Pharmacol 63:353
Lu Q, Qiu T-Q, Yang H (2006) Ligustilide inhibits vascular smooth muscle cells proliferation. Eur J Pharmacol 542:136
Liang MJ, He LC (2006) Inhibitory effects of ligustilide and butylidenephthalide on bFGF-stimulated proliferation of rat smooth muscle cells. Acta Pharm Sin 41:161
Yang P, Zhang W, Rui Y (2004) Use of ligustilide for prevention and treatment of atherosclerosis. Chin Pat 1543859
Miyazawa M, Tsukamoto T, Anzai J, Ishikawa Y (2004) Insecticidal effect of phthalides and furanocoumarins from Angelica acutiloba against Drosophila melanogaster. J Agric Food Chem 52:4401
Wedge DE, Klun JA, Tabanca N, Demirci B, Ozek T, Baser KHC, Liu Z, Zhang S, Cantrell CL, Zhang J (2009) Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity. J Agric Food Chem 57:464
Chae SH, Kim S Il, Yeon SH, Lee SW, Ahn YJ (2011) Adulticidal activity of phthalides identified in Cnidium officinale rhizome to B- and Q-biotypes of Bemisia tabaci. J Agric Food Chem 59:8193
Noto T, Sawada M, Ando K, Koyama K (1969) Some biological properties of mycophenolic acid. J Antibiot 22:165
Abraham EP (1945) The effect of mycophenolic acid on the growth of Staphylococcus aureus in heart broth. Biochem J 39:398
Jones EL, Epinette WW, Hackney VC, Menendez L, Frost P (1975) Treatment of psoriasis with oral mycophenolic acid. J Invest Dermatol 65:537
Hodge EE (1996) The role of mycophenolate mofetil in clinical renal transplantation. World J Urol 14:249
Staatz CE, Tett SE (2007) Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet 46:13
Van Gelder T, Hesselink DA (2015) Mycophenolate revisited. Transpl Int 28:508
Cégiéla-Carlioz P, Bessière JM, David B, Mariotte AM, Gibbons S, Dijoux-Franca MG (2005) Modulation of multi-drug resistance (MDR) in Staphylococcus aureus by Osha (Ligusticum porteri L., Apiaceae) essential oil compounds. Flavour Fragr J 20:671
Radcliff FJ, Fraser JD, Wilson ZE, Heapy AM, Robinson JE, Bryant CJ, Flowers CL, Brimble MA (2008) Anti-Helicobacter pylori activity of derivatives of the phthalide-containing antibacterial agents spirolaxine methyl ether, CJ-12,954, CJ-13,013, CJ-13,102, CJ-13,104, CJ-13,108, and CJ-13,015. Bioorg Med Chem 16:6179
Awaad AS, El-Meligy RM, Soliman GA (2013) Natural products in treatment of ulcerative colitis and peptic ulcer. J Saudi Chem Soc 17:101
Guzman JD, Evangelopoulos D, Gupta A, Prieto JM, Gibbons S, Bhakta S (2013) Antimycobacterials from lovage root (Ligusticum officinale Koch). Phytother Res 27:993
Qin XD, Dong ZJ, Liu JK, Yang LM, Wang RR, Zheng YT, Lu Y, Wu YS, Zheng QT (2006) Concentricolide, an anti-HIV agent from the ascomycete Daldinia concentrica. Helv Chim Acta 89:127
Azuma M, Yoshida M, Horinouchi S, Beppu T (1990) Basidifferquinone, a new inducer for fruiting-body formation of a Basidiomycetes Favolus arcularius from a Streptomyces strain I. Screening and isolation. Agric Biol Chem 54:1441
Azuma M, Yoshida M, Horinouchi S, Beppu T (1993) Basidifferquinone analogues, basidifferquinone B and C, which induce fruiting-body formation of a basidiomycete, Favolus arcularius. Biosci Biotechnol Biochem 57:344
Sekiya K, Tezuka Y, Tanaka K, Prasain JK, Namba T, Katayama K, Koizumi T, Maeda M, Kondo T, Kadota S (2000) Distribution, metabolism and excretion of butylidenephthalide of Ligustici Chuanxiong Rhizoma in hairless mouse after dermal application. J Ethnopharmacol 71:401
Yan R, Nga LK, Li SL, Yun KT, Lin G (2008) Pharmacokinetics and metabolism of ligustilide, a major bioactive component in Rhizoma Chuanxiong, in the rat. Drug Metab Dispos 36:400
Ding C, Sheng Y, Zhang Y, Zhang J, Du C (2008) Identification and comparison of metabolites after oral administration of essential oil of Ligusticum chuanxiong or its major constituent ligustilide in rats. Planta Med 74:1684
Guo J, Duan JA, Shang EX, Tang Y, Qian D (2009) Determination of ligustilide in rat brain after nasal administration of essential oil from Rhizoma Chuanxiong. Fitoterapia 80:168
Ma Z, Bai L (2013) Anti-inflammatory effects of Z-ligustilide nanoemulsion. Inflammation 36:294
Lu Y, Liu S, Zhao Y, Zhu L, Yu S (2014) Complexation of Z-ligustilide with hydroxypropyl-β-cyclodextrin to improve stability and oral bioavailability. Acta Pharm 64:211
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
León, A., Del-Ángel, M., Ávila, J.L., Delgado, G. (2017). Phthalides: Distribution in Nature, Chemical Reactivity, Synthesis, and Biological Activity. In: Kinghorn, A.D., Falk, H., Gibbons, S., Kobayashi, J. (eds) Progress in the Chemistry of Organic Natural Products. Progress in the Chemistry of Organic Natural Products, vol 104. Springer, Cham. https://doi.org/10.1007/978-3-319-45618-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-45618-8_2
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45616-4
Online ISBN: 978-3-319-45618-8
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)